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2Abstract
An efficient DNA damage response is critical for maintaining the integrity
of the mammalian genome, and ensuring the accurate transfer of genetic
information between generations. Of particular biological relevance are
DNA double strand breaks (DSB), which if repaired incorrectly may
contribute to carcinogenesis.
Review of contemporary literature has led to the identification of protein
interactions and transcriptional events, tightly associated with the
mammalian DSB response. Characteristics of selected events have been
manipulated, with the notion of developing a reporter system that offers a
sensitive and rapid method of detecting DSB in living mammalian cell
models. Work presented here provides a quantitative evaluation of DSB
generation in various mammalian cell lines, following chemical and
irradiation treatment, and highlights the limitations of currently used
markers.
A series of recombinant proteins comprising peptide interacting domains,
which exhibit altered spatio-temporal dynamics in relation with each other
following DSB induction, are proposed as potential reporters of damage
in mammalian cells. Novel gene constructs have been engineered that
encode these peptide interacting domains, sandwiched between
fluorescence-resonance-energy transfer (FRET) capable proteins. DSB
specific events are predicted to induce peptide interactions that may be
tracked in real time, by monitoring alterations in the fluorescent properties
of such a recombinant protein.
In an alternative approach, the transcriptional up-regulation of RAD52
mRNA following DSB induction was extended to whole cells. Optimisation
of a fluorescent molecular beacon probe complementary to mammalian
RAD52 mRNA is described, and data obtained in mammalian cells
following DSB induction supports the notion that RAD52 is actively
transcribed as part of the DSB response.
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Abbreviation Definition
53BP1 p53 binding protein 1
µM Micro-molar
Amp Ampicillin
ANOVA Analysis of variance
ATM Ataxia-telangiectasia mutated protein
ATR Ataxia-telangiectasia mutated and Rad3-related protein
ATRIP ATR interacting protein
BCA Bicinchoninic acid
BER Base excision repair
BLM Bloom syndrome protein
bp Base pair
BRCA1/2 Breast cancer gene 1/2
BRCT BRCA1 carboxyl terminus (domain)
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cDNA Complementary deoxyribonucleic acid
c/g/yfp cyano/green/yellow-fluorescent protein
CHK1/2 Checkpoint kinase protein1/2 protein
CHO Chinese hamster ovary cells
CLP Cryptolepine
CO2 Carbon dioxide
dH20 Deionised water
DMSO Dimethyl Sulphoxide
DNA Deoxyribonucleic acid
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DNA PKcs DNA Phosphate kinase catalytic subunit
dNTP Deoxynucleotide Triphosphate
DSB Double strand break
DTT Dithiothreitol
ECVAM European Centre for Validation of Alternative Methods
EDTA Ethylenediaminetetraacetic acid
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FACS Fluorescent activated cell sorter
FAM 6-carboxyfluorescein
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GLP Good Laboratory Practice
Gy Gray (with reference to irradiation)
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IR Irradiation
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MBGW Molecular biology grade water
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MDC1 Mediator of damage checkpoint protein 1
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MMS Methyl methanesulphonate
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Abbreviation Definition
MN Micronucleus /micronuclei
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MRN MRE11-RAD50-NBS1 complex
mRNA Messenger ribonucleic acid
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n Number (in reference to statistical analysis)
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nM Nano-molar
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PBS Phosphate buffered saline
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pM Pico-molar
Poly-L   Poly-lysine
PP2A Protein phosphatase 2A
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Abbreviation Definition
SDS Sodium dodecyl sulfate
SEM Standard error of the mean
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TA Annealing temperature
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1 Introduction
Intricate communication between biochemical pathways is crucial to
ensure aged or damaged cells are replaced in a controlled manner, and
that cell cycle arrest occurs only when necessary. The rate of cellular
proliferation is dictated in part by DNA replication, which is affected by
physiological and external factors. As such, mammalian cells have
evolved the capacity to identify aberrant cellular function, and to
transduce this signal into an appropriate response. If a cell accumulates
excessive DNA damage or is unable to restore the integrity of DNA, a cell
may enter programmed cell death (apoptosis) or dormancy (senescence).
Alternatively cells may enter a transformed (pre-cancerous) state, which
is characterised by excessive, unregulated proliferation.
1.1 Risk Assessment
Novel entities with the potential for human exposure, such as
pharmaceutical drugs, are subject to stringent toxicology testing in order
to provide a comprehensive safety evaluation and to highlight potential
health risks. In the mid-1970’s, mutagenicity testing became a mandatory
part of this process, and since then, regulatory bodies have worked with
the International Conference on Harmonisation (ICH) and groups such as
the International Workshops on Genotoxicity Testing group (IWGT: est.
1993) to offer expert advice as to the conduct of mutagenicity studies
(Kirkland et al., 2007) .
A high priority of safety testing is to ascertain the likelihood of genetic
damage, and also to establish safe or tolerable exposure levels by taking
into consideration mechanisms of action, and risk versus benefit. Of
particular concern are compounds that bear structural resemblance to
known genotoxins, or if substantial human exposure is envisaged and so
a battery of rigorous tests are employed to delineate the genetic toxicity
profile during pre-clinical screening.
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For the purpose of risk assessment, several factors must be considered
during hazard identification, such as relevant exposure levels, since overt
cytotoxicity (e.g. less than 50 percent survival) was reported to induce a
degree of false positive results when using the in vitro mammalian
chromosome aberration assay (Hilliard et al., 1998). Further issues to be
taken into account include compound bioavailability, suitability of cell
models for the anticipated route of exposure, appropriate sampling times
and the generation of potentially toxic metabolites. A model assay should
be reliable, simple to interpret and provide relevant data that is applicable
to carcinogenesis risk assessment.
Compounds of a genotoxic nature may be classified according to the type
of lesion induced by exposure: either cytogenetic (chromosomal
aberrations resulting in altered structure or number of chromosomes) or
mutagenic (by introducing mutations within the primary DNA sequence;
this is usually determined by assessing change at an individual gene
locus). Regardless of origin, a single genotoxic event may sufficiently
compromise genome integrity and hence contribute to the onset of
carcinogenesis. Consequently, the assays available for genetic toxicology
testing reflect the multifarious nature of potential genetic insult.
1.1.1 Genotoxicity Assessment
Assays validated for genotoxicity testing include the in vitro micronucleus
(MN) assay, which provides a measure of chromosome breakage and
more specifically clastogenicity. Micronuclei, which form following
disruption of the mitotic apparatus or as a consequence of strand breaks,
represent acentric fragments of chromosomes that become dislocated
from the mitotic spindle during cell division, and may be scored in a range
of cell lines
(http://cdfc00.rug.ac.be/HealthRisk/genotoxicitytests/micronucleus_test.htm).
Frequently cytokinesis is blocked using a mitotic inhibitor such as
cytochalasin B and binucleate cells are scored, which ensures that only
cells having completed nuclear division are scored and provides
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additional information regarding cellular proliferation capacity
(http://cdfc00.rug.ac.be/HealthRisk/genotoxicitytests/micronucleus_test.htm).
More complex versions of the MN assay involve supplementary staining
using centromere specific antibodies to signify chromosome loss and also
micronuclei formed as the consequence of chromosomal non-disjunction
(Krirsch-Volders et al., 1997). Specifically, a significantly greater
proportion of micronuclei stain positive for kinetochores in response to
aneuploidy as compared with clastogenicity, thus allowing for successful
discrimination between clastogenic and aneugenic acting compounds
(Eastmond and Tucker 1989) (Gudi et al., 1990). Importantly the simple
version of the MN assay is relatively cheap, performed with ease and
recent advances have opened up the possibility for high throughput
processing of samples by flow cytometry (Bryce et al,. 2007).
Since not all chromosome aberrations (e.g. chromosome translocations
and/or non-disjunction) are detected using the simple MN assay, routinely
performed in the absence of additional antibody staining, the
micronucleus is not applicable as a stand-alone assay. Additional testing
may include the chromosome aberration assay, often conducted in
human lymphocytes or Chinese Hamster Ovary cells (CHO), however the
process of cell scoring is laborious and a full characterisation of cell
karyotype is required prior to analysis.
Typically the above clastogenicity assays are used in combination with a
microbial assay such as the Ames reverse mutation test (Ames et al.,
1973) and with mammalian point mutation assays such as thymidine
kinase (TK) or hypoxanthine guanine resistance (HPRT) assays, along
with at least one in vivo study, which typically, by default, is the rodent
bone marrow micronucleus test (Hozier et al., 1981) (Kirkland et al.,
2007).
The Ames test employs bacteria deficient in histidine biosynthesis that
revert back to wild type phenotype following exposure to a mutagen
(Ames et al., 1973), and the TK and HPRT assays require a forward
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mutation event in mammalian cells, to gain triflourothymidine (Clive et al.,
1987) or hypoxanthine guanine resistance, respectively (Knaap and
Simons, 1975). Both assays depend on mutation at a specific gene locus,
which confers a phenotypic trait that encourages colony growth under
selective pressure (hence the description “forward mutation” assay). The
mouse lymphoma TK assay provides data regarding type of damage,
such that large colony growth indicates point mutations or small
intragenic deletions of the TK locus, whereas small colonies represent
larger chromosomal aberrations or chromosome loss (Clive et al., 1979).
Similarly, the HPRT assay detects mutations at a single locus, although
in this instance provides a specific indication of mutagenesis on the X-
chromosome (Knaap and Simons, 1975). The International Conference
for Harmonisation (ICH) documentation provides recommendations for
study design, with reference to dosing and sampling time as well as the
necessity to conduct assays with and without metabolic activation
(http://www.sri.com/biosciences/bdd/toxic/protocol.html#12).
Furthermore, good laboratory practice (GLP) is necessary for the
submission of data to Regulatory agencies, to ensure robust and
consistent study design, data acquisition and reproducibility.
1.1.2 The Future of Mutagenicity Testing: In vitro Assays
With the expansion of compound selection, as the consequence of high
throughput analysis, there is increased pressure on pharmaceutical
companies to generate large amounts of reliable toxicology data for
screening purposes. As a result, routine toxicology tests are under
constant scrutiny in an effort to standardise compound testing on a global
scale.
A large effort is underway to refine existing in vitro tests and develop new
assays, which are more representative of the in vivo environment.
Although in vivo testing is necessary for compound risk assessment, in
vitro testing is often preferential, since in vivo studies are time-consuming
and costly. Furthermore, the intention to reduce the use of animals in
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toxicology is a driving force for innovative approaches in genetic
toxicology testing. The emergence of more reliable and representative in
vitro tests, paves the way for high throughput analysis of potential drugs
for example, so eliminating genotoxic compounds early on, and thereby
reducing the attrition and cost of mid-late stage drug development.
Over the past decade, there has been considerable governmental
pressure, both in the UK and within the EU, to promote the replacement,
reduction and refinement of animal studies in science (Three R’s). The
three R’s concept promotes careful experimental design in order to
minimise animal use and suffering, and also to investigate the application
of alternative, in vitro assays (Zurlo et al., 1996) (The Principles of
Humane Experimental Technique W.M.S. Russell and R.L. Burch). In an
effort to minimise in vivo studies, the European Centre for Validation of
Alternative Methods (ECVAM), established in 1991, strives to validate
novel in vitro methods that may replace and reduce the use of animals
(http://ecvam.jrc.cec.eu.int/index.htm).
Currently applied in vitro assays provide valuable information regarding
genotoxicity, although each assay has associated shortcomings.
Microbial assays provide a relatively simple and inexpensive method of
screening compounds yet fail to detect compounds necessitating
metabolic activation by eukaryotic enzymes. To overcome this however,
rat liver cell homogenate, which supplements cell media with
metabolising enzymes, is employed. In contrast, the TK assay conducted
in mammalian cells, has greater relevance to human toxicology, although
relies on the occurrence of a forward mutagenic event at a single gene
locus. Recent studies have confirmed the suitability of human cell culture
models for detecting DNA damage, in particular HepG2 cells (Uhl et al.,
2000) (Valentin-Severin et al., 2003).
Attempts to develop high throughput assays for monitoring the eukaryotic
DNA damage response, as opposed to mutagenic events at a single
locus, has led to the development of assays such as the GreenScreen,
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currently in early validation. The GreenScreen assay utilises a 96-well
plate set-up to screen compounds in yeast cells containing a rad54-
promoter-gfp expression vector (Cahill et al., 2004) and in human TK6
cells containing a GADD45-promoter-gfp vector (Hastwell et al., 2006).
In this model, green fluorescent protein (gfp) levels are elevated upon
transcription factor binding to the rad54 or GADD45 promoter sequence,
which occurs during the DNA damage response, thus providing an
assayable signal. Application of a similar p53-luciferase reporter
construct provided a sensitive tool for indicating exposure to DSB
inducing treatment (Gallmeier et al., 2005), although the specificity of the
link between p53 transcriptional regulation and DSB generation is
ambiguous. In the field of genetic toxicology, DSB likely have the widest
implications for cellular function.
1.2 DNA Double Strand Breaks (DSB)
DSB are the most biologically significant genotoxic lesions in terms of
carcinogenesis, and are directly associated with an increased likelihood
of chromosome breakage and rearrangement, mutagenesis, and loss of
crucial genetic information. Common inducers of DSB include irradiation
(e.g. gamma IR and X-rays) (vanAnkeren et al., 1988) and radiomimetic
drugs (e.g. bleomycin) (Mirabelli et al., 1985), breaks arising as
intermediates of repair pathways, for example after methyl
methanesulphonate (MMS) exposure (Wyatt and Pittman, 2006), and
following inhibition of topoisomerases (e.g. by etoposide) which facilitate
DNA unwinding in S phase and chromosome decatenation at mitosis
(van Maanen et al., 1988). Cells actively replicating DNA (S phase cells)
are particularly vulnerable to damage, since single strand breaks (SSB)
and base modifications, may be converted to DSB upon collision with the
progressing replication fork, a phenomenon observed to a higher degree
in cells deficient in SSB repair (Pascucci et al., 2005) (Saleh-Gohari et
al., 2005).
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In contrast to IR, which directly induces breaks in the DNA backbone
regardless of cell cycle phase, DNA intercalating compounds are typically
characterised by complex, chemical-bound DNA ends. Thus, the
mechanism of DSB induction is an important consideration when
investigating the mode and kinetics of DNA repair. Additionally,
confounding factors such as the abundance of repair proteins at various
stages of the cell cycle may impact the cellular response to DSB (i.e.
BRCA1 levels fluctuate with cell cycle (Bekker-Jensen et al., 2006)).
The occurrence of a single DSB poses such a threat to cell survival that
latent DNA damage checkpoint proteins are activated, to slow S phase
progression and delay mitotic entry. Cell cycle arrest preferentially allows
time for the repair of genetic lesions, and in the event of excessive
damage, cells may engage in apoptosis.
Genetic toxicology is concerned with DNA lesions, and so key factors
governing the signalling and repair aspects of the DSB response are
considered here.
1.3 DNA Damage, the Cell Cycle and the Tumour Suppressor
Proteins
Tumour suppressor proteins are integral to maintaining the balance
between proliferation and apoptosis, by contributing to cell cycle control
and influencing the general cellular stress response. Highlighted below,
and summarised in Figure 1.1 are tumour suppressor functions of
relevance to the DSB response.
1.3.1 p53: Guardian of the Genome
The tumour suppressor protein p53, frequently referred to as guardian of
the genome, due to the diverse nature with which p53 affords protection
of cellular integrity (Lane, 1992), is targeted for ubiquitination by MDM2
under physiological conditions (Momand et al., 1992). Upon DSB
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induction (Chehab et al., 1999) (Canman et al., 1998) (Restle et al.,
2005), p53 becomes hyperphosphorylated and is rapidly dispersed
throughout the nucleus. Multiple phosphoinositide 3- kinase- (PI-3K)-like
target residues are described and the site of phosphorylation has
implications for p53 activity including protein stabilisation and subsequent
accumulation, which promotes DSB repair or apoptosis (Lees-Miller et al.,
1992) (Canman et al., 1998). (Chehab et al., 1999) (Tibbetts et al., 1999).
More recently, p53 acetylation by the nuclear protein Strap-p300 was
also implicated in DSB associated apoptosis (Demonacos et al., 2004).
Consequently, p53 accumulation ensures an appropriate cellular
response, by engaging cells in cell cycle arrest and DNA repair, or by
mediating the elimination of severely damaged cells via apoptosis. A
central role in controlling nucleotide excision repair (NER) and base
excision repair (BER), following chemical insult, is well documented also
(Seo and Jung, 2004) (Offer et al., 2001).
The central role of p53 in responding to DSB is highlighted by the WIL-
2NS p53 -/- cell line, which exhibits impaired apoptosis, and radio-
resistance in comparison with their wild type counter part TK6 (MacPhail
and Olive, 2001). However, various gain of function mutations are
described for p53, including resistance to non-homologous end joining
(NHEJ) mediated repair (Okorokov et al., 2002) and impaired signalling of
DSB by interfering with MRE11 function (Song et al., 2007). Thus, the
precise nature of p53 function in DSB repair requires further clarification.
1.3.2 Phosphatase and Tensin Homologue (PTEN)
The PTEN gene, which is frequently deleted in cancerous cells, encodes
a tumour suppressor lipid phosphatase, which promotes DNA damage
induced apoptosis, and cell cycle arrest also by regulating cyclin-D
abundance during the G1 to S phase transition (Li et al., 1998) (Radu et
al., 2003). The precise contribution of PTEN to chromosome
maintenance is unclear, although diminished levels of the homologous
recombination (HR) protein RAD51 in PTEN null cells, is associated with
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elevated levels of DSB under physiological conditions (Shen et al., 2007).
Interestingly, expression of PTEN in knockout cells suppresses DSB
repair following IR, although rescues the apoptotic pathway (Pappas et
al., 2007) (Rosser et al., 2004). While PTEN clearly plays an important
role in the response to DSB, further elucidation is necessary.
1.3.3 Retinoblastoma (RB): Guardian of the Cell Cycle & Regulator
of Transcription Factor E2F-1 
RB delays cell cycle progression until DNA replication is complete (Lee,
1989) by preventing E2F-1 mediated activation of mitosis-promoting
transcription factors (Flemington et al., 1993), and as such, deregulation
of this pathway is associated with the accumulation of DSB (Pickering
and Kowalik, 2006) (Hong et al., 2006). E2F-1 exhibits pro-apoptotic (Lin
et al., 2001) and cell cycle promoting behaviour also (Hershko et al.,
2005) and contributes to the DSB response through the transcriptional
regulation of RAD51 and ATM (Shen et al., 2007) (Berkovich and
Ginsberg, 2003). Furthermore, apoptosis and p53 activation by E2F-1 is
attenuated in cells defective in ATM or NBS1, and while the mechanism
of ATM activation by E2F-1 is apparently DSB independent (i.e. proceeds
in the absence of ATM auto-phosphorylation) (Powers et al., 2004), other
sources imply a phenotype mimicking that of DSB induction following
sustained E2F-1 expression (Frame et al., 2006). A noteworthy
observation is the dependence of E2F-1 on the presence of PTEN for
correct regulation of RAD51 (Shen et al., 2007).
The proteins encoded by Breast Cancer genes 1 and 2 (BRCA1 and
BRCA2) also possess tumour suppressor activity, by participating in
genome surveillance complexes that influence cell bias towards
conservative modes of DSB repair. At the biochemical level, the BRCA
proteins are of greater relevance to the immediate DSB response, and
the role of BRCA1 is discussed in Section 1.7.2.
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Figure 1.1 The Cell Cycle in Relation to the DSB Response
Tumour suppressor proteins p53, RB and PTEN contribute to cell cycle control
in mammalian cells. Loss, or mutation of genes encoding these proteins
encourages cell proliferation, and cell cycle arrest in response to DSB is over-
ridden. Consequently, DSB accumulate under physiological conditions in the
absence of one or more tumour suppressors. Throughout cell cycle progression
in wild type cells, DSB-unrelated H2AX foci appear, and signalling complexes
such as MRN are found in association with the progressing replication fork.
Cells are depicted in green: Black spirals represent DNA.
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1.4 An Overview of the DSB Response
The mammalian DSB response is crucial for ensuring faithful replication
of genetic information and to prevent passage of damaged chromosomes
between generations. In mammalian cells, a vast network of proteins and
feedback loops act in concert to initiate repair, and evidence implies the
presence of a damage threshold, above which cell cycle progression is
halted (Buscemi et al., 2004). DSB responding proteins may be loosely
categorised as sensors (MRN complex), signal transducers (ATM/ATR),
mediators (53BP1, MDC1) and effectors (CHK2) of damage (Bekker-
Jensen et al., 2006). Upon recognition of a DSB, signal transducers
become active, which amplify the initial signal by substrate
phosphorylation, to mediate protein accumulation in the vicinity of a break
with subsequent repair. Although a great deal of research has focused on
elucidating the spatio-temporal relationship of these proteins, there is still
a degree of uncertainty, due to the complexity of the response. Multiple
problems are faced when attempting to delineate the DSB response,
owing to the immense database in this field, and diversity of methods and
experimental conditions employed between studies. The following
sections highlight events fundamental in maintaining genetic integrity,
and proteins with specific roles in the response to DSB and HR repair.
1.4.1 Activating the DSB Response
A multitude of cellular responses are controlled at the protein level by the
addition of a phosphate group. During the DSB response, substrate
phosphorylation is catalysed by the following kinases; ataxia-
telangiectasia mutated protein (ATM), ATM and Rad3-related protein
(ATR) and DNA-dependent protein kinase catalytic subunit protein (DNA-
PKcs). Consistent with this notion, altered protein abundance is seldom
observed in response to DSB, with a few exceptions such as the p53
protein, which becomes stabilised upon post-translational modification
(Chehab et al., 1999). Rather, phosphorylation achieves a rapid and
reversible adjustment of protein behaviour in response to DSB, hence
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imparting a high degree of vigilance to the cell (Gately et al., 1998)
(Bekker-Jensen et al., 2006).
1.4.2 Redistribution of DSB Responding Proteins
The distribution pattern observed for a subset of phosphorylated DSB
response proteins may be classified as diffuse or localising. The former
includes signal transduction and effector kinases (i.e. CHK2 (Lukas et al.,
2003)) that promote substrate phosphorylation throughout the nucleus.
Proteins participating in more stable associations with DSB include those
contacting chromatin directly (MRE11), and proteins retained in micro-
compartments by protein-protein interactions (MDC1, 53BP1) (Bekker-
Jensen et al., 2006). Biochemical data implicates the MRN complex and
replication protein A (RPA) as constitutive members in the vicinity of
chromatin-loaded replication machinery (Lavin, 2004) and suggests that a
fraction of ATM is found in the nucleoplasm under all conditions, possibly
to enable rapid signalling of DSB (Brown et al., 1997) (Gately et al.,
1998). It is well established that most DSB responding proteins reside in
the nucleus, although not necessarily within chromatin containing
compartments, and that upon DSB, a subset of proteins localise to
discrete damage associated foci.
1.4.3 Early Events of the DSB Response
Phosphorylated histone H2AX, widely referred to as gamma-H2AX
(H2AX), is recognised as an early and quantitatively relevant event of
the DSB response, the importance of which is discussed in Section 1.6.
However, application of fluorescent-tagged proteins has identified novel
interactions of human telomeric protein TRF2 with damaged genomic
DNA within 10 sec of irradiation, thus raising the possibility of a role
preceding H2AX appearance (Bradshaw et al., 2005). While the
importance of TRF2 in the DSB response is unclear, TRF2 absence
negatively impacts HR repair by impeding RAD51 accumulation into foci
(Mao et al., 2007). It is plausible that TRF2, which prevents telomere
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ends from being misinterpreted as damaged DNA, possibly promotes
DSB signalling through chromatin restructuring. Indeed, competitive
interactions between TRF2 and components of the DSB pathway are
speculated to determine whether or not DNA ends are processed as
breaks. Reports of TRF2 imposed suppression of the major DSB
transducer, ATM, support this hypothesis (Denchi and de Lange, 2007).
Soon after initial DSB induction, Bloom syndrome protein (BLM) rapidly (<
1 min) and specifically redistributes to H2AX, independently of cell cycle
stage, (Karmakar et al., 2006) with a residence of approximately 4 h,
apparently influencing the mode of DSB repair (Restle et al., 2005)
(Wang et al., 2000). Both BLM and the related Werners Syndrome
protein (WRN) are thought to participate early on during DSB signalling,
possibly via helicase modification of chromatin, to generate a common
intermediate signal. In support of this notion, WRN is deemed necessary
for achieving a full ATM response (Davalos et al., 2004), while BLM is
hypothesised to be of greater significance during replication associated
DSB (Wang et al., 2004b) (Davalos et al., 2004). Early events of DSB
signalling are depicted in Figure 1.2.
The MRE11-RAD50-NBS1 (MRN) complex, has received greater
attention in terms of DSB signalling, which is accounted for by nucleolytic
processing of DNA ends (discussed in Section 1.5). Whether MRN, BLM
and WRN act in concert to signal a break remains unclear, as does the
precise timing of events following DSB induction. Clearly, delineation of
the DSB response from signalling through repair is a complex process,
and so only well-defined aspects are considered here.
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Figure 1.2 Early DSB Responding Proteins
(1) TRF2 is among the earliest of proteins found associated with DSB. (2) ATM
activation proceeds almost immediately after DSB induction, leading to H2AX
formation, which enhances MRN residence and recruits the helicases BLM and
WRN. (3) WRN and the MRN complex are necessary for optimal ATM
activation, thus providing a feedback system to amplify the DSB signal.
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1.4.4 Transducers of the DSB Response
ATM, ATR and DNA-PKcs kinases are DSB responsive serine/threonine
kinases crucial for maintaining checkpoint fidelity and efficient DNA
repair. Kinase interaction with partner proteins NBS1, ATRIP (Cortez et
al., 2001) (Itakura et al., 2004) and KU80 respectively, is mediated
through highly conserved carboxyl-terminal motifs, an association which
is considered indispensable for optimal kinase activity (Falck et al., 2005).
The PI-3K related kinases are considered to act on numerous common
substrates, although they become activated upon distinct stimuli. ATM is
primarily activated by DSB, induced by IR for example, while ATR is
responsive to UV-light (Unsal-Kacmaz et al., 2002) and topoisomerase
inhibition, the latter generating DSB as a secondary lesion (Furuta et al.,
2003). In contrast, DNA-PKcs functionally compensates for ATM
deficiency in NBS1 and ATM mutant cell lines (Stiff et al., 2004), and
responds to replication associated DSB also (Furuta et al., 2003).
Recent data however, implies the contribution of ATR to the transduction
of IR associated DSB also, possibly under the control of ATM and/or
KU70/80 (Tomimatsu et al., 2007), which appears to be limited to S and
G2/M phase cells (Wang et al., 2004a). Furthermore a coordinated ATM-
ATR response to replication fork associated DSB is suggested (Cuadrado
et al., 2006) (Davalos et al., 2004), thus demonstrating the extensive
cross talk between various DSB responding pathways.
A summary of the signal transduction pathway is provided in Figure 1.3.
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Figure 1.3 Transducing the DSB Response
ATM, DNA-PKcs and ATR require interaction with partner proteins for optimal
kinase activity following DSB induction. ATM and ATR respond to distinct
lesions, however DNA-PKcs exhibits functional overlap with both kinases.
Kinase substrates: black: accumulate at DSB and orange: diffuse proteins.
Phosphorylation by ATM and ATR of common substrates may occur at kinase
specific, or non-specific residues.
Recently it was suggested that ATR also contributes to ATM relevant pathways
(Tomimatsu, 2007).
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1.4.5 Kinase Substrate Preference
Substrate redundancy between ATM and DNA-PKcs (Stiff et al., 2004) is
indicated by the ability of ATM deficient cells (AT cells) (Gately et al.,
1998) to initiate an appropriate response following high dose IR.
Additionally, ATM and ATR mediate phosphate transfer to common
residues of various proteins including H2AX, p53 and RPA, irrespective
of stimulus (Jowsey et al., 2007) (Block et al., 2004). Nevertheless, a
degree of substrate bias is necessary, as exemplified by the cell cycle
effective kinases. ATM phosphorylates CHK2, whilst ATR mediates
CHK1 phosphorylation, and so manifests a stimulus specific response
(Stiff et al., 2004) (Kang et al., 2005).
In wild type cells, the contribution of each kinase in phosphorylating
common substrates is unclear, although it is likely that the nature of DSB
stimulus is important. Substrate bias is partly dictated by the chemical
environment immediately surrounding the target residue (O'Neill et al.,
2000), and this may encourage phosphate transfer to specific residues
within a single protein, thereby imparting different characteristics. For
example p53 becomes hyper-phosphorylated and while phosphorylation
at ser-20 increases protein stability, ser-15 modification favours apoptosis
promoting behaviour and so elicits the most appropriate response
depending on the magnitude of damage and cellular growth phase
(Chehab et al., 1999) (Canman et al., 1998). A list of kinase substrates is
given in figure 1.3. Of the three kinases described here, ATM is widely
accepted as the major transducer of directly induced DSB (i.e. by IR), as
opposed to breaks generated as secondary lesions.
1.4.6 ATM Activation
ATM exists in the nucleus primarily as dimers (Gately et al., 1998) in
association with protein phosphatase 2A (PP2A), which seemingly
prevents the accumulation of trans-phosphorylated, kinase active ATM
under physiological conditions (Goodarzi et al., 2004). Specifically upon
DSB stimulus (Ismail et al., 2005), the ATM-PP2A interaction is abolished
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(Guo et al., 2002), and trans-phosphorylation of ATM proceeds, resulting
in dissociation into highly mobile monomers (Figure 1.4) (Bakkenist and
Kastan, 2003) of which a fraction becomes chromatin associated
(Andegeko et al., 2001) (Gately et al., 1998). Mutagenesis studies
confirm that ATM activation is mediated by auto-phosphorylation at ser-
1981, (Canman et al., 1998), which is necessary for kinase activity and
subsequent liberation of active monomers (Bakkenist and Kastan, 2003).
More recently, ATM acetylation at Lysine- 3016 (Sun et al., 2007) was
observed within 5 min of DSB, and so it seems that a multitude of
modifications contribute to ATM activation. Indeed, the precise details of
activation remains elusive, however the MRN complex, and MDC1 are
implicated in the recruitment and retention of ATM at DSB respectively,
and thus are considered to be key modulators of the ATM signal
transduction pathway (Lee et al., 2003) (Falck et al., 2005) (Dupre et al.,
2006) (Lou et al., 2006) (Berkovich et al., 2007).
Several immuno-fluorescent studies have failed to reveal alterations in
ATM abundance following IR, and the subcellular distribution closely
resembles the diffuse nuclear staining observed in unstressed cells, with
the exception that chromatin binding is enhanced and colocalisation with
H2AX foci is evident (Brown et al., 1997) (Andegeko et al., 2001).
Furthermore, no fluctuations in ATM content are observed throughout the
cell cycle, and only during mitosis does ATM leave the nuclear region and
diffuse throughout the cell (Brown et al., 1997).
1.4.7 ATM Kinetics and Signal Transduction
ATM activation in mammalian cells proceeds with rapid kinetics (30 sec –
5 min), becoming fully active within 15 min, and declining over a time-
course of 4 – 8 h (Bakkenist and Kastan, 2003) (Horejsi et al., 2004),
which coincides with the accumulation of ligation repair protein XRCC4,
thus indicating completion of repair (Berkovich et al., 2007). Following
activation, ATM triggers a cascade of signal-transduction events by
phosphorylation of a subset of proteins at serine (S) residues within the
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context of an ATM substrate consensus sequence: LSQE (O'Neill et al.,
2000), as outlined in Figure 1.3. Substrates include H2AX, NBS1, MRE11
and RAD50 (O'Neill et al., 2000), which become phosphorylated and
subsequently retained at DSB, while diffuse proteins including CHK2 fail
to accumulate at chromatin after phosphorylation (Lukas et al., 2003).
ATM is activated to optimal levels under conditions predicted to induce
less than 8 DSB per nucleus (Buscemi et al., 2004), and the absence of
functional ATM confers a severe radiosensitive phenotype (Gulston et al.,
2004) (Gulston et al., 2004). Thus, ATM activation is implied as a subtle
indicator of DSB.
1.5 The Relevance of the MRE11-RAD50-NBS1 (MRN) Complex to
the DSB Response
1.5.1 MRN Complex Characteristics
MRE11 and RAD50 exist as hetero-tetramers, comprising 2 MRE11
monomers associated with a RAD50 dimer, which together with the
companion protein NBS1, form the MRN complex. A major role of the
MRN complex is to hold DNA substrates in close proximity, to
concentrate the damage signal (Costanzo et al., 2004), which is achieved
by RAD50, a member of the structural maintenance of chromosome
(SMC) family (Hopfner et al., 2002). DNA end processing activity is
attributable to the exo- and endo- nuclease activity of the MRE11
component (Hopfner et al., 2002), while NBS1 is necessary for nuclear
localisation of the complex, via association with MRE11 (Desai-Mehta et
al., 2001) (Cerosaletti and Concannon, 2003) (Kobayashi et al., 2004).
Upon DSB generation, MRN-chromatin contacts are reinforced through
ATM catalysed phospho-dependent interactions. Specifically, the Fork
Head Associated (FHA) and Breast Cancer Carboxyl Terminus (BRCT)
functional domains of NBS1, along with H2AX are critical for mediating
DSB associated interactions (Durocher et al., 2000) (Furuta et al., 2003)
(Kobayashi, 2004) (Sakamoto et al., 2007).
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Figure 1.4 Activation of ATM Kinase
Under physiological conditions, ATM exists as a dormant dimer in association
with protein phosphatase 2A (PP2A). In response to DSB, ATM trans-auto-
phosphorylation releases active monomers, which phosphorylate H2AX
(H2AX). A positive feedback amplification loop is evident, with H2AX recruiting
ATM to sites of DSB, where it phosphorylates substrates such as MDC1, NBS1
(MRN complex), 53BP1 and BRCA1. The MRN complex is recruited to DSB
independently of active ATM, and thus is implicated in the initial sensing steps.
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Under physiological conditions, the MRN complex is thought to be
associated with chromatin and RPA during replication (Olson et al.,
2007), an interaction which is enhanced upon DSB induced
phosphorylation of RPA and MRE11 (Robison et al., 2004). The
association of the MRN complex with advancing replication forks would
hypothetically enable cells to elicit a rapid response to replication related
stress, via activation of ATR and subsequent inhibition of origin firing
(Shechter et al., 2004) (Lavin, 2004) (Robison et al., 2004). Indeed the
MRN complex is implicated in regulatory aspects of HR (Sakamoto et al.,
2007) in an ATM independent manner (Chen et al., 2007), which is
consistent with reports that HR is preferentially employed to repair DSB
lesions in replicating or mitotically active cells (Rodrigue et al., 2006). In
accordance with this, micro-compartments containing ATR-ATRIP, a
subset of RAD proteins and BRCA1 & 2, along with ssDNA coated RPA
and the MRN complex are commonly found associated with progressing
replication forks (Zou and Elledge, 2003) (Bekker-Jensen et al., 2006).
1.5.2 A Role for NBS1 in the Activation of ATM
NBS1 is considered indispensable for a subset of ATM dependent
events, including p53 phosphorylation and cell cycle regulation, which
ultimately determines the radioresistance of a cell line (Lee et al., 2003).
Specifically, the amino terminus of NBS1 is crucial for mediating the
accumulation of the MRN complex at DSB (Desai-Mehta et al., 2001)
(Kobayashi et al., 2004) (Cerosaletti and Concannon, 2003), while the
carboxyl terminus is a substrate for ATM phosphorylation, and regulates
apoptosis (Difilippantonio et al., 2007). With relevance to the DSB
response, the interaction between NBS1 and ATM is deemed necessary
for achieving optimal ATM activation (Horejsi et al., 2004) (Berkovich et
al., 2007), however in replicating cells the role of NBS1 in promoting
nuclear localisation of MRE11 is of greater significance. This possibly
reflects the inherent capacity of MRE11 to participate in chromatin
interactions and to stabilise the MRN complex, thereby encouraging
tethering of sister chromatids prior to HR repair (Costanzo et al., 2004)
40
(Sakamoto et al., 2007). Thus, NBS1 modulation of ATM activity is of
greater consequence in non-replicating (G1 phase) cells. In support of
this notion, NBS1 is crucial for ATM mediated phosphorylation of CHK2,
whereas CHK1 and p53 phosphorylation, which can be triggered by ATR
stimulating compounds during replication (Furuta et al., 2003), proceeds
adequately in NBS1 deficient cells (Lee and Paull, 2004) (Kang et al.,
2005).
Cells deficient in NBS1 or expressing carboxyl terminal truncated
proteins, consistently exhibit an attenuated response to IR, as indicated
by diminished phosphorylation of ATM substrates, failure of
phosphorylated ATM to form discrete foci, and intra- S and G2/M cell
cycle defects (Horejsi et al., 2004) (Cerosaletti et al., 2006). Intracellular
indications are supported by cell free and humanised NBS1 deficient
mouse studies, albeit with diminished dependence on the MRN complex,
concomitant with elevated DSB (Dupre et al., 2006) (Costanzo et al.,
2004) (Difilippantonio et al., 2005). Specifically, mammalian cells have
the capacity to override regulatory mechanisms, such that amplification of
the ATM signal is compensated for in MRN deficient cells, under
conditions of excessive DSB (Dupre et al., 2006). NBS1 is distinct from
several counterpart proteins, in that both H2AX dependent and
independent associations are observed, the latter more prominent in
replicating cells (Bekker-Jensen et al., 2006). The role of NBS1 is
depicted in Figure 1.5.
1.5.3 Summarising the Role of the MRN Complex
Together these data imply the MRN complex as an integral and early
player in the DSB response, most likely acting to convert the multitude of
variable free DNA ends encountered into a universal signal by exo and
endo-nucleolytic end-processing, prior to holding broken ends in close
proximity to prevent missegregation. Although a fully functioning MRN
complex is not required for DNA repair per se, it does appear to influence
the overall magnitude of response.
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Figure 1.5 A Central Role for NBS1 in the DSB Response
Following DSB induction, NBS1 interacts with MDC1, ATM, H2AX and with the
DSB site directly (possibly mediated by MRE11: chromatin association): it is
unclear whether the interaction with the MRE11/RAD50 complex is specific to
DSB, although NBS1 is necessary for nuclear localisation of the complex. MDC1,
NBS1 and the MRN complex, exhibit mutual benefit relations with ATM (dual
headed black arrows): these proteins are necessary for stimulating optimal ATM
kinase behaviour, and subsequently behave as substrates for phosphorylation.
NBS1 phosphorylation by ATM (green arrow) promotes apoptosis, and direct
contacts with DSB are shown as thin blue arrows. NB: A similar situation is
evident for MDC1, with the exception of participation in the MRE11:RAD50
complex.
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1.6 H2AX: A Universal Marker of DSB
1.6.1 H2AX Phosphorylation
Human chromatin takes on a solenoid, spring-resembling structure,
comprising repeating nucleosome units of histone octamer (H2A, H2B,
H3 and H4) around which a single macromolecule of super-coiled DNA is
wound. Of the core histones, variant H2AX contributes 2 - 25 percent of
the total H2A, an estimated 1 million molecules in normal human
fibroblasts (Hamasaki et al., 2007), and is ubiquitously distributed
throughout the mammalian chromosome. In addition to the structural
importance of histones, epigenetic modifications convey intracellular
signals that contribute to the repair of strand breaks, for example by
histone 2B removal and nuclear reorganisation that promotes the final
stages of repair (Berkovich et al., 2007).
In response to DSB, the H2AX protruding carboxyl tail becomes rapidly
phosphorylated at ser-139 by ATM, ATR and DNA-PKcs (Rogakou et al.,
1998) (Stiff et al., 2004). Whereas ATM and DNA-PKcs display functional
redundancy in phosphorylating H2AX following IR induced DSB (Stiff et
al., 2004), ATR appears more important for replication fork associated
damage (Furuta et al., 2003). H2B also becomes phosphorylated as a
downstream event of H2AX, although the importance of this event in the
DSB response is unclear (Fernandez-Capetillo et al., 2004a).
The appearance of H2AX occurs almost immediately following DSB
generation, achieving plateau within 10 - 30 min (Rogakou et al., 1998),
and each focus is thought to represent a distinct lesion irrespective of the
stimulus. It is widely accepted that H2AX is among the earliest of kinase
substrates to undergo phosphorylation in response to DSB, and
visualisation of antibody labelled foci indicates the spread of H2AX
signal over 2 megabase regions of chromatin predicted to involve over 2
million base pairs of DNA per 1 Gy IR (Rogakou et al., 1999) (Rogakou et
al., 2000). Despite the amplification of signal throughout surrounding
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chromatin, analysis of focus size and number has proved an accurate
indication of dose-related DSB in many studies (Banath and Olive, 2003)
(Gallmeier et al., 2005) (Takahashi and Ohnishi, 2005) (Zhou et al.,
2006). Furthermore, despite concerns regarding the nature of DSB
generation, current data implies H2AX formation as the direct
consequence of DNA free ends, as opposed to epigenetic alterations,
such as chromatin relaxation (MacPhail et al., 2003) (Zhou et al., 2006).
Since DSB are static during the early phases of the damage response
(Nelms et al., 1998), H2AX is fundamental to repair by creating a
cytologically discernible marker in the vicinity of a break, to which repair
proteins migrate and are retained in discrete foci (Paull et al., 2000). Foci
are commonly referred to as Irradiation Induced Foci (IRIF), having been
first identified following exposure to IR (Paull et al., 2000) (Fernandez-
Capetillo et al., 2004b), and more recently chemical exposure has been
shown to induce such foci also. The importance of phospho-peptide
recognition motifs in mediating protein interactions during DSB signalling
and repair, is discussed in Section 1.7 (Durocher et al., 2000) (Cerosaletti
and Concannon, 2003).
1.6.2 Cessation of the H2AX Signal
Termination of H2AX signalling is less well defined and while some
studies indicate a close correlation with DSB repair (Rogakou et al.,
1998), others have reported discrepancies between foci disappearance
and DNA rejoining, as measured by electrophoretic means (Bouquet et
al., 2006). The latter study revealed diminished correlation of H2AX
disappearance with increasing IR, although at low doses, the trend for
H2AX loss closely resembled the anticipated repair kinetics in various
cell lines (Bouquet et al., 2006). Furthermore, discrete DSB related foci
disappeared with more rapid kinetics in comparison with H2AX loss on a
global scale (Bouquet et al., 2006), thus favouring the notion of physical
removal of H2AX from chromatin to abolish the signal. Attenuation of
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H2AX elimination after high IR may be the consequence of phosphatase
saturation, which was recently described in yeast models (Keogh et al.,
2006). A potential candidate for H2AX dephosphorylation in mammalian
cells is PP2A, which accumulates into DSB-related foci (Chowdhury et
al., 2005).
1.6.3 H2AX as an Indicator of DSB
Ideally, H2AX studies should involve few processing steps, whether
treated samples are fixed, stained with H2AX specific antibody and
analysed for fluorescence, or cell lysate probed by Western blotting. Most
commonly, antibody studies are employed for analysis by microscopy or
flow cytometry, to minimise the number of processing steps involved and
hence provide highly reliable data. In comparison with the comet assay
for example, which exhibits a limit of detection of approximately 50 DSB/
cell (equivalent to approximately 2 Gy IR) (Dikomey et al., 2000) H2AX
analysis offers superior sensitivity, thus facilitating the investigation of
more human relevant exposures (i.e. in a clinical setting) (Banath et al.,
2004). A noteworthy issue is that of confounding factors such as V(D)J
class switching, meiotic recombination and senescence related DSB,
detected by H2AX analysis as the consequence of increased assay
sensitivity. Inclusion of appropriate controls however, should abolish any
signal interference.
Data from H2AX studies correlates well with the neutral comet assay,
although greater deviation between cell lines is noted for histone studies,
the consequence of phenotypic variation in key factors that determine the
ability to respond to DSB treatment, including total histone abundance
and kinase activity (MacPhail et al., 2003) (Banath et al., 2004) (Bocker
and Iliakis, 2006). DSB generated by the conversion of SSB or base
modifications upon collision with the replication fork, tend to display
greater variation between cell lines also (Zhou et al., 2006).
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A further concern is the persistence of H2AX for up to 24 h post IR,
which fails to correlate with comet assay derived data (Banath et al.,
2004). It is tempting to speculate that chromatin restructuring imposed by
DSB and subsequent H2AX may generate a mitotically stable
(inheritable) signal. This notion is supported by the observation of H2AX
and RAD51 foci concomitant with differential methyltransferase activity in
non-irradiated bystander cells, documented using co-culture in vitro, and
in vivo mouse models (Koturbash et al., 2006) (Sokolov et al., 2005).
While the impact of IR on bystander cells is intriguing, this falls outside
the scope of this research and so the reader is referred to the above
references for further reading.
1.6.4 Limitations of H2AX as a Marker of DSB
1.6.4.1 Apoptosis Related Foci
While H2AX antibody studies proffer an efficient and convenient
measure of DSB, applicable to a range of in vitro models, detection of
H2AX in living cells is yet to be described. Furthermore, the aptness of
H2AX for representing DSB induction per se is disputable since
apoptosis related laddering of genomic DNA is detected also (MacPhail
et al., 2003) (Banath and Olive, 2003) (Tanaka et al., 2006). H2AX and
ATM phosphorylation events have been reported in early apoptotic cells,
however this generates a more intense H2AX antibody signal (5-10-fold
greater than control cells) relative to that induced by DSB per se, as the
consequence of excess fragmented DNA (MacPhail et al., 2003) (Banath
and Olive, 2003). Where it is desirable to distinguish between treatments
causing damage, which cells attempt to repair, versus overt damage
inducing cell death, identification of an alternative marker may be
preferential. For a more comprehensive discussion of apoptosis
associated H2AX, and current methods for distinguishing these foci, the
reader is referred to a review by Tanaka et al, 2007.
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1.6.4.2 Confounding Constitutive Foci
Constitutively occurring H2AX generates a signal in control cells, which
fluctuates with cell line, and cell cycle progression (Banath et al., 2004)
and a trend for increased H2AX in replicating and mitotically active
populations is described, in association with elevated ATM activity
(McManus and Hendzel, 2005) (Halicka et al., 2005). Detailed analysis of
physiologically related foci has revealed that discrete foci number is
inversely related to the mean focal volume size, such that IR induced
DSB leads to fewer H2AX foci, each occupying a greater nuclear volume
(McManus and Hendzel, 2005).
The identification of DSB-unrelated foci that appear to be cell-cycle
related, and reports of variable constitutive levels of H2AX between cell
lines highlights further areas for consideration when applying H2AX as a
marker of DSB (MacPhail et al., 2003) (Banath et al., 2004) (Zhou et al.,
2006). Thus, due attention should be paid to cell specific attributes, such
as kinase capacity, abundance of H2AX (MacPhail et al., 2003), and the
proportion of cells in each cell cycle stage at any one time.
1.6.4.3 Overcoming H2AX Limitations
Cell cycle heterogeneity, and foci generated during the early stages of
apoptosis, may be distinguished by flow cytometry, using bivariate dot-
plots to analyse samples dual stained for H2AX and a DNA intercalating
dye (Banath and Olive, 2003) (MacPhail et al., 2003) (Banath et al.,
2004) (Halicka et al., 2005). By employing this technique, cells from
different cell cycle stages may be analysed as distinct sub-populations,
and an excess of H2AX at apoptotically relevant time-points facilitates
estimation of DSB induced cytotoxcity (Banath and Olive, 2003).
Alternatively, scoring of nuclear foci, by fluorescence microscopy for
example, may be preferential, depending on study objective. Although
manual scoring is time-consuming and prone to subjectivity, small non-
DSB related foci and apoptotic cells are easily distinguished, and
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application of computational methods, increases the high throughput
nature of foci analysis (Bocker and Iliakis, 2006).
1.6.4.4 Concluding Remarks
Despite the associated difficulties described above, analysis of H2AX
interactions and foci residence has proved invaluable for studying the
repair kinetics and coordination of the DSB response (Rogakou et al.,
1998) (Rapp and Greulich, 2004) (Paull et al., 2000). Importantly, H2AX
foci form in a linear manner with increasing DSB number, and with careful
consideration of cell type, and analysis parameters, misinterpretation of
non-DSB related foci is greatly diminished.
Several investigators have tracked fluorescent-tagged proteins to provide
information regarding the kinetics of events following DSB generation.
This method has proved ideal for mechanistic studies, by highlighting
several DSB associated protein interactions, but is not suitable for
toxicology testing, largely the result of interference from endogenously
expressed proteins and difficulties in developing such systems for high
throughput analysis. The manipulation of relevant peptide interactions
however has the potential for developing novel genetic toxicology
models.
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1.7 DSB Specific Protein-Protein Interactions
1.7.1 Mediator of Damage Checkpoint 1 (MDC1)
MDC1 localises to H2AX, through carboxyl terminal phosphopeptide
recognition domains, with rapid kinetics and reaches steady state levels
within 10 min of insult (Lukas et al., 2004) (Lee et al., 2005). In contrast
with several DSB responding proteins, MDC1 accumulates at DSB
regardless of cell cycle (Bekker-Jensen et al., 2006) (Lou et al., 2006).
Depletion of MDC1 significantly diminishes HR repair capacity (Zhang et
al., 2005) and together with accumulating evidence that MDC1 interacts
specifically with phosphorylated H2AX, BRCA1, 53BP1, ATM, CHK1 and
NBS1, provides an overwhelming argument for MDC1 as an integral
member of the mammalian DSB response (Goldberg et al., 2003) (Xu
and Stern, 2003) (Stucki and Jackson, 2004) (Bekker-Jensen et al.,
2006) (Lou et al., 2006). Indeed, although BRCA1 and NBS1 participate
in both MDC1 and H2AX independent chromatin-contacts, their
prolonged retention at DSB is abolished in MDC1-/- models (Bekker-
Jensen et al., 2006).
Parallels may be drawn with NBS1 function, such that both proteins
interact with ATM through FHA domains (Berkovich et al., 2007) (Lou et
al., 2006) and that cell cycle checkpoint defective phenotypes are
observed in NBS1 or MDC1 deficient cell lines (Horejsi et al., 2004) (Lou
et al., 2006). Furthermore, both MDC1 and NBS1 proteins contain BRCT
domains, which are essential for their accumulation at H2AX-DSB
centres.
Thus MDC1 functions in signal propagation, by recruiting ATM and
substrates to sites of DSB, and thereby encourages phosphorylation
events fundamental to the DSB response
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1.7.2 Breast Cancer protein 1 (BRCA1)
Cells defective in BRCA1 exhibit genome instability as a consequence of
attenuated repair of DSB by HR and precise-NHEJ (Durant and Nickoloff,
2005) (Yun et al., 2005) (Bau et al., 2006) in favour of erroneous NHEJ
repair (Snouwaert et al., 1999) (Wang et al., 2006). Analogous to NBS1,
BRCA1 participates in H2AX-dependent and independent interactions
(Stark et al., 2004) and its retention at sites of DSB, through phospho-
specific interactions with MDC1, promotes the association of BRCA1 with
components of the HR and NHEJ pathways, and thus regulates the
accuracy of lesion repair (Moynahan et al., 1999) (Bekker-Jensen et al.,
2006) (Lou et al., 2006). The identification of multiple putative
phosphorylation motifs has led to speculation that BRCA1 can elicit
diverse responses depending on the stimulus and cell cycle phase,
through participation in various protein complexes (Tibbetts et al., 2000).
One such association is that of BRCA1 and MRN, which were identified
in a common surveillance complex and appeared to be critical for the
resolution of DSB generated during S phase (Chen et al., 2008). Thus,
BRCA1 is crucial for the accurate repair of DSB.
1.8 Spatio-Temporal Aspects of the DSB Response
1.8.1 Implications for Identifying Markers of DSB
The nature and dynamics of interactions between various DSB proteins
have been widely characterised using co-immunoprecipitation and
fluorescent imaging techniques, by several groups including Rapp et al,
who demonstrated novel interactions using a FRET based approach in
response to UV-light exposure (Rapp and Greulich, 2004). Exploration of
H2AX-mediated interactions in particular, has proved useful in
delineating the temporal sequence of events using fluorescent-tagged
proteins and phospho-peptide specific antibodies.
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1.8.2 Identification of Suitable Protein Interactions for Molecular
Manipulation
Among the multitude of key DSB-related associations identified,
candidate events for molecular manipulation include the retention of the
MRN complex at DSB, which is facilitated by H2AX, and MDC1. These
interactions have been detected within 30 min of DSB occurrence, and
are retained in discrete nuclear compartments for prolonged periods.
BRCA1 also exhibits significant redistribution, regardless of DSB
stimulus, into distinct micro-compartments, along with H2AX, MDC1, the
MRN complex (specifically RAD50) (Bekker-Jensen et al., 2006) (Lou et
al., 2006), and RAD51 (Paull et al., 2000). The interaction of RAD51 with
RAD52 continues for at least 5 h, by which time early DSB associated
events such as H2AX are diminished (Bocker and Iliakis, 2006),
however this is predominantly observed in replicating cells, which display
bias for HR repair (Paull et al., 2000) (Rapp and Greulich, 2004) (Bocker
and Iliakis, 2006). Furthermore, RAD51-RAD52 foci co-localise with
slower kinetics and to a lesser magnitude than H2AX, which may be
explained by the direct correlation between H2AX foci and DSB number,
several of which are processed by a common repair centre. In contrast,
MDC1, the MRN complex and 53BP1 accumulate at DSB regardless of
cell cycle position (Bekker-Jensen et al., 2006), in association with H2AX
(Rapp and Greulich, 2004). Protein interactions described here may be
suitable candidates for markers of DSB, and the following sections focus
more specifically on the functional domains that mediate DSB specific
interactions.
1.8.3 The Importance of Phosphopeptide Binding Domains
As part of the kinase cascade hierarchy an abundance of phosphorylative
events take place, conferring a characteristic that deviates from
physiological conditions. The effect of phosphorylation may diminish
monomer interaction of proteins as in the case of ATM (Bakkenist and
Kastan, 2004), or mediate phospho-peptide specific recognition between
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proteins, exemplified by the formation of micro-compartmental foci to
retain proteins pivotal to the repair process (Bekker-Jensen et al., 2006).
Clusters of target Serine and Threonine residues are frequently observed
in readily accessible regions of DSB responding proteins, to enable rapid
phosphorylation with subsequent participation in phospho-peptide
interactions (Traven and Heierhorst, 2005).
Two major phospho-peptide recognition domains contribute to the
accumulation of proteins into discrete nuclear foci; the BRCT and FHA
domains (Kobayashi et al., 2002) (Cerosaletti and Concannon, 2003)
(Rodriguez et al., 2003) (Shang et al., 2003) (Manke et al., 2003)
(Mochan et al., 2004) (Stucki and Jackson, 2004) (Lee et al., 2005). The
pivotal role of structural motifs is highlighted by the multitude of BRCT-
containing proteins, and observations that BRCT mutations or ectopically
expressed BRCT peptides significantly diminishes focus formation (Stucki
and Jackson, 2004) (Shang et al., 2003) (Kobayashi et al., 2002).
Although of limited sequence homology, BRCT repeats exhibit significant
structural identity (Shang et al., 2003) (Lee et al., 2005).
The recognition of various phosphopeptide motifs by DSB responding
proteins is, in part, dictated by the sequence encompassing the
phosphorylation site, which may account for protein specific interactions
(Rodriguez et al., 2003). Proteins BRCA1, 53BP1, MDC1, NBS1 PTIP,
Apraxin and PNK-like factor (APLF) and TOPB1, all contribute to DSB
repair or cell cycle signalling, and recognise short, specific
phosphopeptide motifs, of which phosphorylation is central for mediating
association (Manke et al., 2003) (Stucki and Jackson, 2006) (Iles et al.,
2007).
A second functionally important domain is thought to be the tudor domain
identified in 53BP1, with affinity for dimethylated arginines, which is found
on exposed histone tails (Mochan et al., 2004).
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In addition to DSB-specific protein interactions, investigation of the mode
and kinetics of repair has provided valuable information regarding the
ability of a cell to respond to damage of varying nature and magnitude.
1.9 Repairing the Break: Which Pathway?
Repair of DSB is largely mediated by one of two pathways; either by
error-prone NHEJ, or conservative HR. Research in this field indicates a
strong dependence on cell cycle stage, with quiescent (G0/1 phase) cells
favouring NHEJ, while replicating and mitotic cells, which contain a
homologous sister chromatid that provides a template for recombination
repair, preferentially engage in HR (Rothkamm et al., 2003) (Rodrigue et
al., 2006) (Saintigny et al., 2007). NHEJ is more abundant in
unsynchronised mammalian populations, the consequence of a greater
proportion of cells residing in G0/G1 phase at any one time, however HR
by strand invasion preferentially restores the original DNA sequence.
Although NHEJ is error-prone, the cell apparently compromises high
fidelity repair, in the absence of a homologous sister chromatid template,
rather than allowing a lesion to remain. The high level of non-coding DNA
constituting the human genome, likely minimises the impact of erroneous
repair.
A competitive relationship between HR and NHEJ is hypothesised and
the binding of HR protein RAD52 to DNA ends, has been compared to
the activity of KU, a member of the NHEJ pathway, however experimental
work in this area remains inconclusive (Ristic et al., 2003). Few studies
have investigated the competitive nature, if any does indeed exist,
between mode of repair, however HR is predominantly employed during
S and G2/M phase of the cell cycle, and as such HR is pertinent to the
repair of replication associated breaks.
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A transcriptional up-regulation event of RAD52 mRNA has been
previously reported following exposure of human cells to DSB inducing
agents (Ding et al., 2005) (Smith et al., 2006). For this reason the
following section focuses on HR repair pathway.
1.9.1 Homologous Recombination (HR)
Events Preceding HR
Hyperphosphorylated-RPA-coated ssDNA accumulates at replication
centres, in a dose and time dependent manner post IR, and is a
prerequisite for ATR-ATRIP recruitment and retention in the vicinity of
replication fork associated DSB (Parrilla-Castellar et al., 2004) (MacPhail
and Olive, 2001) (Bekker-Jensen et al., 2006). Although phosphorylated
RPA foci are reported to occur in nuclei exclusively of MRE11 (Park et
al., 1996) (MacPhail and Olive, 2001), other data indicates their co-
localisation along with H2AX and the DNA helicase WRN, which
prevents aberrant HR recombination (Robison et al., 2004). One
hypothesis is that the MRN complex is associated with ssDNA bound
RPA at replication centres, and in response to stalled forks, accumulating
RPA recruits ATR-ATRIP, and subsequently RPA and MRE11 become
phosphorylated (Robison et al., 2004). Consequently, MRN-RPA
interactions are reinforced, and the firing of origins of replication is
blocked (Shechter et al., 2004) (Zou and Elledge, 2003) (Parrilla-
Castellar et al., 2004) (Robison et al., 2004).
Events leading to the recruitment of HR proteins and subsequent repair
processes are depicted in Figure 1.6.
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1.10 An Overview of HR in Mammalian Cells
1.10.1 Introduction to HR
HR is the process whereby DSB are precisely repaired. During
recombination, homologous sister chromatids are held in close proximity
by members of the SMC, including the SMC1/3 cohesion complex, which
promotes invasion of the intact chromatid and exchange of genetic
information (Sjorgen and Nasmyth 2001) (Potts et al., 2006). Following
DNA end resection by MRE11, the MRN complex is thought to
disassemble prior to recruitment of key HR proteins, including RAD51,
RAD51C, RAD52 and RAD54 (Essers et al., 2002) (Rodrigue et al.,
2006). The HR proteins act in concert, to nick intact homologous DNA
with subsequent strand-invasion, linkage at the point of exchange of
genetic information, branch migration and resolution of the intermediary
4-way Holliday junction. HR repair occurs specifically between
homologous sister chromatids, and so reinstates DNA to its former
integrity.
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Figure 1.6 Responding to Replication Associated DSB
Above: Cells respond to a build up of RPA-coated ssDNA at sites of replication
fork associated DSB. ATR is subsequently recruited to damaged chromatin,
where substrate phosphorylation proceeds, including H2AX, MDC1, 53BP1 and
NBS1 (MRN). Below: Consequently, proteins involved in repair accumulate,
including RAD52, which is responsible for mediating RAD51/54 recruitment.
Repair by HR proceeds, resulting in restoration of the DNA sequence.
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1.10.2 Biochemical Control of HR
Association of BRCA1 with components of the MRN complex and RAD51
also, supports the notion of a role for BRCA1 in determining the mode of
repair along with MDC1 and RAD51C, which control RAD51 abundance
and its recruitment to DSB, respectively (Zhang et al., 2005) (Rodrigue et
al., 2006). The MDC1-RAD51 association under physiological conditions
is described to be important for the establishment of H2AX, 53BP1,
RAD51C and XRCC3 containing foci, thus MDC1 appears to promote
error free repair (Zhang et al., 2005) (Rodrigue et al., 2006). Novel
RAD51 regulatory control has also been attributed to PTEN (see Section
1.3.2), a lipid phosphatase involved in PI3-K signalling, which possibly
remodels chromatin, to enhance accessibility of transcription factor E2F-1
to the corresponding promoter consensus in RAD51 (Shen et al., 2007).
E2F-1 (see Section 1.3.3) is released from suppression upon S phase
entry (depicted in Figure 1.1), accounting for elevated RAD51 abundance
observed throughout the cell cycle, which may contribute to the
surveillance of progressing replication forks. In agreement with this
hypothesis, chromatin-associated RAD51 is typically restricted to S-G2
phase cells, in close proximity of DSB and members of the MRN complex
(Rodrigue et al., 2006).
RAD51C contributes to early stages of HR, being fundamental to the
recruitment of RAD51 and XRCC3, and depletion abolishes branch
migration and the resolution of Holliday junctions (Liu et al., 2004)
(Rodrigue et al., 2006). The majority of research, however supports a role
for RPA-bound RAD52 in mediating recruitment of RAD51 (Benson et al.,
1998) (Kim et al., 2001) (Navadgi et al., 2006) (Sleeth et al., 2007),
which is a prerequisite for RAD54 & RAD54B accumulation, and
association with WRN and ATR (Otterlei et al., 2006).
The abundance of HR proteins remains relatively constant following
activation, albeit displaying an altered pattern of distribution, and RAD51
reportedly participates in more stable DNA associations than RAD52 and
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RAD54 (Essers et al., 2002) (Sugiyama et al., 2006). However,
contradicting data implies a prolonged residence period of RAD52 at DSB
surrounding chromatin, in comparison with RAD51, and also association
of the two proteins has been reported for at least 5 h following damage
(Liu and Maizels, 2000) (Rapp and Greulich, 2004). This does not
however rule out the possibility of multiple RAD52 proteins undergoing
dynamic exchange at DSB.
During the final steps of repair, XRCC4 participates in undefined
associations with the RAD51/RAD52 complex (Rapp and Greulich, 2004),
and PNK also, implying that joint molecule formation between damaged
and intact DNA takes place in co-operation with ligation and addition of
phosphate residues to 5’ DNA. Accumulation of XRCC4 appears
dependent on H2AX, and so it would seem that H2AX foci remain until
completion of repair and restoration of DNA integrity.
1.11 Human RAD52
1.11.1 RAD52 Protein: Functional Aspects
DNA binding activity of human RAD52 was first demonstrated in vitro by
Van Dyck et al (Van Dyck et al., 1999), and later shown to play a role in
HR, using co-localisation studies in vivo, which place RAD52 in foci with
H2AX, and RAD50 of the MRN complex (Rapp and Greulich, 2004).
More recently, investigation of the functional consequences of various
mutations within the DSB responding genes has led to the proposal that
mammalian RAD52 may play a key role in the synthesis-dependent
strand annealing (SSA) (a non-cross over error-free branch of HR),
although definite conclusions are yet to be drawn (Sugiyama et al., 2006).
RAD52 (55 kDa) comprises multiple functional domains, including
SUMO-1/ UBL1 conjugating, DNA binding and RPA, RAD51 and self-
interacting motifs, indicative of an integral role for RAD52 during HR (Liu
and Maizels, 2000) (Liu et al., 2002). Both RAD51 and RAD52 are
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described to be under the control of c-Abl tyrosine kinase, which induces
phosphorylative changes upon appropriate stimulus such as IR, although
the precise kinetics remain elusive (Kitao and Yuan, 2002). Furthermore,
biochemical studies implicate RAD52 in DNA strand annealing and
exchange at various stages of HR (Bi et al., 2004) (Kumar and Gupta,
2004) (Sugiyama et al., 2006), although whether this translates to the in
vivo situation is uncertain.
Finally, RAD52 and the DNA helicase WRN are hypothesised to
participate in a mutual benefit relationship. RAD52 has been reported to
stimulate WRN unwinding of free 3’ DNA overhangs (using cell-free in
vitro models) (Baynton et al., 2003), and additionally it is thought that
WRN helicase activity contributes to ATM activation during early stages
of the DSB response.
1.11.2 RAD52 and the Response to DSB
Following IR, mammalian RAD52 accumulates into discrete foci, thought
to represent sites of active repair, which increase in number at between 2
and 4 h, and persist for up to 24 h (Liu and Maizels, 2000). In response to
replication associated breaks, and also DSB arising following IR and UV-
exposure, RAD52 co-localises with an array of proteins, including RAD50
of the MRN complex (Rapp and Greulich, 2004) (Liu and Maizels, 2000),
H2AX, WRN (Baynton et al., 2003) and hyper-phosphorylated RPA, with
subsequent RAD51 recruitment, and displacement of RPA (Benson et al.,
1998) (Sugiyama et al., 2006) (Sleeth et al., 2007). The crucial nature of
the RAD51: RAD52 interaction is implied by diminished HR in the event
of protein imbalance by RAD52-overexpression (Kim et al., 2001) (Lau et
al., 2004) although contrasting data indicates the inverse situation (Park,
1995) (Liu and Maizels, 2000).
The complexity and functional overlap of mammalian HR proteins renders
it difficult to apply specific roles to individual proteins. For example,
RAD51 recruitment proceeds in the absence of RAD52 and a likely
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candidate to compensate this activity is RAD51C, which displays
functional redundancy with RAD52 (Rodrigue et al., 2006). Indeed to
review the RAD family of proteins in isolation is a complex task, since
multiple proteins act in concert at a DSB to generate a recombinase-
active multimer required to achieve high fidelity repair.
1.11.3 Mammalian RAD52 versus Yeast rad52
A large majority of work regarding the RAD52 epistasis genes, as they
are commonly referred to, has been conducted in S.cerevisiae yeast,
which display severe radiosensitivity in the absence of rad52. However
rad52 mutagenesis studies in vertebrate cells failed to identify a
corresponding phenotpe (Yamaguchi-Iwai et al., 1998) (van Veelen et al.,
2005). While RAD52 clearly has a role in the repair of DSB, RAD52 null
mammalian cells display a much less severe phenotype in comparison
with the corresponding yeast mutant, which has raised questions as to
the precise role and importance of RAD52 in higher eukaryotes (van
Veelen et al., 2005) (Yamaguchi-Iwai et al., 1998). Nevertheless, over-
expression of mammalian RAD52 increases survival following MMS
exposure and imparts a higher degree of radio-resistance to monkey
cells, by increasing the incidence of HR events (Park, 1995) (Liu and
Maizels, 2000).
Together these observations imply that RAD52 contributes to the
recruitment of other members of the RAD family of proteins to DSB, and
thus assists in co-ordinating the mammalian HR response.
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1.12 Aims and Objectives
This work was primarily concerned with biochemical pathways of DSB
sensing and signal transduction, and also the conservative branch of
repair by HR. Although a great deal of research has focused on
elucidating the spatio-temporal relationship of DSB responding proteins,
there is still a degree of uncertainty, due to the complexity of the DSB
response, and cross-talk with various biochemical pathways. Research
that contributes to this field could enhance our understanding of
processes governing the DSB response, and potentially provide the basis
of a novel, high content, mutagenicity assay capable of discriminating the
mode of action of a putative genotoxin.
The main objective here was to identify DSB specific protein interactions,
for incorporation into a novel, fluorescent protein based reporter system
for detecting DSB, regardless of stimulus and cell cycle phase. Ideally, a
suitable protein-protein interaction should be induced specifically in a
DSB responsive manner, and persist for long enough to provide a
reasonable window for analysis.
It was hypothesised that phospho-peptide-binding domains and
sites predicted to undergo DSB induced phosphorylation (i.e. by
ATM) could serve as the foundation for the backbone of such a
protein construct.
Secondly, it was hypothesised that molecular beacon technology
may be exploited to detect RAD52 transcriptional regulation events
in whole cells, thereby providing a potential indicator of DSB.
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2 Biochemical Consequences of Irradiation and Chemical
Treatment
2.1 Introduction
The MN and H2AX assays are routinely conducted to provide a
quantitative measure of clastogenic and DSB events respectively,
however each has associated limitations. A major concern with the
H2AX assay is the introduction of confounding factors at highly cytotoxic
doses, since apoptosis related DNA laddering may introduce false
positive results as discussed further in Chapter 1. This is exemplified by
the inability of H2AX analysis to distinguish between clastogenic and
early apoptotic events (Rogakou et al., 2000), which is further
investigated in Chapter 3. Additionally the extent of cell cycle inhibition
may affect the assay outcome, such that mitosis is a prerequisite to MN
formation. Thus, a more comprehensive understanding of the cellular
response to clastogenic agents would facilitate the accurate
characterisation of a novel marker of DSB.
Within this chapter, a series of studies conducted in human cell lines are
presented, which aims to evaluate the impact of chemical and IR
treatment, at DSB-inducing relevant doses. Cell lines of diverse
phenotype, relevant to the mammalian DSB response, were selected for
investigation, with the intention of identifying optimal treatment conditions
for validating the specificity and sensitivity of a novel reporter of DSB,
such as that described in Chapters 4 and 5.
2.1.1 Choice of Cell Lines and Chemical Treatment
The impact of chemical treatment on cellular function was investigated
using the radiomimetic chemical bleomycin (bleo), and the DNA alkylating
chemical methyl methane sulphonate (MMS). Whilst bleo directly
introduces breaks into the DNA backbone, MMS is thought to generate
DSB during progression of the replication fork across alkylated bases or
repair intermediates (Wyatt and Pittman, 2006). In the following sections,
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comparisons were drawn between TK6 cells, which are routinely
employed in genetic toxicological studies (Liber and Thilly, 1982) (Zhang
et al., 1995) (Bryce et al., 2007), and ATM deficient (AT) lymphoblastoid
cells, to determine the importance of ATM in cell cycle control and DSB
signalling.
Many chemical carcinogens require metabolic processing to generate
reactive, toxic intermediates, and as such it is often necessary to employ
metabolically competent in vitro cell models. One such example is the
MCL-5 lymphoblastoid human cell line, which expresses several
metabolic enzymes including CYP1A1, 1A2, 2A6, 3A4, and 2E1 (Crespi
et al., 1991). The capacity of MCL-5 cells to respond to DSB inducing
treatment was validated here using MMS, in comparison with TK6 and AT
cells.
Alternative approaches were employed here, to assess the extent of
cytotoxicity, in terms of viability, replication capacity, and cell cycle
progression. The trypan blue exclusion method was used to determine
cell viability, which provides a direct measure of membrane integrity
whereas colony formation and cell counts more specifically indicate
replication capacity. More detailed cell cycle analysis was performed to
provide further insight into altered cell function.
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2.2 Methods
2.2.1 Cell Culture
Unless otherwise stated, all cell culture reagents were obtained from
GIBCO, Invitrogen (Paisley, UK).
All cells were cultured in a humidified incubator at 37 °C, 5 % CO2.
2.2.2 Suspension Cell Lines
2.2.2.1 TK6 Cells
The human lymphoblastoid cell line TK6, which is heterozygous at the TK
locus (Liber and Thilly, 1982), was purchased from the American Type
Culture Collection (ATCC). Cells were maintained in suspension at 5 x
104 - 3 x 105 cells/ml, in RPMI 1640 media, supplemented by 10 % foetal
bovine serum (FBS), antibiotics (100 iu/ml penicillin and 100 µg/ml
streptomycin), and 2 mM L-glutamine. Pluronic acid was added to culture
media prior to experiments, in order to minimise cell aggregation.
2.2.2.2 AT (ATM deficient) Cells
AT lymphoblastoid cells, originating from a human Ataxia Telangiectasia
patient, were obtained from the European Collection of Cell Cultures
(ECACC), and are characterised by an ATM deficient phenotype. Culture
conditions deviated from TK6, in that AT cells grow preferentially with 4
mM L-glutamine, at 3 x 105 cells/ml. Furthermore, pluronic acid was
omitted from culture media, since replicating AT cells grow optimally
within morphologically large aggregates.
2.2.2.3 MCL-5 Metabolically Competent Cells
Metabolically competent MCL-5 cells (GenTest Corp) (which stably
express enzymes cytochrome P450 1A1, 1A2, 2A6, 2E1 and 3A4), a
derivative of the human lymphoblastoid AHH-1 (TK +/-) cell line (Crespi et
al., 1991), were maintained in RPMI 1640 media, containing 9 % horse
serum and 2 mM L-histidinol, with the regular addition of hygromycin B
(100 µg/ ml) to maintain selection pressure for plasmids encoding
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metabolic enzymes. In comparison with TK6 cells, MCL-5 cells have a
prolonged cell cycle, of 24 h (Yamakage et al., 1998).
The concentration of cells growing in suspension was maintained by
regular dilution of cultures with fresh media (typically at 3 day intervals).
2.2.3 Adherent Cells
2.2.3.1 HepG2 Cells
Human hepatoblastoma epithelial (HepG2) cells were acquired from
ECACC. Cells were cultured in minimum essential medium (MEM)
supplemented with 10 % FBS, antibiotics, 1 % v/v essential amino acids
and 2 mM L-glutamine.
2.2.3.2 SKOV3 (p53 mutated) Cells
The ovarian cell line SKOV3 (p53 mutated) (ECACC) was grown in
similar media to TK6 cells (described in Section 2.2.2.1).
2.2.3.3 A549 (p53 proficient) Cells
A549 lung carcinoma epithelial cells (ECACC) were cultured in full Hams
F12 nutrient media (10 % FBS, 2 mM L-Glutamine and antibiotics).
2.2.3.4 Adherent Cell Line Culture
Adherent cell lines were grown in culture flasks with 5 ml media/ 25 cm3
and incubated at 37 °C, 5 % CO2. Upon reaching ~80 % confluency, cells
were harvested. Media was aspirated and the cell monolayer washed
with pre-warmed PBS (2.5 ml/25 cm3) to remove all traces of serum.
Trypsin-EDTA (0.25 % trypsin) was pipetted onto the flask surface to
ensure complete cell coverage, and culture vessels were incubated under
standard culture conditions for 3-5 min to facilitate cell detachment. An
equal volume of 10 % serum containing media was added to inactivate
the trypsin and cells were centrifuged at 1000 rpm for 5 min (25 °C), and
pellets suspended in an appropriate volume of media. Cells were
routinely sub-cultured and maintained at 6 x 103 - 6 x 104 cells/cm2.
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2.2.4 Procedure for Freezing Cells for Long-term Storage
Exponentially growing cultures were centrifuged (1000 rpm; 5 min) and
adjusted to 2 - 6 x 106 cells/ml in 90 % FBS: 10 % dimethyl sulphoxide
(DMSO) (molecular biology grade) (v/v), the latter serving as a
cryoprotectant. Cell aliquots (1 ml) were transferred to cryovials and
stored overnight at -80 °C, in a polystyrene box, to achieve a gradual
adjustment of cell temperature. Within 24 h of freezing, ampoules were
placed in liquid nitrogen for long-term storage.
2.2.5 Resuscitation of Frozen Cells
Ampoules recovered from liquid nitrogen storage were brought up to
ambient temperature (1 min), then to 37 ºC in a water bath (1 min); rapid
thawing of cells minimises the toxic effects exerted by DMSO. The entire
contents of a 1 ml ampoule were transferred drop-wise to a culture flask
containing pre-warmed media and incubated as above.
2.2.6 Cell Quantification and Viability
2.2.6.1 Cell Counts: Relative Suspension Growth (RSG)
Cell counts of cultures growing in suspension were routinely performed
using a Beckman Coulter counter (Beckman Coulter Inc, US).
Specifically, a 500 µl sample of cells in culture was transferred to a
coulter counter pot, and diluted with 9.5 ml isotonic buffer and values
obtained were used to monitor relative suspension growth (RSG) over
time.
2.2.6.2 Clonogenicity Assay
Following treatment, adherent cells were seeded into 6-well plates in
duplicate, at a density of 100 cells/ml and monitored for colony formation
over a period of 10 days. Cells were stained with 1 % Crystal Violet in
methanol (Sigma-Aldrich, Gillingham, UK) for 30 min, to enable optimal
visualisation of discrete colonies, and washed thoroughly prior to
counting. Colonies, comprising over ~ 50 cells were considered a positive
result, having derived from a single viable cell, and data was normalised
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to the colony forming ability of untreated control samples (representing
100 % colony forming capacity).
2.2.6.3 Trypan Blue Exclusion; Assessment of Viability
Cells suspended in media were diluted with trypan blue (1:4) and an
aliquot (5 -10 µl) was transferred to the chambers of a haemocytometer
by capillary action. Viable and non-viable cells were scored in at least
four major squares of a haemocytometer; non-viable cells appear dark
blue as the consequence of poor membrane integrity. Derived values
were used to estimate the overall cell concentration and the percent of
viable cells.
Cells per ml = [(sum of cells)/ major squares counted] x dilution factor x 104
2.2.7 MN Assay
Cells were incubated under standard cell culture conditions for 24 h post-
treatment, to allow for approximately 1.5 cell cycles (human TK6 cell
cycle ~16 h), at which time the incidence of MN was noted. MN form as
the consequence of missegregation of chromosome during mitosis, and
also by chromosomal fragmentation.
Cell samples were adjusted to 2 x 105 cells per ml, and 100 µl aliquots
spun onto Thermonax™ slides (Nalge, Nunc Int. Rochester, NY) using a
table top Cytocentrifuge (600 rpm for 5 min). All subsequent steps were
performed at room temperature. Slides were allowed to dry for 30 min,
fixed in 100 % methanol for 10 min, and air dried over night. The staining
procedure entailed sequential immersion of slides in Weise buffer (pH
6.4) (5 sec), acridine orange (0.1 mg/ml) (60 sec) and Weise buffer (5
sec), which were then subject to extended washing by a 10 and 20 min
incubation in fresh Weise buffer. Air-dried slides were cover slipped with
sterile water and the incidence of MN scored for 1000 cells per sample, in
triplicate, under a fluorescent microscope (excitation 450-490 nm). MN
are defined as distinct DNA positive (acridine orange stained) bodies
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within the cytoplasm, which morphologically resemble the main nucleus,
but are less than a third of its size.
2.2.8 Gamma-IR (IR) of Cells
2.2.8.1 Suspension Cell Lines
Exponentially growing cells were collected by centrifugation (1000 rpm for
5 min) and irradiated in 15 ml centrifuge tubes, at room temperature,
using a Cs-137 Nordian gamma irradiator to achieve the stated dose (dose
rate ~1 Gy/ min). Cell pellets were gently suspended in warm media, and
transferred to appropriate culture vessels for the desired time.
2.2.8.2 Adherent Cell Lines
Adherent cell lines were seeded at an appropriate concentration into petri
dishes and irradiated directly at 24 h. At the desired time post IR, cells
were trypsinised and collected by centrifugation.
2.2.9 Chemical Treatment of Cells
2.2.9.1 Methyl Methane Sulphonate (MMS)
Stock solutions of MMS (Sigma-Aldrich, Gillingham, UK; CAS # 66-27-3)
were prepared by dissolving 100 % MMS in 2 % aqueous DMSO to a
final concentration of 5 mg/ml, and sterile filtered using a 0.45 µm filter.
Fresh stock was prepared for each experiment and serially diluted in
culture media to the desired final concentration. Cells were cultured in
MMS containing media for 24 h, at which point the cells were prepared
for analysis.
2.2.9.2 Bleomycin (bleo)
Bleo (Sigma-Aldrich, Gillingham, UK CAS # 9041-93-4) was dissolved in
culture media to produce a stock solution of 2 mg/ml, and serially diluted
to obtain the desired concentration. Cells were exposed to bleo for 4 h,
washed in PBS, and then suspended in fresh, chemical-free media until
the time of analysis (24 h).
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2.2.10 Cell Cycle Analysis
2.2.10.1 Cell Staining Procedure
Cells were washed in PBS (following trypsinisation as necessary) and
suspended to 1 x 106 cells/ ml in cell cycle stain, comprising Triton X-100
(0.1 %), RNase H (100 µg/ml) and propidium iodide (PI) (5 µg/ml) (all
supplied by Sigma Aldrich, Gillingham, UK).
2.2.10.2 Data Acquisition
Data was acquired for cell cycle analysis, using a Becton Dickinson
FACScalibur flow cytometer (BD Biosciences, NJ, USA), which excites
samples using a 488 nm argon laser. A constant number of cells falling
within pre-set boundaries (10,000 cells/ sample) were counted by the cell
sorter using the following instrument settings: forward scatter (FSC): E-1,
(6.72 amp gain) and side scatter (SSC): 328 V (4.17 amp gain) (both on
the linear scale, and PI fluorescence was detected using filters of the
FL2-H channel (also measured on a linear scale).
2.2.10.3 Data Analysis
Data collected by flow cytometry was analysed using BD CellQuest Pro
™ Software (BD Biosciences). Healthy cells from each sample were
initially gated according to their FSC and SSC profile, which provides
information on the size and granularity of cells. Further parameters were
set by assessing DNA content (using PI staining) in combination with cell
size, to distinguish between single cells containing replicated DNA
(double the content of DNA in G2/M phase compared with G1 phase
cells), and elevated fluorescence as the consequence of two G1 phase
cells passing through the laser beam in close proximity, and therefore
being counted as a single event. Skeleton histogram plots were created
with boundaries to mark sub-G1, G1, S and G2/M phase cycling cells.
All biological samples were subject to statistical analysis by the one-way
ANOVA test (GraphPad InStat®, GraphPad Software Inc.).
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2.3 Results
2.3.1 Effect of IR on Viability and RSG in TK6 Cells
Low dose IR (1 Gy) did not significantly influence the viability of TK6
cells, as indicated by trypan blue exclusion analysis at 24 h. Specifically,
0.1 – 1 Gy IR diminished cell viability by 4 - 11 % of control populations
(Figure 2.1 A), although following high IR exposure (5 – 10 Gy), viability
was significantly diminished in a dose-dependent manner (Figure 2.1 A).
In contrast, RSG, which is employed as a measure of cellular proliferation
capacity, was only affected at 1 Gy IR and above, although to a greater
extent than viability (Figure 2.1 A). It was noted that data obtained by
trypan blue exclusion displayed minimal inter-population variation and a
more prominent dose-response, compared with RSG derived data,
although the latter parameter was useful for highlighting diminished
replication capacity at 1 Gy IR and above. Together, these results imply
RSG as a more sensitive, although somewhat variable indicator of subtle
changes in cellular function.
2.3.2 Effect of IR on MN Incidence in TK6 Cells
The MN assay was employed as a direct measure of DSB induction,
which indicated clastogenic events in 5, 10, 17 and 30 % of cells
following 0.1, 0.5, 1 and 5 Gy IR, compared with 4 % of control,
unirradiated cells (Figure 2.1 B). This translates to a 4 and 7.5 fold
increase in the number of cells with MN following 1 and 5 Gy IR
respectively, both of which were deemed statistically significant by
ANOVA. Data presented here indicated significant DSB induction in TK6
cells following exposure to 0.5 Gy and above, thus confirming IR as an
efficient source of DNA damage.
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Figure 2.1 Effect of IR on TK6 Cells: Viability, RSG and MN Incidence
(A) Trypan blue exclusion was used as a measure of TK6 cell viability at 24 h
post IR, and was compared with cell proliferation as indicated by total cell
counts (RSG). (B) The incidence of MN formation in TK6 cells was noted as a
measure of clastogenicity. Cells were analysed at 24 h for MN induction: 1000
cells were scored per sample.
N = 3 +/- SEM * P < 0.01 compared to control cells as indicated by ANOVA.
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2.3.3 Effect of IR on Cell Cycle Distribution in TK6 Cells
Cell cycle progression is associated with increasing DNA content, an
attribute that is widely exploited for analytical purposes. By employing
nucleotide-intercalating agents such as PI (see Section 2.2.10.1), sub-
populations representing each distinct phase of the mammalian cell cycle
may be distinguished, as exemplified in Figure 2.2 A.
Within 4 h of irradiating exponentially growing cells, the proportion of non-
replicating G1 phase cells was significantly diminished (> 2-fold),
concomitant with elevated cells in S and G2/M phase, in comparison with
unirradiated populations (Figures 2.2 B). The observed S and G2/M
phase build up of cells was indicative of a rapid cell cycle arrest to
prevent replication of cells containing damaged DNA. At 24 h, following 1
Gy IR, the percent of cells contributing to each phase of the cell cycle
remained altered relative to unirradiated cells, although the overall
distribution pattern more closely resembled that of control populations,
therefore implying restoration of physiological function (Figure 2.2 C).
However, fewer cells were observed in G1 phase relative to S and G2/M
phase at 24 h post 5 Gy IR (Figure 2.2 C), suggesting that cell cycle
progression was more severely compromised with increasing IR
exposure. An elevated sub-G1 population at 24 h following IR
represents apoptosis in a subset of cells, as the consequence of overt
damage (Figure 2.2 C).
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Figure 2.2 Effect of IR on TK6 Cell Cycle Distribution
(A) PI intensity along the X-axis was extrapolated to indicate cell cycle stage:
M1 = G1, M2 = S, M3 = G2/M –phase cells, and pre-M1 = apoptotic cells.
Exponentially growing cells were irradiated and subsequently analysed for DNA
content at 4 h (B) N = 3 +/- SEM + P < 0.05 * P < 0.001 relative to control cell
population distribution (ANOVA), and at 24 h (C) (N = 1).
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2.3.4 Effect of IR on A549 Adherent Cells
A549 cells have been widely exploited during in vitro genetic toxicology
studies (Vock et al., 1998) (Zhu et al., 2005) (Boesewetter et al., 2006).
Irradiated A549 cells were subject to cell cycle analysis at 4 and 24 h,
which revealed a G2/M phase accumulation at 4 h (Figure 2.3 A),
suggesting a rapid response, which blocks mitotic progression and cell
division. In contrast with TK6 cells (Figure 2.2 B), the accumulation of
cells in S and G2/M phase was far less pronounced in A549 cells at 4 h.
The ability of adherent cell lines to form visible colonies over several days
provides a useful indication of the long-term effects of treatment on
cellular function. Following IR, the ability of A549 cells to form colonies
was diminished by 50 and 90 % following 1 and 5 Gy IR respectively
(Figure 2.3 B). Interestingly, 1 Gy IR exposure appeared to have a
growth stimulatory effect on p53 mutated SKOV3 cells (elevated by 50 %
relative to unirradiated cells), although no colonies were observed
following 5 Gy IR (Figure 2.3 B).
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Figure 2.3 Effect of IR on A549 and SKOV3 (p53 mutated) Cells
(A) A549 cells were irradiated (1 Gy) and DNA content was analysed by
flow cytometry following PI staining, at 4 and 24 h. N = 2 (B) A549 or
SKOV3 cells were irradiated, seeded at low density, and the capacity to
generate colonies was determined by manual scoring at 10 days. Data is
expressed as colony forming units (CFU) relative to unirradiated samples.
N = 2.
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2.3.5 Effect of MMS Treatment on Cell Cycle Distribution
MMS is commonly employed as a positive control in genetic toxicology
studies at 50 µg/ml, however data presented here indicated overt
cytotoxicity under similar conditions (Figure 2.4 A), and so a
concentration range of 6.25 - 25 µg/ml was considered most appropriate
for further investigation. Cell counts performed following 24 h incubation
(12.5 µg/ml MMS) suggested that MCL-5 cells were more sensitive to the
cytotoxic effects of MMS relative to TK6 cells (RSG corresponds to 42
and 73 % of control levels respectively) (Figure 2.4 B), which is possibly a
metabolism related effect. In contrast, ATM deficiency in AT cells,
imparted a degree of resistance to the cytotoxic effects of MMS, as
indicated by a less pronounced reduction in RSG (Figure 2.4 B).
A concentration of 6.25 µg/ml MMS (24 h exposure) was sufficient to
impair TK6 function, characterised by diminished RSG (Figure 2.4 A & B)
and fewer cells were observed in G1 phase, accompanied by an S and
G2/M phase accumulation (Figure 2.5 B). With increasing dose, the G2/M
population diminished in a concentration dependent manner, indicative of
fewer cells progressing through S phase, and a more pronounced S
phase and G1 phase accumulation following treatment with 12.5 and 25
µg/ml MMS respectively, was observed (Figure 2.5 B). This result may
correspond to the arrest of cells at earlier stages throughout the cell
cycle, with increasing DNA damage and cytotoxicity. A dose-dependent
accumulation of cells in G2/M and S phase was evident in MCL-5 cells
also (Figure 2.5 A and D), although to a lesser extent, such that exposure
to 12.5 and 25 µg/ml MMS was characterised by a trend similar to that
observed following 6.25 and 12.5 µg/ml MMS treatment of TK6 cells
(Figure 2.5 B).
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Figure 2.4 Effect of MMS Treatment on Suspension Cells
Suspension cells were cultured with MMS for 6 - 24 h prior to analysis of
proliferation capacity as indicated by RSG. (A) TK6 RSG was compared at 6
and 24 h after MMS treatment N = 3 +/- SEM * P < 0.001 by ANOVA. (B) The
impact of MMS on RSG was compared in AT, TK6 and MCL-5 cells following a
24 h exposure to 6.25 – 12.5 µg/ml MMS (N=2).
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Figure 2.5 Effect of MMS on Cell Cycle Distribution in Suspension Cells
(A) Flow cytometric plots represent the cell cycle distribution in MCL-5 cells
following 24 h incubation with 0, 12.5 and 25 µg/ml MMS (top – bottom).
Graphical representation of cell cycle distribution at 24 h in (B) TK6 cells (N =1),
(C) ATM deficient AT cells (N = 3 +/- SEM) and (D) MCL-5 cells (N = 3 +/-
SEM). + P < 0.05; * P < 0.001 by ANOVA, with Dunnetts post test.
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In contrast, MMS treatment had little effect on the cell cycle distribution of
AT cells (Figure 2.5 C), which is in agreement with RSG-derived data
(Figure 2.3 B). A noteworthy effect was a marginal, yet significant
decrease in the G2/M population following MMS exposure, concomitant
with elevated S phase cells relative to control cells (Figure 2.5 C).
Cell cycle data presented here indicated TK6 as the most sensitive cell
line to MMS, although this was contradicted by RSG data, from which it
may be inferred that MCL-5 cells are more sensitive to the growth
inhibitory effects of MMS. However the duration of the MCL-5 cell cycle is
longer than TK6 cells (24 v 16 h) (Yamakage et al., 1998), and possibly
accounts for the differences reported herein.
2.3.6 Effect of Bleo Treatment on Cell Cycle Distribution:
The Impact of ATM Status
Exposure of TK6 cells to the radiomimetic compound bleo led to an
elevated fraction of sub-G1, apoptotic cells, concomitant with a
diminished G1 and S phase population, relative to control samples
(Figure 2.6 A). Bleo treated samples failed to mimic the cell cycle
distribution pattern observed following IR (Figure 2.2), which was
possibly a consequence of cell recovery within the time period employed
here (24 h), in accordance with previous reports (Islaih et al., 2005).
Although bleo did not have a considerable impact on cell cycle
distribution at 24 h, the sub-G1 apoptotic population (Figure 2.6 A), was
substantially elevated following treatment, and was greater than that
observed following IR (Figure 2.2 C). The cell cycle distribution of bleo
exposed AT cells deviated only slightly from control populations, with a
moderate increase in the fraction of cells in S and G2/M phase following
1.25 and 2.5 µg/ml bleo respectively (Figure 2.6 B). In contrast to TK6
cells, the apoptotic (sub-G1) subpopulation was less pronounced in AT
cells following bleo treatment, relative to control cells (Figure 2.6 A & B).
Thus in the absence of ATM signal transduction, the capacity of cells to
undergo apoptosis in response to bleomycin was compromised.
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Figure 2.6 Effect of Bleo on Cell Cycle Distribution: The Role of ATM
TK6 (A) and AT (B) cells were exposed to bleo for 4 h and allowed to recover for
20 h, at which point DNA content was analysed by PI staining as an indication of
cell cycle stage. N = 2.
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2.3.7 Effect of Bleo Treatment on MN Incidence:
The Impact of ATM Status
In response to bleo, the proportion of MN positive TK6 and AT cells was
significantly elevated, in a dose-dependent manner, relative to control
populations (Figure 2.7 A). Despite a similar trend for elevated DSB
regardless of ATM status, the dose response observed in AT cells was
marginally steeper compared to TK6 cells. Furthermore, a greater
incidence of MN positive cells was reported under physiological
conditions in AT cells, thus implying a residual of chromosomal damage
(Figure 2.7 A). This may be accounted for by the accumulation of
endogenously arising DSB, which may not be efficiently repaired in the
absence of ATM signalling.
In contrast to bleo treatment, exposure of AT cells to DSB-inducing
relevant doses of MMS (6.25 – 25 µg/ml) led to an increased percent of
MN positive cells only at 12.5 µg/ml (Figure 2.7 B).
2.3.8 Effect of MMS on Long Term Survival in Relation to p53
Status
The absence of functional p53, rendered cells sensitive to MMS killing,
with CFU reduced to approximately 25 and 6 % of control levels in the
SKOV3 (p53 mutated) cell line, compared with 50 and 38 % in p53
expressing HepG2 cells, following 6.25 and 12.5 µg/ml exposure
respectively (Figure 2.8). Hence long-term cell survival following MMS
exposure apparently depends on p53.
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Figure 2.7 Effect of Bleo and MMS on MN Incidence
(A) The MN assay (a minimum of 1000 cells scored per sample) indicated a
significant induction of DSB in TK6 and AT cells in response to bleo treatment (4
h exposure followed by a 20 h drug-free period). N = 3 +/- SEM + P < 0.05; * P <
0.01 (B) MN assay data derived from MMS treated AT cells (24 h continuous
exposure) (N = 2).
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Figure 2.8 Effect of MMS on Colony Formation
Following 24 h culture in MMS-containing media, p53 proficient (HepG2) or
mutated (SKOV3) cells were seeded at low density (100 cells/ ml) and the ability
to generate colonies was assessed at 10 days.
N = 1 Data is expressed as the percent of colony forming units under control
conditions.
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2.4 Discussion
In order to validate novel markers of DSB, it was deemed necessary to
optimise treatment conditions, to avoid confounding factors such as
apoptotic associated DNA laddering, and to obtain an insight into the
capacity of cells of DSB relevant phenotypes to respond to external
stress.
Specifically, RSG or colony formation, cell cycle analysis, and membrane
integrity was monitored to provide an indication of cellular function. A
more attenuated response was observed under conditions examined,
when analysing membrane integrity, in comparison with RSG, implicating
the latter as a more sensitive indicator of subtle changes in cellular
function. It was however, noted that viability by trypan blue exclusion
displayed less inter-population variation by comparison with RSG.
Herein, cells expressing ATM were deemed capable of eliciting an
appropriate cell cycle response following DSB-inducing treatment that
included MMS and IR. In line with previous reports, TK6 cells elicited an
S and G2/M phase arrest (Buscemi et al., 2004) (Islaih et al., 2005),
within 4 h of IR. However, different levels of sensitivity were evident
between cell lines investigated, such that A549 cells appeared radio-
resistant compared to TK6 cells. In accordance with previous studies, IR
induced clastogenicity in approximately 10 and 20 percent of TK6 cells
following 0.5 and 1 Gy IR (Stopper and Lutz, 2002), and was inversely
related to viability at exposure levels of 1 Gy and above. This result
provided confirmation of DSB induction under experimental conditions
employed here, and was used as a comparator to H2AX antibody data,
which is presented in Chapter 3.
Interestingly, treatment of TK6 cells with the radiomimetic compound bleo
failed to induce a similar cell cycle distribution profile to IR at 24 h.
However, extrapolation of MN derived data, suggests that doses
employed here would have an equivalent clastogenic effect to that
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observed following 0.1 - 0.5 Gy IR, which is below the limit of IR
investigated during cell cycle studies reported here. Bleo treatment, as a
substitute for IR exposure was more clastogenic towards AT cells,
compared to TK6 cells, thus confirming the fundamental role of ATM in
the repair of DSB (Canman et al., 1998). Consistent with this result, cells
originating from Ataxia patients and also ATM knockout models exhibit a
radiosensitive phenotype (Sikpi et al., 1998) (Li et al., 2006).
The trend for an MMS related cell cycle arrest described here for TK6
cells, was observed in MCL-5 cells also, although at double the
concentration of MMS. This was despite MCL-5 cellular proliferation
being more severely attenuated at comparable concentrations. Possibly,
the apparent MMS resistant phenotype observed reflects an inherent
capacity for compound metabolism by MCL-5 cells or alternatively,
differences in cell cycle duration may account for this discrepancy (TK6 ~
16 h v MCL-5 ~ 24 h (Yamakage et al., 1998)). In contrast, ATM deficient
cells (AT) failed to engage a cell cycle arrest following 24 h incubation
with MMS, and the progression of cells containing damaged DNA through
replication and mitosis, would support the formation of MN. Thus, a high
frequency of clastogenic events in AT cells was anticipated, although this
notion was not supported by MN data, which indicated clastogenicity at
12.5 µg/ml MMS only.
BER and HR are reported to contribute towards the repair of MMS
induced lesions (Pascucci et al., 2005) (Lundin et al., 2005), with BER
primarily acting during G1 phase to remove modified bases (Offer et al.,
2001), while HR presumably deals with SSB repair intermediates or
unrepaired lesions, following their conversion to DSB upon collision with
the S phase replication fork. Thus cell cycle inhibition allows time for
repair thereby accounting for the accumulation of MMS exposed cells in
S and G2/M phase observed here. It is reasonable to speculate that AT
cells would elicit a similar MMS-associated response to that described for
ATM proficient cells, due to the prominent role of ATR in responding to S
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phase associated breaks, as opposed to ATM. However data presented
here suggested that ATM was, in part, responsible for implementing the
observed S and G2/M phase arrest in TK6 and MCL-5 cells, based on the
similarity of cell cycle distribution between IR and control AT cell
populations. Together with recent reports of a role for KU-mediated
modulation of ATM dependent ATR activation (Tomimatsu et al., 2007) it
may be inferred that ATM partakes in the cellular response to MMS.
Although p53 mediated apoptosis is widely implicated in the MMS and
IR response, elevated cell death in the absence of p53 has been
reported also (Lackinger et al., 2001), which is in accordance with this
investigation. Data herein supported the notion of attenuated survival of
SKOV3 p53 mutated cells following high dose IR (5 Gy), and MMS
treatment also, relative to p53 proficient cells. Despite previous
investigations having failed to report alterations in the abundance of
apoptosis promoting proteins in SKOV3 cells following IR (Concin et al.,
2003), long term cell survival was diminished to a greater magnitude
relative to A549 (p53 proficient) cells in this study. Thus cell death may
proceed via a p53-independent pathway.
To summarise, work presented within this chapter has identified the
following treatments, in a range of human cells, for further investigation of
DSB induction, in the absence of overt, non-specific cytotoxicty (>50 %):
IR: 0.5-5 Gy; MMS: 6.25-25 µg/ml and bleo: 2.5 µg/ml. Specifically, TK6,
A549 and MCL-5 cells are suggested as suitable in vitro models for
validating a novel marker of DSB, while AT and SKOV3 cells are
applicable for investigating the effect of ATM and p53 deficiency.
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3 H2AX: A Marker of DSB in Human Cells
3.1 Introduction
Several authors have described the application of H2AX to quantify DSB
related damage (Rogakou et al., 1998) (Zhou et al., 2006), along with
associated limitations (MacPhail et al., 2003) (McManus and Hendzel,
2005). Most notably, H2AX detects apoptosis related DNA laddering, so
in this sense behaves as a general marker of cytotoxicity (Banath and
Olive, 2003). Nevertheless, H2AX has found widespread application as
a marker of DNA damage, and in this context the work described herein
aims to investigate existing technologies available for measuring H2AX,
in whole, fixed cells. A comprehensive review of H2AX as a marker of
DNA damage is provided in Chapter 1; section 1.6.
3.1.1 Commercially Available H2AX Assays
At present three validated assays are commercially available for
measuring H2AX. The first, supplied by Upstate Signaling Solutions
employs a FITC (green fluorophore)-conjugated-phospho-H2AX specific
antibody, which is used to stain cells in a 96-well plate format for high
throughput sample processing by flow cytometric analysis. Manufacturers
guidelines indicate the detection of both DNA damage and apoptotic
events, and no attempt is made to differentiate between the two, thus
acknowledging the ambiguity associated with H2AX. A similar assay
provided by CycLex ® Co., Ltd (Nagano, Japan), which is also intended
for high throughput application, exploits Enzyme Linked Immuno-Sorbant
Assay (ELISA) methodology for detecting H2AX in 96-well plates. This
assay entails probing cells with a primary anti-H2AX antibody, followed
by incubation with a secondary antibody conjugated to horseradish
peroxidase (HRP). Following the addition of appropriate reagent,
substrate is converted by HRP to produce an assayable signal, which is
detected using a fluorescent microplate reader. In comparison with the
former assay however, additional stain and wash steps increases assay
duration and sample handling. Finally, the DNA Damage Assay by Active
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Motif ® (Carlsbad, CA, USA) uses a H2AX specific antibody for detecting
the ‘induction of double-stranded DNA breaks and apoptosis’, and
incorporates propidium iodide as a nuclear marker. Plates are
subsequently analysed using a fluorescent microplate reader.
Identifiable limitations of the described assays include:
• Requirement to process cells: fix, permeabilise, stain and wash
• Not applicable to living cells
• No discrimination between DSB and apoptotic events
• Plate reader assays require optimisation of cell number per well
Of the assays described, the Upstate Cell Signaling Solutions assay
appears preferable for minimising sample handling by employing a single
antibody stain step. Although data acquisition takes longer using flow
cytometry in comparison with microplate reader platforms, utilisation of
automated high throughput cytometers renders this a minor issue.
As a comparator to the novel DSB reporter described within this thesis,
the application of H2AX as a marker of DSB was investigated. Here, the
sensitivity and suitability of a flow cytometric based assay (Upstate
Signaling Solution H2A.X Phosphorylation Assay Kit: Millipore, Herts, UK)
was compared with fluorescence microscopy and digital imaging
platforms, following the treatment of various cell lines with reference
clastogenic and mutagenic agents. Further studies were conducted to
delineate the H2AX response of selected cell lines to the dietary
mutagen 2- amino-1- methyl- 4- phenylimidazol [4, 5- B] pyridine (PhIP)
and the anti-malarial compound Cryptolepine (CLP), which is reported
here for the first time.
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3.2 Methods
3.2.1 Cell Culture
Cell culture methodology is described in Section 2.2.3.
3.2.2 Irradiation
Cells were irradiated as described in Section 2.2.8.
3.2.3 Chemical Treatment of Cells
Stock solution was achieved by dissolving PhIP (MW 224) or CLP (MW
232) (both obtained from Professor Nigel J Gooderham, Imperial College
London, UK) in sterile 2 % aqueous DMSO to achieve a final
concentration of 10 mM, passed through a sterile 45 µM filter, and diluted
into media to obtain the required concentration. MMS was prepared as
described in Section 2.2.9.1. Exponentially growing cells were exposed to
chemical for the desired time, at which point the media was replenished,
and culture vessels were returned to the incubator until time of analysis.
3.2.4 Inhibition of ATM Kinase Activity using Wortmannin (WRT)
Cells were incubated in media containing 10 µM WRT for 30 min, washed
with PBS and fresh media added, prior to further chemical or irradiation
treatment.
3.2.5 Whole Cell Antibody Studies
3.2.5.1 Cell Fixation
Cells intended for antibody staining were washed with PBS to remove
any trace of serum and suspended* in 70 % ice-cold ethanol (prepared
with nuclease free PBS) to 2 x 106 cells/ ml. Specifically, ethanol was
added to cell pellets in a drop-wise manner with gentle vortexing to
prevent cell aggregation, and incubated at -20 °C for at least 1 h. Cells
were stored at < 0 °C until time of analysis.
* Adherent cells were first trypsinised and brought into suspension (Chapter 2.2.3.3)
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For microscopy applications, adherent cells were cultured and chemically
or IR treated directly on 5 mm diameter cover slips, or suspension cells
were cytospun onto slides (described in Section 2.2.7) immediately
before fixation. Slides, or cover slips were immersed in PBS to wash cells
and transferred to ice-cold 70 % ethanol and fixed for at least 1 h at -20
°C.
3.2.5.2 Cell Blocking and Antibody Staining
Fixed cells were washed and incubated in 3 % Bovine Serum Albumin
(BSA)-PBS (v/v) blocking solution at room temperature for 30 min
followed by a 30 min incubation with FITC-conjugated H2AX specific
antibody (Upstate cell Signalling Solutions: Millipore, Herts, UK) (diluted
1: 650 in blocking solution) on ice. For flow cytometry, cells were washed
with PBS to remove non-specifically bound antibody and suspended in
either FACS-flow (BD Biosciences, NJ, USA), or cell cycle analysis
solution (Section 2.2.10.1).
3.2.6 Flow Cytometry
Prior to flow cytometry analysis cells were passed through a 45 µM filter
(BD Biosciences, NJ, USA) to remove extensive cell aggregates. Flow
cytometric analysis was then performed in accordance with methodology
outlined in Section 2.2.10.2-3
Samples excited by a 488 nm laser were analysed for FITC-anti-H2AX
antibody fluorescence in the FL-1H channel (green) (log scale), and
where applicable PI was measured in the FL-2H channel (red) (linear
scale). Specific markers were applied to dot- plots, for indicating H2AX
antibody staining in relation to cell cycle.
3.2.7 Fluorescent Microscopy
Immediately after antibody staining, cells were briefly stained with the
nuclear marker DAPI (1 µg/ml) (Sigma-Aldrich, Gillingham, UK), washed
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in PBS, and cover slips were mounted using Vectashield® HardSet
Mounting Medium (Vector Laboratories, Peterborough, UK) to prolong
fluorescent molecule half-life. Slides were stored in the dark at 4 °C
overnight. Images were captured using a Zeiss wide-field microscope
digital imaging set-up (Carl Zeiss MicroImaging Inc., Thornwood, NY,
USA) and the incidence of H2AX was scored for a minimum of 20 cells
per slide, in 3- Z planes. Only foci appearing in the nuclei, as indicated by
DAPI staining, were considered meaningful in this study.
3.3 Results
3.3.1 H2AX: A Marker of DSB: Flow Cytometric Analysis
3.3.1.1 IR of TK6 Cells
During initial studies a limited IR dose range was chosen for H2AX
analysis, to provide data on populations that were predicted to contain
minimal foci, (0 Gy) and significant levels of DSB related foci (5 Gy). The
intensity of H2AX and distribution of foci was also investigated under
overtly cytotoxic conditions (10 Gy) and IR exposure levels were
selected based on the data described in Chapter 2. Sample populations
were analysed at 30 min and 4 h for H2AX induction, in conjunction with
DNA staining by PI, the latter employed to denote cell-cycle stage. Within
30 min, a trend for elevated fluorescence intensity on the Y-axis of flow
cytometric bivariate plots was observed, indicative of H2AX
phosphorylation under all treatment conditions, and by 4 h H2AX
staining was greatly diminished, although to a lesser extent with
increasing IR (Figure 3.1). It was noted that G1 phase cells (red box
region) displayed the greatest fold induction following treatment, which
was most likely the consequence of less intense FITC-anti-H2AX
staining detected in G1, unirradiated cells compared with cells from all
other stages of the cell cycle (evident from plots shown in Figure 3.1). A
further observation of interest was the intensely FITC-anti-H2AX stained
population (green oval) detected almost exclusively following 5 and 10 Gy
IR, which was thought to represent early apoptotic cells (Figure 3.1).
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Figure 3.1 Analysis of H2AX in Relation to Cell Cycle
Dual staining of TK6 cells with FITC-anti-H2AX antibody (along the Y-axis) and
the DNA intercalating dye PI (along the X-axis) provides information regarding
H2AX intensity in relation to cell cycle position. A boundary was applied to
contain the majority of control cells (black region), G1 cells (red region) and the
H2AX intensity of cells anticipated in response to apoptosis (green oval) (ie:
pre-apoptotic cells).
Time Post-IR: 30 min 4 h
R R
R
R
RR
Dose
IR
0 Gy
1 Gy
5 Gy
10 Gy
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To allow time for sample preparation prior to analysis, a 1 h time-point
was deemed logistically favourable for further studies. Less than 20 % of
unirradiated TK6 cells were positive for H2AX, which was elevated at 1 h
post IR in an exposure dependent manner (Figure 3.2 A). This
observation was in agreement with MN data, although following low dose
IR (0.5 Gy) the MN assay appeared to provide a more sensitive indicator
of clastogenicity (Figure 2.1 B). Initially, the percent of cells exhibiting
significant levels of H2AX (as indicated by analysis in accordance with
the manufacturers guidelines), and the mean fluorescence intensity (Fl-I)
of FITC-anti-H2AX per cell were compared, both of which increased in a
dose-dependent manner (Figure 3.2 A).
Since the mean fluorescence intensity of anti-H2AX per cell was
pronounced at all IR exposure levels (Figure 3.2 A), this parameter was
considered to display greater sensitivity compared with the percent of
H2AX positive cells, and so was employed in subsequent studies
A cell-cycle dependent effect was apparent from bivariate flow cytometric
plots, (Figure 3.1), and due to a greater intensity of FITC-anti-H2AX
staining during S and G2/M phase, a more prominent increase in H2AX
was evident in G1 cells following IR (Figure 3.2 B). It was speculated
that S and G2/M phase related foci represent endogenously occurring
breaks generated during DNA replication and via metabolism related
oxidative stress, however this hypothesis was not investigated here.
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Figure 3.2 Analysis of H2AX in Irradiated TK6 Cells
(A) Graphical representation of the percent of H2AX positive cells, and the
mean fluorescence intensity of FITC-anti-H2AX antibody per cell. (B)
Populations were analysed for H2AX induction in conjunction with cell cycle
phase. Data is presented relative to control, unirradiated cells.
N = 3 +/- SEM * P <0.05 ** P < 0.0005 compared with control samples
(ANOVA).
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Unless otherwise stated, data in the following sections is presented as
the fold-induction in mean fluorescence intensity of FITC-anti-H2AX per
cell, relative to control populations.
3.3.1.2 MMS Treatment of TK6 and MCL-5 Cells
A growing body of evidence indicates the formation of DSB following
exposure of cells to the alkylating chemical MMS including the induction
of DNA repair genes (Boesewetter et al., 2006) (Smith et al., 2006) and
elevated levels of H2AX (Zhou et al., 2006). The generation of DSB is
further supported by the COMET assay but not MN derived data
(Valentin-Severin et al., 2003), and consequently it has been suggested
that DSB may arise from heat-labile methylated bases during sample
preparation procedures (Lundin et al., 2005).
Under test conditions employed here, MMS treatment significantly
induced H2AX in TK6 cells, regardless of cell-cycle position at 24 but not
6 h (Figure 3.3 A). It is reasonable to postulate that 6 h exposure
provides sufficient time for MMS diffusion across cellular membranes, to
access and react with DNA, and thus the absence of H2AX at this time-
point supports the notion that DSB formation is secondary to MMS
induced methyl-DNA-adducts (i.e. DSB are generated as an intermediate
of BER (Wyatt and Pittman, 2006)). At all concentrations of MMS, H2AX
was significantly elevated in a dose-dependent manner (Figure 3.3 B),
although at 50 µg/ml this effect was attenuated, indicative of a diminished
capacity of cells to manifest a repair associated response. This
conclusion is supported by cytotoxicity data shown in Chapter 2.3 A.
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Figure 3.3 Analysis of H2AX in MMS Treated TK6 Cells
(A)TK6 cells analysed for H2AX in relation to cell cycle after 6 and 24 h
exposure to MMS (12.5 µg/ml) are depicted as flow cytometric plots; coloured
boxes contain the majority of control cells (G1, S and G2/M- phase cells are
contained within red, yellow and blue regions, respectively). The absence of an
intensely stained population implied a lack of apoptotic cells. (B) Induction of
H2AX relative to control cells at 24 h.
N = 3 +/- SEM * P < 0.05 ** P < 0.001 compared to control samples as indicated
by ANOVA.
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Following exposure of the metabolically competent cell line MCL-5 to
MMS, an increase in H2AX was observed for concentrations up to 50
µg/ml, (Figure 3.4 A and B), however the overall magnitude of response
was attenuated in comparison with TK6 cells (Figure 3.3 B). Furthermore,
a discrete apoptotic population was evident on flow cytometric plots of
MCL-5 cells following 12.5 µg/ml MMS treatment (Figure 3.4 A (green
oval)), which was absent from TK6 cell samples (Figure 3.3 A).
Together, these observations indicate a diminished capacity of MCL-5
cells to signal DSB through H2AX modification compared with TK6 cells,
possibly due to lower kinase activity, thus reducing the relative induction
ratio upon damage.
3.3.1.3 PhIP Treatment of MCL-5 Cells
The impact of the dietary heterocyclic amine PhIP, which requires
metabolic conversion to generate the reactive N-OH-PhIP derivative, was
investigated here using metabolically competent MCL-5 cells. Following
24 h incubation with PhIP, a small (17 %) but significant increase in
H2AX above basal levels was observed, but only at the highest
concentration (100 µM) (Figure 3.4 C). DNA staining however revealed a
trend for elevated H2AX in a dose-dependent manner in S phase cells at
all doses, thus emphasising the advantage of dual staining flow cytometry
(Figure 3.4 D). 
 
PhIP treatment at human relevant exposure levels, causes a range of
biological effects in vitro, including the induction of genes involved in cell
cycle regulation and apoptosis, and, elevated p53 levels concomitant with
growth inhibition and accumulation of cells in G1 phase (Creton et al.,
2005) (Zhu et al., 2005) (Gooderham et al., 2007). PhIP has only recently
been shown to directly induce DNA strand breaks, the mechanism being
attributable to the generation of reactive oxygen species, and in the
present study, significant genotoxicity (DSB) was indicated only at 100
µM, which is in accordance with previous observations (Wilson et al.,
2007).
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Figure 3.4 Analysis H2AX in MMS and PhIP Treated MCL-5 Cells
(A) Flow cytometric plots represent dual stained MCL-5 populations for
simultaneous analysis of cell cycle distribution and H2AX: left - right: 0, 12.5 &
25 µg/ml MMS; Overtly intense H2AX signal represents apoptotic cells (green
boundaries). (B) Graphical representation of H2AX induction following MMS
treatment. (C) The impact of PhIP exposure on H2AX in MCL-5 cells. (D) The
impact of PhIP on H2AX intensity/cell in relation to cell cycle.
N = 3 +/- SEM + P = 0.01; * P < 0.05 compared to control samples, as indicated
by ANOVA.
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However, the origin of breaks detected here was speculated to be the
consequence of genetic lesions (i.e. N-OH-PhIP adducts), colliding with
the replication fork, thus accounting for the induction of H2AX foci
predominantly in replicating and mitotic cells (Figure 3.4 D). Since H2AX
levels were elevated only slightly, the effect observed here was unlikely
to be apoptosis related.
3.3.1.4 CLP Treatment of TK6 Cells
The aqueous root extract of the plant Cryptolepis sanguinolenta contains
the active alkaloid; cryptolepine (CLP), which intercalates with and
stabilises DNA bound Topoisomerase II (Bonjean, K Biochemistry 1998),
induces apoptosis in human cells (Dassonneville et al., 2000) and is
deemed mutagenic and clastogenic in the mouse lymphoma and MN
assays, respectively (Ansah et al., 2005) (Internal unpublished data).
Following a 24 h exposure to CLP TK6 cell viability was significantly
diminished at CLP  5 µM (Figure 3.5 A), however cells failed to manifest
a DSB response, as indicated by the mean fluorescence intensity of
FITC-anti-H2AX per cell (Figure 3.5 B). However the percent of cells
displaying FITC-anti-H2AX levels above a defined threshold was
significantly altered following CLP exposure, relative to control cells (i.e.
the H2AX positive cell population was diminished at  5 µM and
elevated at 10 µM CLP exposure) (Figure 3.5 B). Under similar conditions
to those employed here, the induction of DSB has been indicated by MN
studies conducted in V79 Chinese Hamster fibroblasts (Ansah et al.,
2005) although no significant increase in MN incidence was reported
using human HepG2 cells (Ansah et al; unpublished data). HPRT data
was also negative in the HepG2 cell line, which suggests that CLP is not
a mutagen (Ansah and Gooderham, 2002). Data presented herein, along
with previous reports that CLP fails to induce MN in HepG2 cells, have
led to the speculation that human cells may exhibit greater resistance to
the genotoxic effects of CLP compared with rodent cell lines.
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Figure 3.5 Analysis of H2AX in CLP Treated TK6 Cells
(A) The impact of CLP on TK6 viability was determined by trypan blue analysis,
following 24 h continuous exposure. N = 4 +/- SEM (B) The impact of CLP (24 h
exposure) on H2AX. The mean fluorescence intensity (FL-I) and the percent of
gated cells were compared here.
N = 4 - 6 +/- SEM * P  0.01 compared to control cells as indicated by ANOVA.
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3.3.2 H2AX: A Marker of DSB: Fluorescent Microscopy
3.3.2.1 IR TK6 Cells
The mean number of discrete H2AX foci scored per nucleus was
positively correlated with IR and remained elevated at 6 h (Figure 3.6 A).
At 1 h, 5 Gy IR induced foci in all cells, of which more than half
contained greater than 10 foci (Figure 3.7 A), and at 10 Gy the
appearance of intensely stained foci were observed (Figure 3.6 B). Under
all conditions, a faint homogeneous staining throughout the volume of the
nucleus was noted, which at high resolution presented as minute foci,
most likely denoting non-DSB related H2AX (McManus and Hendzel,
2005). The application of a minimum foci size eliminated the scoring of
non-DSB related foci, and significantly reduced the background signal in
control cells compared with flow cytometric analysis. This is a clear
example where imaging permits a higher degree of investigator control
compared to population analysis by flow cytometry.
Within 6 h, H2AX staining was diminished after 1 Gy IR, although with
increasing dose the loss of discrete foci was attenuated, and following 10
Gy IR, H2AX incidence continued to increase (95 % cells displayed >
10 foci) (Figures 3.6 A & B, and Figure 3.7 B). The accumulation of DSB
at 10 Gy as the consequence of apoptosis was not ruled out here,
although this seemed unlikely since only cells of healthy appearance
were scored. This contrasts with flow cytometric data, which indicated
diminished H2AX staining within 4 h of IR, and so fluorescence
microscopy appears the more sensitive tool in this instance.
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Figure 3.6 Effect of IR on TK6 Cells: Analysing H2AX by Microscopy (I)
TK6 cells were irradiated and analysed for H2AX at 1 and 6 h, by fluorescence
microscopy. (A) At 1 h the mean number of H2AX foci per nucleus in 1 plane of
view increased in a dose-dependent manner between 0 and 10 Gy IR (B) Cells
at 6 h are represented following 0 (left) and 10 Gy (right) IR.
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Figure 3.7 Effect of IR on TK6 Cells: Analysing H2AX by Microscopy (II)
TK6 cells were irradiated and analysed for H2AX at 1 and 6 h (A and B
respectively) by fluorescence microscopy, to provide a detailed insight into
H2AX foci formation in response to IR: 20 cells were scored per image in a
single plane of view.
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3.3.2.2 IR of A549 and SKOV3 Adherent Cells
The use of adherent cell lines was deemed preferential for microscopy
studies, since cells are cultured directly on microscope slides, and so
fewer processing steps are required during antibody studies. Additionally,
nuclear and cytoplasmic compartments may be more easily distinguished
due to the greater surface area covered by adherent cells. To further
enable distinction between nuclear and cytoplasmic foci, the DNA stain
DAPI was employed in conjunction with FITC-anti-H2AX, and three
planes of view were analysed per image, thus providing a more
comprehensive overview of H2AX distribution.
Following 1 or 5 Gy IR, multiple foci were observed in the nucleus of 89
and 100 % of A549 lung carcinoma cells respectively, and pre-treatment
with the ATM kinase inhibitor WRT diminished foci incidence
approximately 6-fold following 1 Gy IR (Figure 3.8 A). This result
indicated the importance of ATM mediated H2AX phosphorylation during
the response to IR. Next, the impact of p53 status on H2AX formation in
response to IR was investigated using SKOV3 (p53 mutated) cells. At 1
h post IR, 75 % of cells displayed an incidence of  11 foci per nucleus,
in comparison with fewer than 15 % of A549 p53 proficient cells (Figures
3.8 B and 3.9), however it was noted that SKOV3 cells contained foci (
1) in a subset of control cells also (Figure 3.8 B). Treatment of cells with
WRT, prior to IR, diminished H2AX foci incidence to below background
levels in SKOV3 cells, thus suggesting that foci observed in control cells
was a consequence of kinase signalling of endogenously occurring DSB.
In summary SKOV3 cells appeared to exhibit enhanced radio-sensitivity
compared to A549 cells, which supports observations previously reported
in cervical p53 -/- cells (Banath et al., 2004).
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Figure 3.8 Effect of IR on A549 and SKOV3 (p53 mutated) Cells (I)
(A) A549 cells were IR and analysed for H2AX incidence at 1 h. Pre-treatment
(30 min incubation) of cells with the fungal metabolite WRT was employed to
demonstrate dependence of H2AX phosphorylation on ATM. (B) Similar
investigations were performed in SKOV3 p53 mutated cells. Data plotted on bar
charts represents the foci scored in 3 planes of view, from a minimum of 20 cells
per slide.
A
B
105
Figure 3.9 Effect of IR on A549 and SKOV3 (p53 mutated) Cells (II)
(A) A direct comparison of foci incidence at 1 h following 1 Gy IR is shown in
p53 proficient and deficient cell lines; A549 and SKOV3 cells respectively, (B) A
3-D image depicting the distribution of H2AX foci throughout the nucleus of a 1
Gy IR SKOV3 cell (3-planes of view overlayed). Data plotted on bar charts
represents the foci scored in 3 planes of view, from a minimum of 20 cells per
slide.
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3.3.2.3 MMS Treatment of HepG2 and SKOV3 Adherent Cells
Adherent human HepG2 and SKOV3 cell lines were analysed for H2AX
formation following MMS chemical treatment. The majority of HepG2 cells
displayed no H2AX under control conditions and the number of cells
displaying 1–10 foci per nucleus increased in an MMS concentration-
dependent manner (Figure 3.10 A). In contrast, up to 20 % of untreated
SKOV3 cells contained discrete foci in the nucleus and although a similar
concentration-dependent increase in H2AX foci was observed relative to
HepG2 cells, a greater percent of nuclei had 11–20 and > 20 foci (Figure
3.10 B). Thus, p53 appears to contribute to the MMS associated
response.
3.3.3 An Overview of Fluorescent Microscopy Data
Of the human cell lines tested here, A549 cells displayed no foci under
control conditions, in comparison with approximately 5, 15 and 20 % of
HepG2, TK6 and SKOV3 cells respectively, and so indicates A549 and
HepG2 as most appropriate for DNA DSB studies. Since the mean
incidence of H2AX in TK6 cells was below one under control conditions
however, and due to the prevalent application of TK6 cells in toxicology
studies it was deemed appropriate to continue studies in this cell line
also.
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Figure 3.10 Effect of MMS on HepG2 and SKOV3 (p53 mutated) Cells
HepG2 (p53 proficient) (A) and SKOV3 (p53 mutated) (B) cells were analysed
for nuclear H2AX foci following 24 h exposure to MMS. (C) top: control and
bottom 12.5 µg/ml MMS treated SKOV3 cells co-stained with DAPI nuclear
staining dye (blue) and FITC-anti-H2AX (green).(Data was obtained and
analysed courtesy of Miss V Nicolaidiou).
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3.4 Summary
Analysis of H2AX foci by fluorescent, digital imaging revealed a trend for
increasing foci number in all cell types following DSB inducing
treatments, thus confirming its application as a marker of clastogenicity. It
should be noted that foci were scored under the assumption of being
directly related to DNA-damage as opposed to apoptosis, since only
healthy looking cells were included in the analysis. In contrast, a positive
result using a commercially available flow cytometric assay did not
differentiate between cells that were processing DSB for repair or cells
committed to apoptosis. Thus information regarding the kinetics of
treatment-induced DNA damage/apoptosis is essential for correct
interpretation of data. Co-staining with PI however, to enable
discrimination of cell cycle sub-populations during flow cytometry,
provided a more comprehensive overview of the cellular response to DSB
inducing treatments. Furthermore, with careful application of analytical
boundaries to flow cytometric plots, it is possible to distinguish between
DSB related H2AX and early-apoptotic cells.
Overall, the data presented here suggests that fluorescence microscopy
is the more informative and sensitive method for measuring DSB-
associated H2AX foci, compared with flow cytometry. However, data
acquisition by microscopy is more laborious and prone to investigator
subjectivity. Importantly, H2AX analysis by either method requires prior
fixation of cells, so necessitating careful choice of time-of-analysis.
We foresee the development of new DSB-specific assays, which permit
data acquisition in real-time, as beneficial for multiple time-point analysis
and for obtaining information regarding DSB induction kinetics by novel
chemicals.
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4 Identifying Suitable Markers of DSB and Incorporation into FRET
Capable Reporters for Expression in Human Cells
4.1 Introduction
4.1.1 Fluorescent Proteins in Cellular Studies
Fluorescence provides a useful analytical metric in biological sciences,
having found widespread application, from protein specific staining using
antibodies (Coons, 1951), to DNA intercalating dyes (Huang and
Darzynkiewicz, 2006). The spectral distinction between certain
fluorophores renders multi-parameter analysis of relative ease, thus
multiple events may be monitored in the same cell at a single time point.
Flow cytometry is routinely employed for high throughput data acquisition,
while fluorescence microscopy is the platform of choice for providing a
comprehensive understanding of inter- and intra- cellular events.
Standard fluorescent imaging permits visualisation of events at the
macromolecular level, however constraints are imposed by image
resolution such that proteins observed in close proximity may not directly
interact so necessitating further studies to resolve this issue.
Preferentially, studies conducted in real-time eliminate the requirement
for sample fixation, thereby reducing the number of processing steps
involved and abolishes concerns of interference by external factors. In
particular, methods involving dehydration (i.e. alcohol fixation) have a
negative impact on the fluorescence of gfp and variants, which also
exhibit a degree of sensitivity towards buffer pH and chemical
composition (Brock et al., 1999).
4.1.2 Application of Fluorescent Proteins in Reporter Systems
First generation reporter systems require the addition of a substrate for
enzymatic conversion to a readily assayed signal (An et al., 1982) which
increases the number of processing steps, thus spatially separating initial
stimulus from signal output. More recently the intrinsic fluorescence of
gfp, which was isolated from Aequorea victoria (Prasher et al., 1992), has
been manipulated for observing protein function in living cells, by the
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introduction of gfp-protein fusion expressing vectors. Mutagenesis of gfp
has led to the generation of enhanced gfp (egfp), which is optimal for
human expression, monomeric forms for ease of incorporation into
recombinant constructs, and a multitude of derivatives including cyano-
(cfp) and yellow- (yfp) fluorescent proteins. Techniques such as
Fluorescent Loss In Photobleaching (FLIP) and Fluorescent Recovery
After Photobleaching (FRAP), have been developed to monitor loss or
recovery of fluorescence in specified cellular volumes, as a measure of
intracellular dynamics while Fluorescence Energy Resonance Transfer
(FRET) between appropriate fluorescent proteins is used to quantify
protein-protein interactions.
4.1.3 Fluorescence Resonance Energy Transfer (FRET)
Pairs of fluorescent molecules that demonstrate significant overlap in
their emission-excitation spectra are commonly employed in FRET
studies (Figure 4.1). Following excitation, energy is transferred from
donor to acceptor molecule, and FRET may be quantified by comparing
the emission ratio in appropriate fluorescence channels. Energy transfer
is restricted by spatial constraints so that FRET proceeds only between
molecules within close proximity (20-100 Å or 10 nm), and thus infers a
physical interaction of proteins to which fluorescent molecules are tagged
(dos Remedios and Moens, 1995) (Tyagi et al., 2000) (Hink et al., 2002)
(Kretzschmar et al., 2004) (Robers et al., 2008).
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Figure 4.1 FRET Capable Recombinant Proteins
Donor and acceptor fluorescent proteins (FP) (in this example: donor: cfp and
acceptor: yfp) are attached to peptide domains (grey oval and clear circle),
which are predicted to interact in a stimulus specific manner. Peptide domains
are separated by a flexible linker, which encourages protein rotation and internal
movement. Upon stimulus, peptide domains interact, bringing donor and
acceptor FP in close proximity, such that excitation of cfp results in fluorescence
detection in the yfp channel, as a result of FRET. Pink arrows indicate the
direction of energy transfer following laser excitation.
CFP YFP
YFP
CFP
Stimulus
FRETNo FRET
 430 nm  430 nm
 465 nm
 535 nm
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Traditionally, cfp and yfp are employed for FRET analysis although
recently this has been extended to cfp or gfp, coupled with the red
fluorescent protein, dsRed, which is encoded by Discosoma species
(Haas et al., 1996) (Mizuno et al., 2001) (He et al., 2003) (Erickson et al.,
2003). Both cfp and gfp have lower energy requirements, and behave as
donors, which upon excitation transfer energy to yfp or dsRed
respectively. The proof of principle for FRET capable constructs to report
phospho-peptide specific interactions in mammalian models has been
demonstrated previously (Ting et al., 2001) (Sato et al., 2002) (Lin and
Ting, 2004) (Schleifenbaum et al., 2004). Typically a FRET is anticipated
upon interaction of internal peptide domains, although surprisingly FRET
appears diminished in certain constructs (Cullen, 2003). Thus
comprehensive validation of FRET reporters is necessary to confirm the
nature of peptide domain interactions, due to problems faced when
attempting to predict the orientation and rotation of domains relative to
each other. The reader is referred to Ni et al for a recent review of kinase
based FRET reporters (Ni et al., 2006).
4.1.4 FRET versus Traditional Fluorescence Reporters of Damage
Several reporter systems comprise gene-specific promoter-fluorescent
protein fusions, which are expressed in mammalian cells and provide a
useful tool for indicating transcriptional events. The process of mRNA
transcription and protein translation to generate a fluorescent signal
however, can take up to 24 - 48 h, so limits the application of such
reporters for obtaining information regarding the time-span of damage
induction. Bearing this in mind FRET is proposed to be superior for
rapidly detecting events in real time, by monitoring the altered
fluorescence properties of a constitutively expressed protein.
Furthermore, manipulation of a DSB specific interaction is speculated to
serve as a more specific marker compared with transcriptional
responses, which may occur as part of multiple biochemical pathways.
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4.1.5 Aim
It was proposed here that DSB may be sensitively detected by creating a
reporter cell line to assess phosphorylation-mediated interactions of key
DSB proteins.
4.2 Methods
4.2.1 Plasmid Design
Gene sequences were obtained from the Entrez Nucleotide Database
provided by the National Library of Medicine and National Institute of
Health (http://www.ncbi.nlm.nih.gov/sites/entrez?db=Nucleotide&itool=toolbar),
and modules encoding specific peptide domains were confirmed by
consultation with the Genatlas database (http://www.dsi.univ-
paris5.fr/genatlas/) and by searches of the relevant literature using Entrez
Pubmed (http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&db=pubmed).
Individual gene fragments were assembled into plasmid maps using
Clone Manager (MFC Application Company: Scientific & Educational
Software version 1.0.0.1), to ensure that all modules were in the correct
reading frame, and was also used to devise unique restriction profiles for
indicating PCR and sub-cloning success. Restriction analysis was also
performed using the New England Biolab (NEB) web-interface cutter
(http://tools.neb.com/NEBcutter2/index.php).
4.2.2 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
for First Strand Synthesis of cDNA
HepG2 cells were detached from the culture vessel, washed with PBS
and lysed at a density of 5 x 106 cells/ml; the resulting lysate was filtered
and washed, to remove residing impurities from total RNA, using the
Nucleospin® RNA II kit (Machery-Nagel, GmbH & Co. KG). The
RevertAid™ First Strand cDNA Synthesis Kit was employed to reverse
transcribe purified RNA. The initial reaction mixture comprised 1 µl oligo
(dT) primer and 11 µl HepG2 RNA; for the remainder of the reaction the
standard protocol was adhered to.
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4.2.3 Primer Design
Primers were custom designed for PCR, and the length and GC content
of each set of primers was determined by the desired melting
temperature (routinely 64 - 68 °C) as outlined using the following
equation:
TM (melting temperature) = (2 x AT) + (4 x GC)
TA (annealing temperature) = TM – (3-5) °C
For primers longer than 21 nucleotides the nearest neighbour method
was applied to calculate TM, using the web-based oligo-calculator
provided at: http://www.basic.northwestern.edu/biotools/oligocalc.html
Specific primers were designed to amplify the appropriate gene region
and to incorporate restriction sites, for the purpose of sub-cloning, and
additional elements necessary for optimal transcription in human cells.
Primers are listed in Table 4.1 (supplementary information).
Primers synthesised by MWG (Ebersberg, Germany), or Applied
Biosystems (Foster City, USA) were supplied as freeze-dried samples,
which were hydrated in nuclease-free deionised water (dH2O) to achieve
a stock of 100 pmol/µl, and further diluted to obtain a working solution of
10 pmol/µl.
4.2.4 Taq Polymerase PCR
PCR was routinely performed using Taq polymerase (Invitrogen, Paisley,
UK) with the addition of 400 nM each of sequence specific 5’ (forward)
and 3’ (reverse) primers, PCR buffer (1x), dNTP mix, magnesium chloride
(MgCl2) (25 mM) and Taq polymerase (1 unit). Template DNA was added
to a final concentration of 1-100 nM depending on the origin, using a
higher concentration when employing mixed genomic DNA as opposed to
plasmid template. The total volume was made up to 50 µl with PCR grade
water. In the event of poor yield or non-specific product, MgCl2
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concentration and TA were optimised by titration studies. Variations of
standard conditions are outlined as necessary.
PCR was performed in a PTC- 200 Peltier Thermal Cycler (MJ Research
Inc., Waltham, MA, USA) using standard cycling parameters:
Initial denaturation & enzyme activation step: 5 min 95 ºC
Amplification: Denaturation 30 sec 95 ºC
x [n cycles] Primer annealing 30 sec TA ºC
Extension 60 sec/Kb 72 ºC
Final extension: 15 min 72 ºC
To ensure that PCR products were efficiently modified by primers, a two-
stage PCR cycling protocol was designed. Initial cycling parameters were
optimal for primer-template hybridisation and TA for subsequent cycles
was adjusted to take into account the increased region of primer-template
homology as the result of incorporation of gene extensions. This method
improves PCR yield and sensitivity (see Table 4.1).
4.2.5 Splicing by Overlap Extension (SOE) PCR
SOE involves a series of amplification reactions during which, a fusion of
desired coding sequence is created (Horton et al., 1989). Initial PCR
reactions employ primers that introduce an extension into one amplified
gene product, which is complementary to a 21 - 24 bp region of the
second gene. The products of these reactions were mixed at a molar
ratio of 1:1 in the presence of appropriate primers to encourage PCR
across both fragments to create a joint molecule. SOE is used as an
alternative to conventional sub-cloning using restriction enzymes.
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4.2.6 Sequencing
Plasmid DNA (1 µg) was mixed with appropriate sequencing primers (10
pmol) and dH20 to a final volume of 20 µl in 96-well plates and
sequenced in-house (GSK Genoportal; Harlow, UK). Data files were
retrieved in FASTA format and BLAST and ClustalW alignment analyses
performed for confirmatory purposes. Appropriate software was found at
the following web-interfaces: http://www.ncbi.nlm.nih.gov/blast/ and
http://clustalw.genome.ad.jp/.
4.2.7 Agarose Gel Analysis of DNA
DNA was run on agarose gels (Sigma-Aldrich, Gillingham, UK),
containing ethidium bromide (0.5 µg/ ml), which enabled the visualisation
of DNA under UV light. Agarose gels (1 - 2 % agarose depending on the
desired resolution) loaded with 5 volumes of sample DNA to 1 volume of
6 x Orange loading dye solution, alongside appropriate molecular weight
ladders (all obtained from Fermentas, Helena Biosciences, York, UK),
were placed in a mini-gel box, immersed in Tris-borate EDTA (TBE)
buffer, and run at 7 volts/ cm for 45 min. Bands were visualised in a UV
transilluminator box (wavelength 365 nm) and sections of DNA-containing
agarose gel were excised with a sterile scalpel (Swann-Morton Ltd,
Sheffield, UK). DNA was purified from agarose gel sections using the
Qiagen gel clean-up kit (Qiagen, Crawley, UK) and eluted with 50 µl
molecular biology grade water (MBGW) (LCG PromoChem Ltd, Herts,
UK).
4.2.8 Sub-cloning
4.2.8.1 Cloning Directly from PCR
For sequencing purposes, gene fragments amplified by PCR were cloned
directly into pCR2.1 (Figure 4.2), which was supplied as part of the TA-
TOPO cloning kit (Invitrogen, Poole, UK). In accordance with
manufacturers’ guidelines, linear pCR2.1 covalently attached to ligase
(50 ng), fresh PCR product (4 - 8 % final PCR reaction) and NaCl, made
up to a final volume of 6 µl with MBGW, were incubated for 5 min at room
117
temperature. Ligated vector (2 µl) was gently mixed with chemically super
competent TOP10 E.coli cells (50 µl), incubated on ice for 30 min, and
heat shocked at 42 °C for 30 sec. Transformed bacteria were diluted with
SOC media (250 µl), and transferred to a shaking incubator (225 rpm; 37
°C) for 1 h prior to spreading on antibiotic selective LB-agar plates (50
µg/ml ampicillin) pre-spread with 40 µl X-gal (40 mg/ml).
Following 18 h incubation at 37 °C, plates were analysed for colonies
containing recombinant vector. The LacZ gene is interrupted by ligation of
a PCR product with linearised pCR2.1, which prevents transcription of the
-galactosidase protein. In the presence of -galactosidase, X-gal is
enzymatically converted to a visible blue dye. Plates were visually
inspected for white colonies, which indicate that the originating bacterium
has been transformed by a recombinant vector, thus accounting for the
lack of X-gal conversion. Individual white colonies were used to inoculate
LB broth (50 µg/ml ampicillin) for propagation.
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Figure 4.2: Cloning into pCR2.1
Vector pCR2.1 was routinely employed for cloning PCR products. Amplicon
becomes inserted in the multiple cloning site (MCS) and may be released by
digestion with EcoRI.
MCS
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4.2.8.2 Routine Transformation of DH5- Bacteria
DH5- E.coli were aliquoted (50 µl) into pre-chilled sterile Eppendorf
tubes (1.5 ml) to which 1-2 µl plasmid DNA was added with gentle mixing.
Following a 30 min incubation on ice, bacteria were heat shocked at 42
°C for 20 sec, transferred to ice for a further 2 min, and finally 450 µl LB-
broth was added and samples were incubated with vigorous shaking (>
200 rpm) at 37 °C for 1 h.
4.2.8.3 Bacteria Cultivation
Selective LB-broth (50-100 µg/ml amp) was inoculated by a single,
isolated colony picked from a freshly streaked LB-agar plate, and
propagated for the desired time (typically 6 - 16 h) at 37 °C in a shaking
incubator (225 rpm). Cultures were set up for plasmid DNA isolation and
also to generate stocks for long term frozen storage.
4.2.8.4 Procedure for Freezing Bacterial Stocks
Aliquots of exponentially growing culture (OD 600 = 1.6 - 1.8) were mixed
with sterile glycerol to a final concentration of 20 % glycerol: 80 % culture
(v/v) and incubated on wet ice for 30 min prior to storage at -80 °C.
4.2.8.5 Plasmid Isolation: Mini-Prep
Ampicillin selective LB-broth (1 - 5 ml) was inoculated with bacteria and
propagated over night (14 -16 h) for isolating small quantities of plasmid
DNA (< 20 µg high copy plasmid) (Qiagen, Crawley, UK). Standard
guidelines were adhered to at all stages and plasmid was eluted into 50
µl MBGW. DNA isolated by mini-preps was used to analyse ligation
success by restriction analysis and sequencing also.
4.2.8.6 Plasmid Isolation: Midi-Prep
In order to obtain quantities of plasmid DNA  100 µg, large culture
volumes of LB-broth (50 ml) were inoculated with 50 µl of a starter culture
(1 ml inoculated by a single colony and propagated for 6-8 h), and
incubated overnight (for ~14 h) under standard cultivation conditions. All
119
steps were carried out according to the manufacturers’ guidelines, and
DNA was suspended in 50-200 µl of MBGW depending on the size of the
pellet.
4.2.8.7 Establishing Nucleotide Concentration and Purity
Purified plasmid DNA or cellular RNA was diluted in sterile water (100-
200 fold) to a final volume of 1 ml in UV compatible plastic cuvettes
(Sigma-Aldrich, Gillingham, UK), and the nucleotide content was
determined using a GeneQuant pro (Biochrom Ltd, Cambridge UK).
Absorbance was measured at 260 nm and 280 nm to determine DNA or
RNA concentration and purity using the following calculations:
RNA (µg/ml) = A260 x 40 (RNA conversion factor) x dilution factor
DNA (µg/ml) = A260 x 50 (DNA conversion factor) x dilution factor
Purity = A260/A280
For quality control purposes, plasmid isolations were only used for sub-
cloning if the purity was 1.8- 2.0 arbitrary units.
4.2.8.8 Restriction Digestion
Restriction digests were performed to release specific gene fragments
from plasmids for the purpose of sub-cloning, and to confirm the success
of ligation reactions. When it was necessary to digest DNA with two
enzymes simultaneously, the manufacturers’ guidelines were consulted
to determine optimal buffer reaction conditions. DNA (1-3 µg/ 20 µl
reaction) was digested with enzymes (10 u/reaction) in the optimal buffer,
and adjusted to a final volume of 20 µl by the addition of dH20. Reaction
tubes were incubated at 37 °C for 90 min, and then at 65 °C for 15 min:
this latter step was necessary to inactivate the enzymes and prevents
non-specific digestion.
DNA intended for cloning applications, was digested over night (37 °C)
using 1 unit of enzyme to ensure complete digestion. Recipient vector
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was dephosphorylated by the addition of shrimp alkaline phosphatase
(SAP) directly to the digestion reaction, to prevent recircularisation.
Tubes were incubated for a further 30 min at 37 °C prior to enzyme
inactivation at 65 °C. SAP was added at a concentration of 1 unit per 10
pmol DNA termini.
Reagents for restriction digestion were purchased from Fermentas,
Helena biosciences, Sunderland, UK or Roche Diagnostics, USA.
4.2.8.9 DNA Ligation
Freshly digested DNA was ligated by T4 ligase (Invitrogen, Paisley, UK)
using a molar ratio of 1:1, 3:1 and 5:1 insert:vector, as determined by the
following formula:
[ vector (ng) x insert (kb) ] x [molar ratio of insert:vector] = Insert (ng)
Vector (kb)
The total content of DNA was maintained at less than 100 ng per
reaction, and ligations were performed in the presence of 0.1-1 unit T4
ligase, 1 x T4 ligase buffer (Invitrogen, Poole, UK), and MBGW to 20 µl.
Reactions were incubated at room temperature for 30 - 60 min and then
transferred to 4 °C for 16 - 18 h, or incubated in a PTC-200 Peltier
thermal cycler for 18 h (Temperature = 15 °C + 0.5 °C/h). DH5-
subcloning efficiency bacteria (50 µl) were transformed using 1 - 2 µl (<
10 % final volume) of ligation reaction and incubated on ice for 30 min
followed by 20 sec heat shock at 42 °C. Finally, bacteria were incubated
at 37 °C with 450 µl LB-broth in a shaking incubator and spread on
ampicillin selective LB-agar plates.
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4.3 Results
4.3.1 Reporter Gene Construct Design
For reasons outlined in the introduction, it was deemed appropriate to
generate alternative reporter genes, comprising the ATM and ATR
consensus sequence (LSQE) in the context of H2AX, and either the FHA-
BRCT domain encoded by the amino terminal of NBS1, or the MDC1
BRCT domain.
The first reporter gene considered here (designated CNHY), was
designed to encode a cfp amino tagged NBS1 peptide (FHA-BRCT
encompassing domain: amino acids 1-216), separated by a short flexible
linker from a yfp carboxyl tagged H2AX peptide (amino acids 109-143:
encompassing the serine-139 ATM target residue: (Rogakou et al.,
1998)). The H2AX domain of CNHY was predicted to be phosphorylated
by DSB transducer kinases (i.e. ATM) and subsequently interact with the
FHA-BRCT phosphopeptide recognition domain encoded by NBS1.
Provided this interaction is stable, the distance between cfp and yfp was
postulated to reduce sufficiently to bring about FRET. A second reporter
gene was designed in which H2AX was separated from the MDC1- BRCT
peptide (C terminal amino acids 1891-2089: (Lee et al., 2005) with a
flexible linker. In a manner analogous to the CNHY construct, MDC1-
H2AX would be sandwiched between FRET capable proteins; in this case
dsRed and gfp were employed (the recombinant protein was designated
RHMG). Both recombinant proteins were predicted to exhibit altered
fluorescence spectral properties, specifically upon H2AX mediated
interactions. A mass of data indicates that the interactions between
H2AX and NBS1 or MDC1 are specific to the DSB response, notably
related to ATM function. Only proteins of well-characterised function were
considered as reporters of damage here.
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4.3.2 Notable Gene Features
4.3.2.1 Design of a Flexible Linker
The incorporation of a flexible linker was hypothesised to introduce
sufficient protein fluidity to enable the interaction of individual peptide
domains and fluorescent proteins under FRET associated conditions. A
linker was designed to contain a central restriction site (Figure 4.3), with
the notion of incorporating each half of the linker into NBS1 and H2AX
gene fragments by PCR, prior to sub-cloning into pcDNA3. Taking into
account restriction sites within the recombinant gene, appropriate cutting
sites were identified as BamHI, Bstx1 and NotI, all of which are centrally
located in the MCS of pcDNA3 (Invitrogen, Poole, UK), and are absent
from CNHY. Investigation of the literature revealed a range of linkers
previously employed for similar protein constructs, and so were used as a
basis for linker design. A bias for CG residues (> 55 %) is apparent for
achieving optimal linker flexibility. (Sato et al., 2002).
A list of employed restriction site sequences is given in Chapter 4
Supplementary information Table 4.3.
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Figure 4.3: Designing a Flexible Linker
Previously employed linkers are aligned below, and regions of mismatch
highlighted, as potential residues tolerating replacement for restriction site
addition. The linker denoted in bold was chosen for modification since it was
previously employed for similar applications, for which FRET was successfully
demonstrated (Sato et al., 2002). A high chance of success was anticipated by
modifying this linker.
1) gnn ggn ggs nng gnn gng g n = a/ t/ c/ g
2) gca ggc ggc acc ggc ggc agc ctc s = c/ g
3) gnn ggn ggs nng ngg ngn ngg nng ngg
Three potential linkers were proposed for incorporation into a FRET construct,
which are aligned with linker 2 below. The amino-acid sequence (under-lined) is
provided also, which reveals a bias for glycine rich domains.
A G G T G G S L Linker (2)
gca ggc ggc acc ggc ggc agc ctc
A) A G A T G V G G
gca ggc gcc acc ggc/ gtg ggg ggg
B) A G G S G G S L
gca ggc g/ga tcc ggc ggc agc ctc
C) A G G T G R S L
gca ggc ggc acc/ ggc cgc agc ctc
Linkers B and C result in minimal alteration at the amino acid level of a linker
sequence previously employed (Sato et al., 2002). Introduction of an EagI
restriction site (linker C) generates complementary ends to NotI digested DNA,
while a BamHI site may be incorporated into linker B for direct cloning into the
BamHI site within pcDNA3-MCS. Linker B was chosen for the final construct
since the amino acid change; threonine (Thr) to serine (Ser) was predicted to
introduce minimal alteration of the linker structure compared with linker C, since
Thr and Ser are of similar chemical nature.
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4.3.2.2 Mammalian Expression and Nuclear Localisation
To achieve optimal protein expression in human cells, a species specific
Kozak sequence (GCCAACATGG) was incorporated into the N-terminus
of CNHY surrounding the ATG start codon, which was predicted to
enhance initiation of transcription (Kozak, 1991). Nuclear localisation of
the CNHY protein was deemed necessary for simulating the in vivo
situation, since the majority of DSB signalling events occur in the
nucleus, and so a short nuclear localisation signal (NLS) was
incorporated as used by previous investigators. The reader is referred to
Figure 4.4 for specifics of reporter protein CNHY.
Figure 4.4: Recombinant Protein Construct: CNHY
The chimeric protein contains a flexible linker to enable the NBS1 and H2AX
domains to interact following phosphorylation (A). cfp is excited at 458 nm and
transfers energy to yfp when the fluorophores are in close proximity (within 10
nm) (B).
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4.3.3 CNHY Reporter Design
4.3.3.1 Early Development
Primers were created to introduce appropriate sequences for optimal
expression in mammalian cells (Kozak sequence) (Kozak, 1991), a C-
terminal NLS (Miyawaki et al., 1997), and a flexible linker (Ting et al.,
2001) (Zhang et al., 2001) (Sato et al., 2002) (Lin and Ting, 2004).
Finally, individual gene fragments were extended with restriction sites
where appropriate for cloning purposes, with careful prior analysis of
DNA sequence to ensure that primers amplified the necessary domain
only. Details of primers are given in the supplementary data, Table 4.1.
The desired NBS1 and H2AX gene modules were amplified from human
derived cDNA template, while cfp and yfp were amplified from plasmids
kindly provided by Professor Tony Magee of Imperial College London.
Fragments were modified using PCR, to contain a region complementary
to the adjacent fragment of the reporter gene for fusion by SOE (H2AX
and yfp), or extended with appropriate restriction sites for sub-cloning
(Figure 4.5 A). A traditional sub-cloning approach was employed to
assemble cfp and NBS1 fragments into mammalian expression vector
pcDNA3 in a stepwise manner (Figure 4.5 B), however due to the large
difference of vector and insert size (~ 100 bp v 4.4 kb), it was deemed
appropriate to fuse H2AX to yfp prior to sub-cloning (Horton et al., 1989)
(Figure 4.5 C).
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Figure 4.5: Cloning of the CNHY Construct
(A) Individual gene fragments were PCR amplified from template DNA using
primers to introduce appropriate 5’ and 3’ extensions (Table 4.1) (B) cfp and
NBS1 (left) were sequentially cloned into pcDNA3, which was confirmed by
restriction digest using HindIII and BamHI restriction enzymes (right) (cfp-NBS1
~ 1300 bp). (C) Equal molar ratios of yfp and H2AX encoding complementary
modules (see Section 4.2.5 for details) were fused by SOE (H2AX-yfp: ~ 900
bp).
A
B
C
bp
1000
500
100
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1000
500
100
bp
1000
500
100
bp
1000
500
100
cfp NBS1 yfp
H2AX
cfp NBS1 cfp-NBS1
H2AX-yfp
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4.3.3.2 CNHY: The Final Construct
Problems were encountered during the final ligation step to introduce
H2AX-yfp into the cfp-NBS1-pcDNA3 plasmid, possibly due to the GC-
rich nature of the region surrounding the restriction site (BamHI within the
flexible linker: Figure 4.2). Consequently, the final construct was obtained
from GenScript Corporation (New Jersey, USA) and CNHY was sub-
cloned into the MCS of pcDNA3. Vector pcDNA3 encodes the neomycin
gene, which confers resistance to geneticin antibiotic, thereby providing a
selectable marker of expression in mammalian cells. The efficiency of
CNHY expression was significantly diminished over time however, while
cells retained the ability to grow under geneticin selection (the reader is
referred to Chapter 5 Section 5.3.3 for more detail). Using the expression
vector pcDNA3, neomycin and CNHY are translated from separate
mRNA transcripts, and it was thought that cells may efficiently discard of
unnecessary genetic information, while retaining genes conferring a
growth advantage, thus accounting for the loss of CNHY, but not
neomycin expression. Therefore, in order to achieve a stably expressing
human cell line, CNHY was sub-cloned into the vector pEFIRES_P
(Hobbs et al., 1998). This vector is optimised for high-level protein
expression in human cells, with the MCS located in line with a pac gene,
so that pac and CNHY are translated from a single bicistronic transcript
(Figure 4.6). Thus, loss of CNHY expression directly indicates loss of pac
and vice versa, and so selection of puromycin resistant clones that do not
express CNHY was deemed unlikely.
Sub-cloning steps are summarised in Figure 4.7, and CNHY sequence
details given in Figure 4.8.
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pCDNA3
5446 bps
1000
2000
3000
4000
5000
BglII
MunI
NruI
MluI
NdeI
SnaBI
HindIII
Asp718
KpnI
BamHI
EcoRI
EcoRV
NotI
XhoI
XbaI
ApaI
BbsI
DraIII
SexAI
BseRI ++
AvrII
SmaI
XmaI
BbeI
EheI
KasI
NarI
BalI
TthI
BssHII
RsrII
AsuII
BsmI
Bst1107
Eam1105
PvuI
ScaI
SspI
CMV promoter
T7 promoter
Sp6 promoter
BGH PolyA
SV40 promoter
SV40 ori
NeoRSV40 PolyA
ColE1 ori
AmpR
pEFIRES_P
5689 bps
AgeI
FseI
PstI
AflII
NheI
XhoI
EcoRI
MluI
XbaI
NotI
SplI
BalI
HpaI
BamHI
NdeI
AseI
Eam1105 Human EF-1a promoter
Chimaeric intron
MCS
CITE IRES sequence ex p-CITE1
pac
SV40 PolyA
f1 ori
AmpR
ColE1 ori
Figure 4.6 Vectors Employed for Protein Expression in Mammalian Cells
Plasmid pcDNA3 contains a CMV promoter for expression in mammalian cells,
and encodes neomycin resistance. In contrast, pEFIRES_P comprises a human
specific Elongation factor-1 promoter and encodes puromycin resistance on a
common transcript with the inserted gene (CNHY).
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pUC-CHNY
4894 bps
NdeI
HindIII
SacII
ApaI
Bsp120I
BclI
HincII
HpaI
SphI
BsmI
PflMI
SgrAI
BbsI
SfiI
StuI
BsaAI
PstI
BamHI
SmaI
XmaI
Ecl136
SacI
AflIII
AlwNI
Eam1105
BsaI
ScaI
XmnI
EcoO109
''LacZMCS''
CFP
NBS1
Linker
H2AX
YFP'MCS
LacZ'
Ori
AmpR
pGS-21a-CHNY
8456 bps
XbaI
NdeI
BglII
NcoI
EcoRV
SacI
SalI
HindIII
SacII
BsmI
AatII
StuI
SpeI
EcoRV
NotI
XhoI
Bpu1102
DraIII
PvuI
BsaI
Eam1105
AlwNI
Bst1107
TthI
PpuMI
PshAI
BssHII
BstEII
MluI
ClaI
T7 promoter
CFP
NBS1
H2AX
YFP
f1 oriAmpR
LacI
B) Sub-cloning of CNHY into vector pGS-21a for protein expression
A) CNHY was provided in bacterial expression vector pUC 18
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pEFIRES-CHNY
7951 bps
AgeI
FseI
AflII
NheI
BclI
SphI
SapI
SgrAI
SfiI
SpeI
EcoRV
NotI
AvrII
PmaCI
TthI
SplI
AccI
SalI
RsrII
BstEII
BalI
BssHII
SexAI
NcoI
NdeI
AseI
Eam1105
Human EF-1a promoter
CFP
NBS1
H2AX
YFPpac
AmpR
Figure 4.7: CNHY: Sub-cloning Strategy
(A) The gene encoding CNHY was provided in a pUC18 vector between HindIII
and BamHI, and sub-cloned into mammalian expression vector pcDNA3
(HindIII-BamHI) (not shown), which introduced a 3’ terminal flanking XhoI site.
(B) CNHY was subsequently cloned into the MCS of the protein expression
vector pGS-21-a between HindIII and XhoI, and released by double digestion
with SalI and NotI digestion, both of which are present in the MCS flanking
CNHY. (C) Digestion with SalI generated complementary ends to XhoI digested
DNA, thus CNHY could be introduced into the human bicistronic-expression
vector pEFIRES_P MCS between XhoI and NotI.
C) Sub-cloning of CNHY into human expression vector pEFIRES_P
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A) >CNHY (GenScript)
AAGCTTGCCAACATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTG
GACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAG
CTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGA
CCTGGGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCAT
GCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAG
GTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCA
ACATCCTGGGGCACAAGCTGGAGTACAACTACATCAGCCACAACGTCTATATCACCGCCGACAAGCAGAAG
AACGGCATCAAGGCCAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACT
ACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCTACCAGTC
CGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGG
GATCACTCTCGGCATGGACGAGCTGTACAAGTGGAAACTGCTGCCCGCCGCGGGCCCGGCAGGAGGAGA
ACCATACAGACTTTTGACTGGCGTTGAGTACGTTGTTGGAAGGAAAAACTGTGCCATTCTGATTGAAAATGA
TCAGTCGATCAGCCGAAATCATGCTGTGTTAACTGCTAACTTTTCTGTAACCAACCTGAGTCAAACAGATGA
AATCCCTGTATTGACATTAAAAGATAATTCTAAGTATGGTACCTTTGTTAATGAGGAAAAAATGCAGAATGGC
TTTTCCCGAACTTTGAAGTCGGGGGATGGTATTACTTTTGGAGTGTTTGGAAGTAAATTCAGAATAGAGTAT
GAGCCTTTGGTTGCATGCTCTTCTTGTTTAGATGTCTCTGGGAAAACTGCTTTAAATCAAGCTATATTGCAAC
TTGGAGGATTTACTGTAAACAATTGGACAGAAGAATGCACTCACCTTGTCATGGTATCAGTGAAAGTTACCA
TTAAAACAATATGTGCACTCATTTGTGGACGTCCAATTGTAAAGCCAGAATATTTTACTGAATTCCTGAAAGC
AGTTGAGTCCAAGAAGCAGCCTCCACAAATTGAAAGTTTTTACCCACCTCTTGATGAACCATCTATTGGAAG
TAAAAATGTTGATCTGTCAGGACGGCAGGAAGCAGGCGGCACCGGCGGCAGCCTCCCCAACATCCAGGCC
GTGCTGCTGCCCAAGAAGACCAGCGCCACCGTGGGGCCGAAGGCGCCCTCGGGCGGCAAGAAGGCCAC
CCAGGCCTCCCAGGAGTACGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGA
GCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGG
CAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACC
TTCGGCTACGGCCTGCAGTGCTTCGCCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCG
CCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGC
CGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGAC
GGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCA
GAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGAC
CACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCTACC
AGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGC
CGGGATCACTCTCGGCATGGACGAGCTGTACAAGCCCAAGAAAAAGAGGAAGTAAGGATCC
B) >CNHY
M V S K G E E L F T G V V P I L V E L D G D V N G H K F S V S G E G E G D A T Y G K L T L
K F I C T T G K L P V P W P T L V T T L T W G V Q C F S R Y P D H M K Q H D F F K S A M P
E G Y V Q E R T I F F K D D G N Y K T R A E V K F E G D T L V N R I E L K G I D F K E D G N
I L G H K L E Y N Y I S H N V Y I T A D K Q K N G I K A N F K I R H N I E D G S V Q L A D H Y
Q Q N T P I G D G P V L L P D N H Y L S Y Q S A L S K D P N E K R D H M V L L E F V T A A
G I T L G M D E L Y K W K L L P A A G P A G G E P Y R L L T G V E Y V V G R K N C A I L I E
N D Q S I S R N H A V L T A N F S V T N L S Q T D E I P V L T L K D N S K Y G T F V N E E K
M Q N G F S R T L K S G D G I T F G V F G S K F R I E Y E P L V A C S S C L D V S G K T A L
N Q A I L Q L G G F T V N N W T E E C T H L V M V S V K V T I K T I C A L I C G R P I V K P E
Y F T E F L K A V E S K K Q P P Q I E S F Y P P L D E P S I G S K N V D L S G R Q E A G G T
G G S L P N I Q A V L L P K K T S A T V G P K A P S G G K K A T Q A S Q E Y V S K G E E L
F T G V V P I L V E L D G D V N G H K F S V S G E G E G D A T Y G K L T L K F I C T T G K L
P V P W P
(Protein sequence was translated from CNHY sequence using the expasy
translate tool at http://www.expasy.ch/tools/dna.html)
Figure 4.8: CNHY Gene and Protein Sequence
(A) CNHY comprises a Kozak sequence for optimal expression in mammalian
cells (red font, boxed region), cfp (blue highlighted), NBS1 (grey highlighted), a
flexible linker (green highlighted), H2AX (purple highlighted), yfp (yellow
highlighted) and a NLS (blue font, boxed region). Start and stop codons are
shown in bold and restriction sites in black italiacs (N-ter HindIII and C-ter
BamHI). (B) Protein sequence is denoted in bold.
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4.3.4 RHMG Reporter Design
A second construct was devised which comprises dsRed tagged H2AX
(amino acids 109 – 143) and gfp tagged MDC1 (amino acids 1891 –
2089) (Figure 4.9). PCR modification of gfp introduced unique restriction
sites, which were used for subcloning the gene into the human
expression vector pEFIRES_P. MDC1 was amplified from human cDNA
and the flexible linker incorporated by three successive PCR reactions,
using custom designed primers to gradually build the GC- rich linker
along with the addition of a terminal restriction site. Following sub-cloning
into pCR2.1, flexible linker-MDC1 was ligated into pEFIRES_P in front of
gfp. In parallel, gene fragments dsRed and H2AX were fused by SOE
PCR and cloned into pCR2.1. At the time of writing, no further work had
been conducted on this construct as the focus was shifted to the CNHY
recombinant protein.
Figure 4.9: Generation of pEFIRES-RMHG
Human expression of dsRed-H2AX linked to MDC1-gfp by a flexible linker
(shown in Figure 4.3) was proposed to provide a novel reporter of DSB.
pEFRMHG
7855 bps
AgeI
FseI
AflII
NheI
Eco47-3
Sse8387
BglII
BsrGI
PvuII
BspMII
SfiI
XhoI
SgrAI
SapI
SexAI
BglII
SphI
BclI
Bsu36
MluI
BsrGI
NotI
AvrII
PmaCI
TthI
SplI
RsrII
BalI
BssHII
SexAI
BsaBI
HpaI
BamHI
NdeI
AseI Human EF-1a promoter
Chimaeric intron
dsRED-H2AX''
MDC1
GFPpac
SV40 PolyA
f1 ori
AmpR
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4.3.5 ATM Based Reporter of Damage
A final reporter gene was designed that exploits the characteristic of ATM
dissociation into active monomers upon DSB induction (Bakkenist and
Kastan, 2003). It was hypothesised that careful choice of ATM domain
would result in generation of a reporter protein that demonstrates FRET
under physiological conditions, which is abolished upon ATM auto-
phosphorylation dimer dissociation. The FAT domain of ATM (amino
acids 1961- 2046) (designated ATM 1) (Bosotti et al., 2000)
encompasses the site of auto-phosphorylation (Ser-1981), while the
second domain exhibits kinase activity (designated ATM 2) (amino acids
2715- 3011) (Bakkenist and Kastan, 2003). Both domains have been
demonstrated to solubilise in bacteria, thus providing good evidence for
their application as stand alone peptides, despite the large size of domain
2 (Bakkenist and Kastan, 2003). Preliminary cloning work was begun on
this construct, with the generation of a pEFIRES-dsRed-ATM region 1
fusion and pEFIRES-gfp plasmids intended for human expression,
however problems were encountered during the introduction of ATM
region 2 into the latter vector (Work in this area was conducted with the
assistance of Miss Vicky Nicolaidou 2006).
Table 4.2 (supplementary information) summarises the features of
plasmids successfully created during reporter gene development.
4.3.6 Summary
Development of expression vectors, theoretically encoding a series of
novel FRET capable reporter proteins that were speculated to specifically
and sensitively detect DSB in human cells, in real-time, are described
herein. Discrete peptide domains were chosen that should interact
following DSB-associated phosphorylation, as indicated by extensive
review of the literature. Expression of interacting peptide modules within
a common reporter protein was postulated to diminish the likelihood of
unfavourable interactions with endogenously expressed protein, which
may impair reporter sensitivity. Furthermore, the ratio of associating
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peptide modules would remain constant, in comparison with proteins
expressed from discrete vectors.
In the time course of studies described here, work regarding pEFIRES-
CNHY has advanced, such that expression of CNHY was successfully
demonstrated in human TK6 cells; this is discussed in the following
chapter.
135
Supplementary Information
Table 4.1 PCR Primers
Region Primer Sequence Tm °C 1 2
eCFP For atcc[aagctt]ggccacc|ATGgtgagcaagggcgagga 64
Rev ta[ggtacc]cttgtacagctcgtccatgcc 66
NBS1 For at[ggtacc]tggaaactgctgcccgccg 64
Rev [ggatcc]gcctgc|tctttcctgccgtcctgacag 66
MDC1 For att[ggtacc]ataccaagccgcagcctcc 62
Rev [ggatcc]gcctgcggtggatgacatctccaaagg 64
H2AX For [ggatcc]ggcggcagcctc|cccaacatccaggccgtgct 66
Rev ta[gaattc]gtactcctgggaggcctgg 64
eYFP For acccaggcctcccaggagtac|gtgagcaagggcgaggagc 64 75
167
Rev at[ctcgag]|TTActtcctctttttcttgggcttgtacagctcgtccatgcc 66
dsRed For at[gctagc]cgccaccATGgacaacacc 62
Rev attgagtccggactgggagcc 64
H2AX For ggctcccagtccggactca|cccaacatccaggccgtg 60
Rev at[ctcgag]gtactcctgggaggcctgg 64
MDC1 For A ggcagcctcataccaagccgcagcctcc 62
B ggcaccggcggcagcctcataccaagc 58
C at[ctcgag]gcaggcggcaccggcggcagcctc 66
Rev at[acgcgt]ggtggatgacatctccaaagg 64
eGFP For at[acgcgt]gtgagcaagggcgaggagc
Rev at[gcggccgc]TTActtcctctttttcttgggcttgtacagctcgtccatgc
ATM 1 For at[acgcgt]gccaaggtagctcagtcttgtg 68 70
Rev at[tctaga]TTActtcctctttttcttggggagg tcatatgttactagggct 64 73
dsRed For at[gaattc]cgccaccATGgacaacacc 62 66
Rev cacaagactgagctaccttggc|tgagtccggactgggagcc 64 75
GFP For at[gaattc]cgccaccATGgtgagcaagg 66 68
Rev at[acgcgt]cttgtacagctcgtccatgc 62 68
ATM 2 For at[acgcgt]gaggaagtaggtctccttagg 64 68
Rev at[gcggccgc]TTA cttcctctttttcttgggcacccaagctttccatcctgg 66 75
1 Tm used during SOE with H2AX
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Primer region colour coding:
F: Forward primer; R: Reverse primer (reverse complement strand)
Blue: complementary to ecfp
Grey: complementary to NBS1
Green: flexible linker containing BamHI RS
Purple: complementary toH2AX
Yellow: complementary to eyfp
Black font: modifications introduced by PCR
[Italics] Restriction sites
BOLD CAPS: ATG (start) and TAA (stop) codon
Boxed bold: For primer: Kozac mammalian
Boxed Rev primer: Nuclear localisation signal (NLS)
Red font complementary to dsRed
black bold complementary to MDC1
Green font complementary to egfp
Blue font complementary to ATM region 1
Purple font complementary to ATM region 2
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Table 4.2 Expression Vector Plasmids Created
Gene Description Template
Plasmid
ecfp HindIII-ecfp (entire gene)-KpnI Plasmid gift
pCR2.1
NBS1 KpnI-NBS1(nt 114-767)-[Linker]-BamHI NM_002485
pCR2.1
ecfp-NBS1 HindIII-ecfp-KpnI-NBS1-[linker-BamHI] ecfp/NBS1
pCDNA3
H2AX [linker-BamHI]-H2AX (401-503 nt)-EcoRI NM_002105
pCR2.1
eYFP EcoRI-eyfp-[NLS-stop]-XhoI Plasmid gift
pCR2.1
H2AX-eyfp [BamHI-linker]-H2AX-eyfp-EcoRI H2AX/eyfp
pCR2.1
CNHY HindIII-ecfp-NBS1-linker-H2AX- eyfp-BamHI N/A
pUC18
CNHY HindIII-CNHY-BamHI-XhoI pUC18-CNHY
pCDNA3
CNHY SalI-HindIII-CNHY-XhoI-NotI pCDNA3
pGS-21-a 
CNHY HindIII-CNHY-XhoI-NotI pGS-21-a  
pEFIRES
NHGFP MluI-NBS1-linker-H2AX-MluI-egfp-NotI pUC18-CNHY
pEFIRES
Egfp plasmid gift
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Gene Description Template
Plasmid
dsred EcoRI-dsred-MluI Plasmid name
pCR2.1
ATM 1 EcoRI-ATM (6013-6342 nt) NM_000051.3
pCR2.1
dsred-ATM 1 EcoRI-dsRed-ATM 1-XbaI ATM 1
pEFIRES
ATM 2 ATM 2(7453-9357 nt) NM_000051.3
pCR2.1
egfp Mlui-egfp-NotI-[NLS-TAA] Plasmid gift
pCR2.1
egfp [kozac ATG]-EcoRI-egfp-MluI Plasmid gift
pEFIRES
MDC1 MDC1(5673-6267 nt) NM_014641
pCR2.1
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Table 4.3 Restriction Enzymes
Restriction Enzyme Recognition Sequence
BamHI G/GATCC
BglII A/GATCT
EcoRI G/AATTC
HindIII A/AGCTT
KpnI GGTAC/C
MluI A/CGCGT
NheI G/CTAGC
NotI GC/GGCCGC
SalI G/TCGAC
XbaI T/CTAGA
XhoI C/TCGAG
Forward slash represents cut site.
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5. CNHY Expression in Human TK6 Cells
5.1. Introduction
A number of recombinant proteins have been described, which exploit
FRET-imaging technology to provide a rapid and reversible signal in
response to kinase-mediated events (Ting et al., 2001) (Sato et al., 2002)
(Cullen, 2003) (Violin et al., 2003) (Schleifenbaum et al., 2004) (Kunkel et
al., 2005) (Ni et al., 2006) (Johnson et al., 2007). In Chapter 4, the
construction of a series of expression vectors encoding hypothetical
reporters of DSB were described, which structurally resemble previously
employed FRET-based reporter constructs (Ting et al., 2001) (Sato et al.,
2002). Herein, steps were taken to generate a TK6 cell line stably
expressing CNHY, with the potential for detecting DSB in real-time in
living cells.
5.2. Methods
5.2.1. Electroporation
Circular vector (pEFIRES-CNHY, pcDNA3-CNHY, pcDNA3-cfp or
pcDNA3-yfp) was introduced into AT or TK6 suspension cells by
electroporation. Cells (1 x 107) were collected by centrifugation at 1800
rpm, 4 °C for 5 min, washed with ice cold PBS (10 ml) and suspended in
600 µl PBS along with 10 µg plasmid DNA, in a pre-cooled 0.4 cm
electroporation cuvette (BioRad, Hemel Hampstead, UK) for 10 min on
ice. Finally cells were electroporated at 270 volts, 950 µF using a BioRad
gene pulser II and subsequently incubated on ice for 10 min and
transferred drop-wise to a T75 culture vessel containing pre-warmed
media (15 ml). At 2 days, cells were analysed for yfp fluorescence by flow
cytometry (485 / 520 nm: ex / em) and positive samples were placed
under appropriate antibiotic selection pressure.
5.2.2. Selection of Stably Expressing Clones
Expression vectors employed here each transcribed a protein conferring
resistance either to the antibiotic geneticin (the product of the neo gene
on pcDNA3) or puromycin (the product of the pac gene on pEFIRES_P).
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Mammalian cells are susceptible to antibiotic killing, and so growth of
cells in the presence of antibiotic suggests successful protein expression
from vector-encoded genes.
5.2.2.1. Geneticin
The minimal concentration of geneticin necessary for achieving 100 %
death of non-transfected cells was determined over a period of 7 days, by
employing a concentration range of 0 – 100 µg/ml. Cell viability was
monitored at regular intervals by trypan blue exclusion (methodology
described in Section 2.2.6.3), from which an antibiotic kill curve was
established to indicate optimal selection conditions. Specifically, TK6
cells in solution (2 x 105 cells in 1 ml media +/- antibiotic) were transferred
to 6 well plates and supplemented every 3 days, with media (1 ml)
containing sufficient antibiotic to maintain initial concentrations, taking
into account the presumed degradation of previously added antibiotic.
Selection of pcDNA3-CNHY transfected cells was begun at 48 h after
electroporation, with the addition of geneticin (500 µg/ml of media) to T75
vessels containing cells in culture. At 1 week, cells were seeded into 24
well plates (5 x 103 cells /well), with fresh media added at 3-day intervals,
and cells were monitored under a standard light microscope for colony
expansion. Contents of those wells in which cell growth was evident,
were transferred to wells of increasing size and eventually into culture
flasks for expansion of CNHY expressing cells.
.
5.2.2.2. Puromycin
A puromycin kill curve was established over 5 days to indicate optimal
selection conditions using concentrations of 0 – 1 µg/ml.
Selection of transfected cells was achieved by the addition of puromycin
(0.25 µg/ml), in a manner analogous to that described for geneticin
selection, only scaled down for selection in 24 well plates.
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5.2.3. Immuno-blotting Protocol
5.2.3.1. Protein Extraction from Cultured Cells
Cultured cells were washed with PBS, collected by centrifugation and
suspended to a final concentration of 1 x 107 cells /ml, in tissue-protein
extraction reagent (T-PER) (Pierce, Rockford, USA) containing 1 x
protease inhibitor (Pierce, Rockford). Cell membranes were ruptured by
sonication (3 x 10 sec pulses on ice), and samples were centrifuged at
full speed, in an Eppendorf refrigerated microcentrifuge (Fisher Scientific
UK Ltd, UK) at 4 °C for 20 sec, to pellet cellular debris, which was
subsequently discarded. Protein extracts were stored at -80 °C until
required.
5.2.3.2. Determination of Protein Concentration
Protein concentration was determined using the Quanti-BCA assay
(Sigma-Aldrich, Gillingham, UK) according to the manufacturers’
instructions. Extracts were diluted 10 - 20 fold, incubated with BCA
reagent for 2 h at 37 °C, or overnight at room temperature, and
absorbance measurements were taken at 600 nm using a Victor
microplate reader. The Prism spline fit program (GraphPad Software, Inc;
Prism 5) was employed to calculate protein concentration from a
standard curve, derived from BSA samples of known concentration. This
enabled equal loading of samples during SDS-PAGE electrophoresis.
5.2.3.3. SDS-PAGE and Immunoblotting Procedure
Protein extracts (15 - 20 µg/ sample) were added to SDS sample loading
buffer at a ratio of 2 protein units: 1 loading buffer and heated for 5 min at
100 °C, to disrupt peptide disulphide bonds. Denatured protein was
loaded into individual wells of an 8 - 15 % gel alongside a protein
standard ladder (Invitrogen, Poole, UK), which were submerged in
electrophoresis buffer and run at 120 volts in a tetra-gel BioRad
electrophoresis chamber (Bio-Rad Laboratories, Inc. UK). Protein was
transferred from gels to nitrocellulose membranes (Sigma-Aldrich,
Gillingham, UK) using the Bio-Rad Western blotting system (400 mA for
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75 min). The even transfer of protein was verified by incubating
membranes briefly with 0.1 % Ponceau red solution (0.1 %) (Sigma-
Aldrich, Gillingham, UK). Nitrocellulose membrane was blocked in 5 %
non-fat powdered milk blocking solution, and incubated with primary
antibody at an appropriate dilution in blocking solution overnight, at 4 °C
with gentle tilting. Specifically, blocked nitrocellulose membranes were
probed with anti-H2AX (Abcam Inc., Cambridge, MA, USA) diluted 1:
5000 in blocking solution (12 ml), overnight at 4 °C, washed with PBS-
tween wash buffer (4 x 10 min incubations), and probed with an
appropriate HRP conjugated secondary antibody (Sigma-Aldrich,
Gillingham, UK) (1: 8000) for 1 h at room temperature. Membranes were
developed by incubation with Pierce Chemiluminescence HRP substrate
(Pierce, Rockford, USA) and exposed to film in a Kodak cassette for 2-5
min. Finally the film was viewed following sequential washes in developer
(3.5 min), H20 (1 min), fixer (4 min) and H20 (1 min).
5.2.4. Flow Cytometry
Flow cytometry was performed as described in Chapter 2, with
measurements obtained in the FL-1-H channel (520 nm emission). (refer
to Section 2.2.10 for details).
5.2.5. PCR
Basic PCR methodology was described in Section 4.2.4. Specific primer
details are given within the text.
5.2.6. Detecting FRET in Living TK6 Cells
5.2.6.1. Fluorescent Microscopy
Suspension TK6 cells were immobilised onto the base of 24-well, glass
bottom plates (MatTek Corporation, Ashland, MA, USA) pre-coated with 1
M hydrochloric acid (30 min incubation followed with 3 x 10 min washes
in dH20, and UV sterilisation in a cell culture cabinet overnight). For digital
imaging, 24-well plates were viewed using a Zeiss Wide-field Fluorescent
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Microscope with excitation at 433 nm and emission detected at 535 nm,
using a dichroic mirror.
5.2.6.2. Microplate Analysis
TK6 cells suspended in media, which is compatible for green fluorescent
applications (In-house formulation: GSK), were plated into 96-well plates
at a final concentration of 2 x 105 cells per well (100 µl). Bleo was added
to wells at a top concentration of 40 µg /ml and serially diluted down to
0.5 µg /ml. Absorbance readings were used to normalise fluorescent
values to cell number, which were obtained using the following filter
combinations:
–Absorbance: 612 nm
–Fl 430 ex / 465 em cfp
–Fl 485 ex / 535 em yfp
–Fl 430 ex / 535 em FRET
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5.3. Results
5.3.1. Establishing a Geneticin Kill Curve for TK6 Cells
Geneticin is routinely employed in the range of 500 – 1000 µg/ml for
selecting pcDNA3 transfected mammalian cells. To determine the
minimum concentration of geneticin necessary for preventing TK6 cell
growth, a kill curve was constructed from data obtained by trypan blue
exclusion of samples at 3, 5 and 7 days. High dose exposure (500 µg/ml
and above) greatly diminished proliferation as indicated by a 4-fold
reduction in total cell count, relative to the initial cell concentration,
following 7 days under selection pressure (Figures 5.1 A and B). This
was confirmed by cytotoxicity data (Figure 5.1 C). After 7 days in the
presence of 500 µg/ml geneticin, viability was diminished to 8 % and
proliferation completely abolished, as indicated by the absence of
aggregates, depicted in Figure 5.1 A. It was noted that as the
consequence of over crowding in control wells, cell viability under control
conditions (no geneticin) was greatly diminished at 7 days also (53 %
compared with 99 % at day 3). A concentration of 500 µg/ml geneticin
was chosen to sufficiently impair cellular function in the absence of
pcDNA3 encoded neomycin.
5.3.2. Establishing a Puromycin Kill Curve for TK6 Cells
At 3 days less than 20 % of puromycin (0.2 – 1 µg/ml) exposed cells were
viable (Figure 5.2 A), and after 5 days under continuous selection, no
cells of healthy appearance were observed by standard light microscopy.
To ensure rapid and specific cell death, a concentration of 0.25 µg/ml
puromycin was chosen for selection of pEFIRES_P transfected cells. In
contrast with geneticin selection (Figure 5.1 B & C), puromycin
manifested an adverse cellular response with more rapid kinetics (Figure
5.2 A), thus preferentially encouraged the expansion of positive clones
early after transfection (Figure 5.2 B).
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Figure 5.1 Establishing a Geneticin Kill Curve in TK6 Cells
Cells (2 x 10 5 / well in a 6 well plate) were incubated with increasing geneticin
concentration. (A) Images of cells at 7 days in the presence of 0 and 500 µg/ml
geneticin (left and right, respectively). (B) The total number of viable cells at day
7 and (C) the percent of healthy cells was analysed by trypan blue exclusion.
N = 1
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Figure 5.2 Establishing a Puromycin Kill Curve in TK6 Cells
(A) Cells (5 x 103 / well in a 24-well plate) were incubated with increasing
concentration of puromycin and analysed at 3 days for viability by trypan blue
exclusion. N = 3 +/- SEM (B) Counts of cells electroporated with or without
pEFIRES_P vector were taken at 3 day post addition of puromycin (0.25 µg/ml)
and are represented here as the percent of surviving cells relative to day 0 (day
0 = time of electroporation). N = 2.
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5.3.3. Confirming Expression of CNHY from pcDNA3 in TK6 Cells
TK6 cells transfected with pcDNA3-CNHY were selected under geneticin
pressure, as described in Section 5.2.2.1.
5.3.3.1. CNHY Transcription
PCR and RT-PCR of TK6 cell extracts with CNHY specific primers (cfp
forward + NBS1 reverse) generated a product only in pcDNA3-CNHY
transfected cells, indicative of active gene transcription (Figure 5.3 A).
5.3.3.2. CNHY Translation
Fluorescence of transfected cells in the yfp channel was taken to indicate
successful protein expression, since yfp is the final domain of CNHY to
be transcribed and translated. At 48 h, the majority of cells displayed
increased fluorescence relative to mock transfections (Figure 5.3 B),
indicative of CNHY expression from pcDNA3, which was confirmed by
immuno-blotting (Figure 5.3 C left). Specifically, nitrocellulose
membranes were probed with an anti-H2AX antibody, which was
predicted to bind the region of H2AX encoded within CNHY (protocol
details are given in Section 5.2.3). A dense band at approximately 20 kDa
was observed in all samples, which is indicative of endogenous H2AX,
and an additional faint band at approximately 90 kDa was detected in
plasmid-transfected cells only (Figure 5.3 C: left). The 90 kDa protein was
thought to represent CNHY, which has a predicted molecular weight of
approximately 80 kDa, as determined by appropriate computer software.
Within 14 days of transfection however, cells maintained under geneticin
selection appeared to lose CNHY expression. Immuno-blotting revealed
the absence of a 90 kDa band at 14 days (Figure 5.3 C: right) compared
with samples probed at 5 days (Figure 5.3 C: left), under similar
experimental conditions. This was postulated to be a consequence of
cells discarding of CNHY, while retaining the neo gene, the latter
conferring a growth advantage. Thus studies were continued using the
human optimised vector pEFIRES_P as described in Chapter 4 Section
4.3.3.4.
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Figure 5.3 Demonstrating CNHY Expression from pcDNA3 in TK6 Cells
(A) PCR amplification (left gel) of CN (1300 bp) and NBS1 (680 bp) from whole
cell extracts of electroporated cells, and RT-PCR (right gel) amplification of CN
from mock (lane 1) or pcDNA3-CNHY electroporated cells (lanes 2-3) (5 days
post electroporation). (B) The fluorescence of healthy cells (green) was elevated
in pcDNA3-CNHY electroporated cells (right), at 48 h, relative to mock
electroporated samples (left). (C) Immunoblotting was performed on protein
extracts with an anti-H2AX antibody from mock and CNHY electroporated
samples at 5 days (left) and 14 days (right) post electroporation (l-r: control,
mock and pcDNA3-CNHY electroporated cell populations after: 0 or 0.5 Gy IR).
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5.3.4. Confirming Expression of CNHY from pEFIRES in TK6 Cells
5.3.4.1. CNHY Transcription
At 5 days post-electroporation, whole cell extracts (as described in
Section 5.2.3.1, only without the final step to remove cell debris), were
probed for CNHY using specific primers (NBS1 forward + H2AX reverse).
A band corresponding to the predicted size of the NBS1-H2AX amplified
region of CNHY was observed in transfected cells only (Figure 5.4 A).
5.3.4.2. CNHY Translation
pEFIRES-CNHY transfected cells were cultured in the presence of
puromycin (0.25 µg/ml) to select for cells actively transcribing both CNHY
and pac from a single, bicistronic transcript. Cells were analysed for yfp
fluorescence at regular intervals by flow cytometry and the mean
fluorescence intensity was elevated approximately 25-fold in cells
expressing CNHY relative to mock transfected cells (Figure 5.4 B). Cell
aggregates, as determined by the forward scatter of flow cytometric plots,
indicated that over half of all transfected cells existed as multi-cell
aggregates, of which 97 % were positive for yfp. The presence of
aggregates was verified by standard light microscopy imaging, which
revealed the presence of healthy, proliferating cells, in contrast to mock-
transfected samples, in which cells appeared as isolated, granular
events.
Imaging of cells by fluorescent microscopy revealed approximately 60 %
of cells fluorescing in the yfp channel with a subset of more brightly
fluorescing cells, consistent with flow cytometric data (Figure 5.4 C).
Fluorescence did not appear to be specific to the nucleus, as indicated by
DAPI staining (not shown here), implying that the nuclear localisation
signal was not successfully directing the protein to the nucleus.
Furthermore, not all CNHY expressing cells exhibited cfp fluorescence,
despite a detectable yfp signal. Indeed cfp was only detected in cells with
intense yfp, therefore suggesting that cfp fluorescence was dim in
comparison (Figure 5.4 C).
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Figure 5.4 Demonstrating CNHY Expression from pEFIRES_P in TK6 Cells
(A) PCR was carried out on whole cell extracts from pEFIRES-CNHY or mock-
transfected TK6 cells, using primer combinations specific to CNHY. (B) yfp was
monitored by flow cytometry; left: Flow cytometric plots of mock (top) and
pEFIRES-CNHY (bottom) electroporated cells: M1 indicates elevated
fluorescence in the yfp channel. Right: Graphical representation of flow
cytometric data: RFU represents the mean fluorescent intensity per cell. N = 2.
(C) Images of CNHY-TK6 cells captured using yfp (left), cfp (middle) and FRET
(right) channels under control conditions.
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Although this raised concerns regarding the ability of CNHY to generate a
detectable FRET under test conditions, the signal in control cfp
expressing cells was weak also, thus it is possible that analysis
conditions require further optimisation (i.e. choice of detection filters).
Markedly, a signal was detected in the FRET channel in the absence of
external stimulus, in cells displaying a strong cfp and yfp signal (Figure
5.4 C). Whilst a FRET signal in control cells may simply indicate bleed-
through of cfp fluorescence, equally this raises the possibility that CNHY
folds into a FRET capable conformation under control conditions.
5.3.5. Application of CNHY in Living Cells
5.3.5.1. Bleo Treatment
TK6 and AT suspension cells were exposed to increasing concentrations
of bleo in 96-well plates and fluorescence readings were taken at 2 h
using a Tecan microplate reader (Tecan UK Ltd, Theale, UK). Following
correction of fluorescence to absorbance values, which is a useful
indicator of cell density, yfp intensity was employed as a function of
CNHY expression within discrete populations, and finally values were
normalised to the 0 µg/ml negative control, using the following equation:
FRET normalised to Abs + correction value (+ 14.54 for TK6 cells)
yfp normalised to Abs (- 0.595 for AT cells)
Resultant arbitrary values were considered to be an indicator of FRET as
shown below:
Bleo
µg/ml
0 0.625 1.250 2.500 5.00 10.00 20.00
TK6 0 13.92 14.51 14.6 14.8 15.34 17.67
AT 0 0.152 0.145 0.199 0.336 0.429 0.395
–Abs 612nm
–Fl 430-465nm cfp
–Fl 485-535nm yfp
–Fl 430-535nm FRET
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A general trend for elevated FRET signal with increasing bleo
concentration suggested that CNHY might be responding to the induction
of DSB. In contrast, an attenuated FRET response was observed in AT
(ATM deficient) cells compared to TK6 (ATM proficient) cells, which
supports the hypothesis of diminished H2AX phosphorylation in the
absence of ATM kinase activity, hence affecting phosphorylation
dependent alterations in CNHY conformation. It was noted however, that
cfp values were either extremely low or negative, possibly the
consequence of sub-optimal filter combinations, or weak fluorescence of
cfp, which was confirmed by imaging (Figure 5.4 C). Therefore data
presented here was considered preliminary rather than conclusive.
5.3.6. Summary
Presented herein is data to support the successful expression of a novel,
hypothetical reporter protein of DSB; designated CNHY, in TK6 human
lymphoblastoid cells, which are routinely employed during toxicology
studies. The presence of the cfp, NBS1 and H2AX domains of the
construct were verified by PCR, and H2AX expression was confirmed by
immuno-blotting. Additionally, various fluorescent platforms were
employed to provide a sensitive and rapid indication of CNHY expression,
which revealed a strong signal specific to CNHY expressing cells under
yfp filters, however cfp fluorescence was attenuated in comparison. Since
the sequence of cfp within CNHY is identical to that of FRET capable
reporter proteins that have been previously employed with considerable
success, it was speculated that optimisation of cfp detection channels/
filters is necessary.
Preliminary studies using a microplate reader set-up indicated a possible
FRET following exposure of cells to the DSB inducing radiomimetic bleo.
Values obtained using filter combinations applicable to FRET studies,
suggested a positive correlation with bleo concentration in both ATM
proficient (TK6) and ATM deficient (AT) cells, although to a lesser
magnitude in the absence of ATM. In Chapter 2, 2.5 µg/ml bleo was
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shown to induce apoptosis in approximately 20 % of TK6 cells at 24 h
concomitant with 10 % of cells scored with MN, whereas 20 % of AT cells
contained MN. Taking into account the anticipated level of DSB damage
and apoptosis at 2.5 µg/ml bleo, it is perhaps surprising that an apparent
FRET was detected following exposure levels of up to 20 µg/ml, at which
dose, overt toxicity and cell death would be anticipated. However in the
MN assay, cells were analysed at 24 h, whereas here analysis was
performed at 2 h, thus DSB may be expected as an early response,
which later manifests as apoptosis.
Herein, CNHY as indicated by yfp fluorescence was observed throughout
the entire cellular volume, and not limited to the nucleus. For optimal
reporter protein activity it will be desirable to achieve complete nuclear
localisation, as this is the cellular compartment in which DSB signalling
and repair is executed.
At the time of writing, a recent publication described the validation of a
reporter HeLa cell line, which expresses an ATM substrate domain
(CHK2) and phosphopeptide recognition domain of yeast rad53,
sandwiched between CFP and YFP (Johnson et al., 2007). This adds
weight to the approach taken here, and provides convincing evidence
that the reporter cell line described herein has been conceived and
engineered with a high chance of success.
5.3.7. Future Directions
Work conducted here constitutes the early stages in developing a novel,
reporter of DSB with the intention of high throughput analysis of living
cells for toxicological applications, although a more comprehensive
characterisation of CNHY activity is necessary. A series of potential steps
to characterise CNHY behaviour are outlined in Figure 5.5.
Proposed work includes the expression and isolation of large quantities of
CNHY from bacteria, for characterisation in cell free models. Several
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approaches for investigating FRET in response to DSB are envisaged,
such as the creation of a reconstituted system, in which blunt end
restriction digested DNA (to mimic DSB) is added to CNHY in cell
extracts. Further studies to deplete essential proteins from extracts, such
as kinases responsible for CNHY phosphorylation, along with the
generation of a phosphate recipient-defective CNHY mutant, are
postulated for validating the dependence of FRET on CNHY
phosphorylation.
A further consideration is the conformation of CNHY. Essentially,
obtaining a crystallography structure of CNHY would indicate whether
FRET is anticipated in control cells, as described for some constructs, for
which phosphorylation mediated interactions diminish FRET due to
altered constraints placed upon fluorescent proteins relative to each other
(Kunkel et al., 2005) (Johnson et al., 2007).
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Figure 5.5 Proposed Future Steps to Characterise CNHY Behaviour
A series of cell free in vitro situations are envisaged (dark blue boxes) using
purified CNHY following expression in a bacteria system (green boxes), to
complement human intracellular studies (red boxes: using TK6 stably
transfected cells).
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6 A Molecular Beacon to Detect RAD52 mRNA in Whole Cells
6.1 Introduction
6.1.1 Transcriptional Regulation of DSB Related Genes
DNA repair genes are thought to be infrequently regulated at the
transcriptional level, yet there is a degree of discrepancy in the literature,
possibly the consequence of different cell lines, time points and methods
of analysis employed during gene expression studies. Subsets of genes
displaying differential expression, following DSB inducing treatment,
typically encode general-stress activated proteins (i.e. GADD45, MDM2
and ATF3) (Akerman et al., 2005) and those which function in cell cycle
regulation (Cyclin G1) (Amundson and Fornace, 2001) or apoptosis (i.e.
BAX) (Akerman et al., 2005). In agreement, Inoue et al reported no
significant alterations in BER related genes following appropriate cell
treatment, although the expression of cell cycle related genes (i.e.
CDKN1A) were induced at early time-points (Inoue et al., 2004).
Regardless, a subset of human DNA damage genes are reported to
undergo transcriptional regulation, including DDB2 and RAD23 (XPC),
which are induced and repressed, respectively in a dose-dependent
manner following IR (Akerman et al., 2005) (Amundson and Fornace,
2001). The transcriptional regulation of DSB repair and cell cycle related
genes was also observed in various cell lines exposed to MMS,
etoposide and radiation (Amundson and Fornace, 2001) (Akerman et al.,
2005) (Ding et al., 2005) (Smith et al., 2006) (Zschenker et al., 2006). Of
particular significance was the RAD52 mRNA transcript, which was
elevated over 5-fold following chemical treatment with MMS, compared to
control samples (Smith et al., 2006). In contrast, a separate report, which
provided an overview of gene expression in A549 lung carcinoma cells
exposed to the DSB inducing chemicals MMS and etoposide, did not
report RAD52 among the array of differentially regulated genes
(Boesewetter et al., 2006). This was possibly due to application of an
alternative threshold of significance, or differences in experimental
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protocol. The latter point is exemplified by reports of significant
differences in GADD45 expression depending on method of analysis
employed, such that a 5-fold induction was indicated by cDNA microarray
technology, which translated into a 10 fold increase using qRT-PCR (20
Gy IR) (Akerman et al., 2005).
As described in Section 1.11, RAD52 contributes to the HR pathway of
DSB repair. It was hypothesised here that the application of MB
technology to monitor RAD52 mRNA in whole cells, offers the potential
for detecting DSB in real-time. To our knowledge, only DNA damage
repaired by BER has so far been investigated by MB technology. In the
former study, fluorescence as the consequence of MB activaton, was
monitored as a direct function of base removal from the MB stem
(Maksimenko et al., 2004).
6.1.2 Molecular Beacons
MB are dual-labelled fluorescent, single-stranded oligonucleotide probes
that theoretically provide a sensitive method for detecting nucleic acids in
living cells (Tyagi and Kramer, 1996). A typical beacon comprises short
complementary sequences surrounding a central probe region designed
to bind the nucleic acid sequence of interest. Under control experimental
conditions, probe termini are predicted to hybridise, and consequently the
MB assumes a stem-loop conformation in which the fluorophore and
quencher are in close proximity (Figure 6.1). In this scenario,
fluorescence emitted from the fluorophore is transferred to the adjacent
quencher (by FRET), which subsequently dissipates energy as heat.
Thus, fluorescence is predicted to be negligible under control conditions.
Upon binding a complementary nucleic acid, MB is forced into a linear
conformation, which physically separates the fluorophore and quencher
sufficiently to impede FRET (Tyagi and Kramer, 1996) (Tan et al., 2000).
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Figure 6.1 Molecular Beacon Concept
(A) MB’s are self-hybridising nucleotide probes, sandwiched between a
fluorescent molecule (green circle) and an energy-quenching molecule (blue
circle), which exist in a stem-loop configuration under control conditions. (B) The
kinetics of MB hybridisation with target nucleotide is preferential to self-
annealing, and consequently quenching is relieved and a fluorescent signal
detected
A B
+
Target Nucleotide
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MB’s offer several advantages in comparison to methods of detecting
nucleic acids such as in situ hybridisation. For example, the requirement
to separate probe-target hybrids from excess probe is abolished, a
process that is both time consuming and may adversely affect the assay
outcome (Tyagi et al., 2000). Furthermore, unlike quantitative real-time
PCR (qRT-PCR), which is frequently used for gene expression analysis,
there is no requirement for mRNA isolation and amplification from
multiple sample populations, thus minimising the stages at which
experimental variability may influence the final outcome. Most notable
however, is the application of MBs in living cell models, such that the
concept of real-time imaging of transcriptional events is attainable (Liu et
al., 2002).
Early applications combined MB and FRET technology, for detecting
nucleic acid hybridisation as described in 1988 by Cardullo et al (Cardullo
et al., 1988). However, the full potential of FRET capable oligonucleotides
was not realised until the mid nineties, with the development of MB for
qRT-PCR as the new generation of Taqman probes (Tyagi and Kramer,
1996) (Kong et al., 2007) (Paillard et al., 2007). Soon after their first
applications, the intracellular detection of nucleic acids was successfully
demonstrated by micro-injecting cells with MB and target
oligodeoxynucleotide (Sokol et al., 1998). Most recently, MBs have been
used to identify differentially expressed genes in tumour cells (Shah and
El-Deiry, 2004) (Drake et al., 2005) (Peng et al., 2005) and as indicators
of contaminating infectious agents (Gubala and Proll, 2006) (Kim et al.,
2007a). [For a more in depth discussion of MB applications the reader is
referred to Tan, W et al., 2000].
A great deal of work has focused on optimising the stability of MBs in
biological systems, and more recently the incorporation of artificial
oligonucleotide backbones comprising 2’-O-methyl modified RNA
(Tsourkas et al., 2002) or L-DNA (Kim et al., 2007b) have proved
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indispensable for diminishing false positives induced by enzymatic
degradation.
Data presented within this chapter describes steps taken towards
developing and optimising a human RAD52 mRNA specific MB in cell
free systems.
6.2 Methods
6.2.1 Fluorescent Oligonucleotide and MB Synthesis
Custom designed MB’s and unlabelled or FITC labelled oligonucleotides
(ON) were commissioned and synthesised by Eurogentech Ltd, Belgium.
Lyphophilised samples were suspended in TE buffer (pH 8) to a final
concentration of 20 µM and aliquots stored in the dark at -20 °C for up to
6 months.
6.2.2 Cell Free Studies
MB (200 nM unless otherwise stated) +/- complementary target ON was
incubated in specified buffer (PBS or media) in black, clear-bottom 96-
well plates (Costar, Sigma-Aldrich, Gillingham, UK) under standard cell
culture conditions (37 °C; 5 % CO2) unless otherwise stated. Incubation
steps performed in a background of excess DNA was achieved by the
addition of salmon sperm DNA (Invitrogen, Poole, UK) to a final
concentration of 10 µM.
6.2.3 Fluorimetry: Fluorescence Applications
Fluorescence values were obtained using a BMG POLARstar4 microplate
reader (BMG Labtech, Aylesbury, UK), at 25 °C or 37 °C, using
appropriate excitation and emission filter combinations as stated within
the main text. Gain settings were determined during preliminary
experiments to achieve optimal fluorescent read out, and was specific to
each fluorescent probe combination employed.
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6.2.4 Oligofectamine Transfection
A549 cells were seeded in antibiotic-free media (400 µl), at 9 x 10 5cells/
well of a 12-well plate and left to adhere for 18 h. Oligofectamine reagent
(Invitrogen, Poole, UK) was diluted to 10 µl/ well with serum free Opti-
MEM or full Hams media and incubated at room temperature for 10 min,
and a further 25 min following the addition of nucleotide (diluted to 90 µl/
well in Opti-MEM media). During optimisation studies, transfections were
performed using 2 - 4 µl Oligofectamine reagent per well. Transfection
complexes were pipetted onto cells and incubated under standard culture
conditions for 4 h. Fluorescence measurements were taken at between 4
and 24 h by flow cytometry.
6.3 Results
6.3.1 MB Design
A RAD52 specific MB was designed by modifying a probe successfully
used to detect RAD52 mRNA by qRT-PCR (Smith et al., 2006), with a
nucleotide extension to promote self-hybridisation and formation of a
stem-loop configuration. Special consideration was taken in the design of
MB stem and backbone to achieve optimal self-annealing under control
conditions, while favouring probe-target hybridisation in the presence of
complementary nucleotide (cell culture in vitro conditions = 37 °C).
Computational analyses provided a theoretical estimation of probe
characteristics, including BLAST sequence analysis to confirm MB
specificity, and the DNA/RNA Zucker m-fold web-interface, which predicts
MB structure and identifies potential regions of internal hybridisation that
may adversely impact MB thermodynamics.
Alternative MB’s were designed to compare the utility of different
fluorescent molecules for signal detection, and to test the hypothesis that
dual-labelled FRET capable constructs are superior by achieving optimal
emission and excitation separation (Tyagi et al., 2000) (Figure 6.2).
Application of a FRET type MB should abolish the interference of cellular
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auto-fluorescence and components of the media, some of which
fluoresce in a similar spectrum to commonly employed fluorophores.
Next, the impact of nucleotide composition on MB stem properties was
explored, by replacing the DNA backbone with 2’-O-methylated RNA,
which reportedly confers superior hybridisation kinetics, diminished non-
specific nucleic acid/protein interaction and greater resistance to
enzymatic degradation in comparison with their DNA counterparts
(Tsourkas et al., 2002).
In summary, three MB designs were explored in the optimisation of
human RAD52 mRNA detection, using a cell-free system. A summary of
MB properties is shown below;
1) Texas Red labelled DNA MB
a. Excitation: 520 nm / Emission: 620 nm
2) Dual Labelled FRET capable DNA MB
a. FITC and TAMRA dual labelled: FRET capable
b. Excitation: 485 nm /Emission: 590 nm
3) FAM Labelled 2’-O-methylated RNA MB
a. 2’-O-methyl RNA stem: increased intracellular stability
b. Excitation: 485 nm /Emission: 520 nm
Specifics of MB design are shown in Figure 6.2
In the following sections, fluorescence measurements are presented as
an indicator of MB activation.
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5’-CA-AAC-GCT-GTG-TGG-AGT-CC G-TTT-G-3’
TTT-TTT 5’-CA-AAC-GCT-GTG-TGG-AGT-CC G-TTT-G-3’
GU-UUG-CGA-CAC-ACC-ACU-GG
5’-GCU-AAC-GCU-GUG-UGG-AGU-CCU-GUU-AGG-3’
i)
C - G
A - U
A - U
U - A
C –G
G
C - G
A - T
A - T
A - T
C –G
[TTT]2
ii) iii)
Figure 6.2 MB Design
The sequence of three MB, designed by modifying a qRT-PCR (Smith et al.,
2006) are shown as follows; (i) Top; Texas red-MB, Middle; FRET-MB and
bottom; FAM-MB (the complementary region of RAD52 mRNA is shown in black
italics). Purple (DNA) and blue (2’-O-methylated RNA) indicates sequence
complementary to nucleotides 1485-1503 of RAD52 mRNA (GenBank
Accession: U12134.1), and black text denotes probe extension to introduce a
self-annealing stem (i-iii). Filled circles represent chemical modifications: black:
DabCyl, green: FITC or 6-FAM (as indicated in the text), red: Texas red and
orange: TAMRA. The molecular structure is depicted for FRET-MB (ii) and FAM-
MB (iii), indicating the predicted ‘closed’ MB configuration under control
conditions.
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6.3.2 Confirming Specificity of Texas-Red MB
Specificity of texas red-labelled MB (200 nM) was confirmed using cell-
free studies, which revealed significant MB activation only in the
presence of hybridising ON (37 °C; 24 h). At 24 h, texas red MB was
activated in a concentration dependent manner (following incubation with
50, 100 or 200 nM hybridising ON) and was induced over 5 fold at a ratio
of MB 1:1 ON (Figure 6.3 A). Titration of hybridising ON to 10 nM (MB:
ON ratio; 20:1) was sufficient to induce texas red-MB to comparable
levels after 1, 4 and 18 h (1.2 - 1.5-fold indcution), in comparison with
control samples (no target), as indicated by fluoriometric analysis (Figure
6.3 B). The persistence of a signal at 18 h suggested negligible
fluorophore fading, although the intrinsic stability of MB may be
compromised over time, since fluorescence was elevated slightly over
time in control wells also (Figure 6.3 B). Since texas red was not
optimally excited by the flow cytometry equipment available to this
project, and MB induction was minimal at low concentrations of target,
which was speculated to mimic the intracellular situation (Figure 6.3 B), a
second probe was designed in an attempt to increase MB sensitivity.
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Figure 6.3 Texas-Red-MB Specificity & Sensitivity in a Cell-Free System
(A) Texas red-MB (200 nM) was incubated, at 37 °C in PBS, with hybridising or
non-hybridising ON, and fluorescence measurements were taken at 24 h using
a microplate reader. (B) MB sensitivity was determined in a similar manner,
following incubation with increasing ON concentration, in a background of
excess non-hybridising DNA (10 µM). N = 3 +/- SEM * P < 0.01, as indicated by
one way ANOVA comparison with MB alone (no target control wells).
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6.3.3 FRET-MB
Modification of texas red MB led to the design of a FRET capable MB
(FRET-MB) for reasons described in Section 6.3.1. Texas red was
replaced by TAMRA and FITC, separated by 6 thymidine bases (Figure
6.2) such that following excitation of FITC (485 nm), emitted energy was
transferred to TAMRA, and a signal detected at 590 nm.
6.3.4 Intrinsic Fluorescence Properties of FRET-MB
The intrinsic fluorescent properties of FRET-MB in the hairpin and linear
conformations were defined by fluorimetric analysis in 96-well plates.
FITC signal (485 / 530 nm) was negligible in the absence of target and
remained unaffected by the addition of hybridising ON (Figure 6.4 A),
suggesting that efficiency of energy transfer from FITC to TAMRA or from
FITC to DabCyl (in the linear and hairpin configuration respectively) was
comparable. In contrast, TAMRA (530 / 580 nm) and FITC-TAMRA FRET
(485 / 580 nm) fluorescent signals were elevated above basal levels
following 24 h incubation with 10 - 50 nM of hybridising ON (Figure 6.4
A). This result implied that FRET induction was specific to MB activation
and also suggested that monitoring the FITC signal may provide an
indication of transfection efficiency in living cells.
6.3.5 Confirming the Specificity of FRET-MB
FRET-MB and complementary ON hybridised with rapid kinetics (within
30 min of ON addition), and the persistence of MB activation for at least
48 h, as indicated by fluorescence elevated above basal levels,
suggested the stability of FRET-MB/ON complexes (Figure 6.4 B).
Optimal FRET-MB activation occurred at 1 h following incubation with
equimolar quantities of target ON (14-fold), and a slight decrease in
fluorescent signal was observed between 1 and 48 h. Nevertheless,
FRET-MB remained substantially induced at 48 h, compared with time 0,
under conditions in which MB was in 10-fold molar excess of ON (20 nM
target) (Figure 6.4 B).
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Figure 6.4 FRET-MB Specificity & Sensitivity in a Cell-Free System
Fluorescence of FRET-MB (200 nM) was determined by fluorimetry following
incubation at 37 °C with increasing concentration of hybridising ON in PBS. (A)
Fluorescence of FITC (485/530 nm) and TAMRA (530/590 nm) was compared
with FRET (485/590 nm) at 24 h. N = 6 +/- SEM. (B) The impact of ON
concentration on FRET-MB activation was monitored over 48 h. Values were
corrected to FRET-MB values in control wells (no ON).
N = 3 +/- SEM. + p <0.01 * p <0.001 compared to control wells (ANOVA).
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In addition to MB capacity for detecting the small amounts of nucleotide
anticipated in cell models, the signal should be readily translated into a
relative quantity of target. To a limited extent, FRET-MB satisfied these
criteria by sensitively and specifically reporting the presence of target
nucleotide, from which a clear concentration-dependent response was
established. With the aim of incorporating FRET-MB into a living cell in
vitro model, the compatibility of fluorescence detection under standard
cell culture conditions, and in live cells was investigated.
6.3.6 Optimal Conditions for Intracellular Applications
6.3.7 The Impact of Cell Culture Media on MB Fluorescence
Phenol red, FBS and riboflavin are routinely added to cell culture media,
although there are concerns regarding their auto-fluorescent properties.
This may be overcome by the application of a FRET type MB to increase
the spectral range over which measurements are taken. To further
explore this assumption, FRET-MB (200 nM) was incubated in 96-well
plates plus or minus hybridising ON (MB:ON ratio; 1:1), in the presence
of DMEM:Hams F12 1:1 media (phenol red free) +/- FBS (10 %). PBS,
which is predicted to exhibit minimal auto-fluorescence, was employed as
a negative control, +/- FBS. Fluorescence values obtained were
normalised to wells containing incubation media only.
In PBS alone, FRET-MB fluorescence was elevated 8 fold following the
addition of hybridising ON, while the presence of FBS abolished MB
induction to background levels due to increased noise in control wells (no
target) (Figure 6.5). Similarly, in phenol red-free media, FRET was
elevated 6 fold by hybridising ON (1:1 ratio), however FRET-MB
activation was not detected in media supplemented with FBS, again due
to elevated signal under control conditions (Figure 6.5). It was inferred
from this result that non-specific binding with serum proteins possibly
activates MB, since FBS alone displayed minimal auto-fluorescence.
Addition of FBS to media apparently limited the sensitivity of FRET-MB,
and so subsequent incubations were conducted in PBS alone.
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Figure 6.5 FRET-MB Specificity & Sensitivity in Culture Media
(A) FRET-MB +/- target (1:1) was incubated (1 h; 37 °C) in PBS, or phenol-red
free medium (DMEM:Hams) +/- 10 % FBS. Fluorescence readings were
obtained at 1 h using a mircroplate reader. Data is presented as relative
fluorescent units (RFU) from which the background fluorescence of incubation
reagent alone was subtracted.
N = 3 +/- SEM Data was deemed not significant by ANOVA.
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6.3.8 Optimising Transfection Conditions
Experiments were devised to achieve optimal delivery of FRET-MB into
cells during which a FITC-labelled ON (FITC-Scr) of similar nucleotide
composition, albeit of scrambled sequence, was employed. FITC-Scr
lacked the quencher present in the MB and so provided a constitutive
signal, which was exploited as a marker of transfection.
Although transfection by Oligofectamine is typically conducted under low
serum conditions, investigations conducted here indicated optimal
transfection efficiency in the presence of FBS (Figure 6.6 A), which
possibly related to enhanced cell viability.
6.3.9 Detection of FRET-MB in Living A549 Cells
FRET-MB (200 nM) was incubated in PBS with or without the addition of
50, 100 or 200 nM hybridising ON (1 h; 37 °C), and subsequently
introduced into A549 cells by Oligofectamine transfection. After 4 h,
fluorescence was measured by flow cytometry. The mean fluorescence
(FRET) was elevated between 1.3 and 1.4-fold in live cells following
transfection with FRET-MB/ON complexes, compared to cells transfected
with FRET-MB alone (Figure 6.6 B). This corresponds to a 2.5, 2.8 and
2.7-fold increase in the percent of cells exhibiting FRET elevated above a
predefined threshold, following transfection with FRET-MB/ON
complexes at the following ratios: 4:1, 2:1 and 1:1 (MB:ON) (Figure 6.6
B). This study demonstrated the successful detection of activated FRET-
MB in living cells, by flow cytometry, although there was little evidence of
a dose response. Thus, FRET-MB may not be suitable for providing a
direct measure of RAD52 mRNA content in living cells.
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Figure 6.6 FRET-MB Specificity & Sensitivity in Living Cells
(A) Optimal transfection conditions of A549 cells were determined using a
constitutively fluorescing FITC labelled ON and analysed by flow cytometry
(485/520 nm) (B) FRET- MB was pre-incubated with target ON in PBS (37 °C; 1
h) and transfected into A549 cells. FRET was analysed by flow cytometry
(485/590 nm) at 4 h. N = 3 +/- SEM. + P < 0.01; * P < 0.001 compared to control
samples (ANOVA).
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6.3.10 FAM-MB
The application of a MB comprising a 2’-O-methylated RNA backbone, for
achieving superior RNA hybridisation and enhanced intracellular stability,
was explored. MB’s comprising artificial nucleotide backbones are a
relatively new concept, and as such only mono-fluorophore labelled
probes were available at the time of investigation. A FAM (green
fluorescing: 485 / 530 nm) modification was chosen, which is compatible
with widely used fluorescent analytical platforms such as flow cytometry
and microscopy.
6.3.11 Confirming Sensitivity & Specificity of FAM-MB
Hybridisation of FAM-MB (200 nM) with complementary ON occurred
within 5 min, as indicated by increased fluorescence relative to control
wells (no hybridising ON) (Figure 6.7 A). Within 30 min a positive
fluorescent signal was evident at all concentrations of hybridising ON (10
– 100 nM) in a concentration-dependant manner, indicative of rapid and
specific hybridisation kinetics (Figure 6.7 A). The signal continued to
increase for up to 4 h relative to control wells, which suggested the
stability of FAM-MB over the time-course of the study. As such, during
subsequent applications, FAM-MB was kept at ambient temperature for
at least 1 h following thawing, and PBS was pre-warmed to 37 °C, in
order to confer optimal hybridisation conditions. Intrinsic stability of FAM-
MB was confirmed by extended incubation (18 h) with hybridising ON,
and optimal induction was detected in the presence of 500 nM
complementary ON (2.5-fold excess) in an excess of non-hybridising
DNA (Figure 6.7 B). Incubation of FAM-MB with equal molar quantities of
target ON was hypothesised to represent absolute MB activation,
however data here indicated optimal activation under conditions of
excess hybridising ON (Figure 6.7 B). Thus, even after prolonged
incubation, FAM-MB failed to hybridise with the total pool of available
target ON.
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Figure 6.7 Kinetics of the FAM-MB Response in a Cell-Free System
(A) FAM-MB elicited a dose-dependent response, as determined following
incubation in PBS with hybridising ON and excess non-hybridising DNA.
Fluorescence was monitored over time by fluorimetry (485/530 nm) and is
presented as RFU corrected to background values measured in control (no
target) wells. (B) FAM fluorescence was significantly (*) induced at all
concentrations of ON above 10 nM at 18 h. Data was normalised to the
fluorescence value acquired prior to the addition of hybridising ON.
N = 4 +/-SEM; * p  0.001 as determined by ANOVA.
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6.3.12 Optimising FAM–MB Hybridisation Conditions
In order to minimise the addition of foreign agents to cells during the
measurement of genetic toxicology events (so as to reduce the influence
of external factors on experimental outcome), the impact of FAM-MB
concentration was investigated. Under standard incubation conditions (1
h; 37 °C) 6.25 – 50 nM hybridising ON activated 100 and 200 nM FAM-
MB to a similar extent (Figure 6.8 A), and so 100 nM was considered
suitable for intracellular indications.
To confirm the predicted optimal incubation conditions (37 °C), the
detection of complementary nucleic acid by FAM-MB (100 nM) was
compared in a cell free system, following incubation at 25 and 37 °C.
FAM-MB preferentially hybridised with ON (6.25 - 25 nM) in PBS, at 37
°C compared with incubation at 25 °C, as determined by measuring
fluorescence at 1 h (Figure 6.8 B). At 37 °C, FAM-MB fluorescence was
induced 2-fold above basal levels, in the presence of 6.25 nM hybridising
ON, which increased in a concentration dependent manner (Figures 6.8
A and B). In contrast, FAM-MB activation was marginal following
incubation with hybridising ON at 25 °C (Figure 6.8 B).
6.3.13 Comparison of Alternative MB Design
In a background of excess non-hybridising DNA, FAM-MB exhibited
superior sensitivity for detecting low concentrations of target ON (< 20
nM, which corresponded to a 10 fold excess of MB) at 1 h, compared with
Texas red-MB and FRET-MB constructs (Figure 6.9). With increasing
concentration of target ON, the FRET MB achieved optimal signal:
background fluorescence, although the capacity of FRET-MB and FAM-
MB to detect 10 and 20 nM complementary ON (10 – 20-fold excess MB)
was comparable (Figure 6.9). It was noted that FAM-MB activation
displayed less variation between replicates, and so was predicted to
convey a high degree of inter-experimental consistency.
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Figure 6.8 FAM-MB Characterisation in a Cell-Free System
FAM-MB was incubated with increasing concentration of target ON in PBS and
excess non-hybridising DNA (for 1 h) and fluorescence of FAM-MB was
measured by fluorimetry. (A) The effect of MB concentration on hybridisation
kinetics (37 °C): N = 3 +/- SEM: + p <0.01 * p < 0.001: 100 nM v 200 nM (B) The
effect of temperature on MB – target hybridisation (100 nM MB) Data was
normalised to fluorescence value prior to addition of complementary ON. N = 3
+/- SEM: + p < 0.01 * p < 0.001: 25 v 37 °C, by ANOVA.
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Figure 6.9 Comparison of Various MB Designs in Cell-Free Systems
MB (200 nM) was incubated with target ON in an excess of non-hybridising DNA
(10 µM) (1 h; 37 °C) and fluorescence was measured by fluorimetry.
N= 3 +/- SEM. * P < 0.001 (ANOVA).
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6.4 Summary
Texas Red MB was the least successful MB described here, in terms of
relative induction in the presence of hybridising ON, while FRET-MB and
FAM-MB both provided sensitive methods for detecting complementary
ON in a background of non-hybridising DNA. Separation of emission –
excitation spectrum by employing a FRET type MB failed to overcome
fluorescent ‘noise’ in control no target wells, when incubated in complete
media containing FBS. This may be the consequence of MB activation
upon non-specific binding with serum proteins. Alternatively serum
components may hydrolyse MB, although this was considered unlikely,
since the use of heat inactivated serum during these studies, should
abolish enzyme activity.
FRET-MB activation at low concentrations of complementary target was
slightly inferior to that of FAM-MB, which may be due to the dependence
of energy transfer efficiency between fluorophores in the former
construct. The final outcome of cell-free and preliminary cell-based
studies presented here was the application of FAM-MB (100 nM) as a
reporter of RAD52 mRNA in cells, following a 1 h incubation, in pre-
warmed PBS, at 37 °C.
Data presented herein indicates that 100 nM FAM-MB was sufficient for
detecting small quantities of target in a specific manner, with rapid
hybridisation kinetics. For optimal FAM-MB signal detection, a 4 h
incubation step was necessary, but this was overcome by pre-warming to
ensure conditions that facilitate optimal MB configuration, and so 1 h
incubation at 37 °C was deemed appropriate for rapidly detecting RAD52
mRNA in human cells.
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7 Intracellular Studies Employing RAD52- MB
7.1 Introduction
Human RAD52 protein displays a preference for binding ssDNA rather
than DNA blunt ends, in vitro (Navadgi et al., 2003), most likely reflecting
the capacity of RAD52 to associate with intermediates of DSB repair (i.e.
MRE11 processed 3’ over hang ssDNA molecules). While the precise
role of human RAD52 remains elusive, in vitro studies implicate RAD52
participation at various stages throughout HR, from the initial recruitment
of RAD51 into discrete repair centres (although this role is a subject of
debate) (Navadgi et al., 2006), through to promoting DNA strand
exchange (Bi et al., 2004) (Kumar and Gupta, 2004). Additionally,
RAD52 appears to facilitate the association of ssDNA with duplex
dsDNA, apparently mimicking the assembly of damaged DNA into a
complex with an intact homologous chromatid, a process that is
mandatory for repair (Navadgi et al., 2003) (Bi et al., 2004) (Wu et al.,
2006). Recent work also implicates RAD52 in promoting annealing of the
DNA strand that is displaced during cross-over recombination, thus
RAD52 ultimately ensures restoration of DNA sequence integrity
(Sugiyama et al., 2006). The role of RAD52 in HR, in particular during
the cellular response to stalled replication forks, is further supported by
intracellular studies, which have established the association of RAD52
with HR related proteins RAD51, RPA and WRN (see Chapter 1: Figure
1.6 for details) (Shukla et al., 2005) (Van Dyck et al., 1998) (Baynton et
al., 2003). The reader is referred to Chapter 1: Section 1.10 for a more in
depth discussion of HR and RAD52.
Notably, RAD52 expression has been closely linked with various cancers,
such that diminished amounts of transcript were detected in colorectal
adenocarinoma samples (Galamb et al., 2006), and the RAD52 gene
locus is located within a chromosomal region commonly associated with
loss of heterozygosity in breast cancer cells (Nowacka-Zawisza et al.,
2006). Together with reports of altered transcriptional regulation in
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response to DSB inducing agents (Ding et al., 2005) (Smith et al.,
2006), and participation in HR repair, there is a strong case for
implicating RAD52 in the maintenance of genome integrity.
Given the significance of RAD52 in DNA repair, a series of intracellular
studies were devised, using FRET-MB and FAM-MB (the design of which
was described in Chapter 6) to extend the observation of transcriptional
up-regulation to whole cells. In addition, the aptness of MB technology for
signifying RAD52 mRNA expression in various human cell lines, following
exposure to genotoxic stress was explored. The results of these studies
are described herein.
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7.2 Methods
7.2.1 Quantitative Real Time-PCR (qRT-PCR)
7.2.1.1 RNA: Qualitative Analysis
Agilent 2100 Bioanalyzer reagents were supplied by Life Sciences &
Chemical Analysis (Agilent Technologies Inc., Santa Clara, CA, USA).
RNA 6000 Nano gel matrix (550 µl) was spun onto a spin filter (1,500 g
for 10 min) and 65 µl aliquots of filtrate were stored for future use. Vortex
mixed RNA 6000 Nano dye was added to 65 µl aliquots of filtrate, mixed
by vortex and spun down at 13,000 g for 10 min. Gel-dye mix was then
introduced to a fresh RNA Nano chip using the Chip Priming Station
provided, as outlined by manufacturers’ guidelines. Heat denatured (5
min incubation at 70 °C) RNA ladder (1 µl) and RNA samples (1 µl), were
pipetted into appropriate wells. Finally the chip was vortexed for 1 min at
2400 rpm, and run in an Agilent 2100 Bioanalyzer using the Eukaryote
Total RNA Nano assay program.
The quality of RNA was determined from Agilent Bioanalyzer
Electropherograms (2100 Expert Software), which show two major peaks
representing 18S and 28S ribosomal RNA. In the event of RNase
contamination, a series of smaller peaks or smears are indicative of RNA
degradation.
7.2.1.2 RNA Quantification
A NanoDrop ND-1000 UV-Vis Spectrophotometer (NanoDrop
Technologies, Inc., Wilmington, USA) was employed for quantification of
RNA, which was normalised against dH20.
7.2.1.3 Reverse Transcription of RNA (cDNA production)
RNA (1 µg) was mixed with random hexamers (50 ng/ µl), 10 mM dNTP
mix (1 µl) and made up to a final volume of 10 µl with MBGW. Following
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incubation at 65 °C for 10 min, samples were placed on ice for 10 min,
and the entire reaction was subsequently transferred to a fresh tube,
containing RT-buffer (1 X), 25 mM MgCl2 (4 µl), 0.1 M DTT (2 µl) and
E.coli derived RNaseOUT ribonuclease inhibitor (1 µl), in the presence or
absence of SuperScript II reverse transcriptase. Samples were
incubated at 25 °C for 10 min followed by 50 min at 42 °C, and 15 min at
70 °C, the latter step necessary to terminate the reaction. RNase H (1 µl)
was subsequently added to samples, which were incubated for 20 min at
37 °C, to remove all traces of RNA. Finally, samples were made up to 50
µl with MBGW, to achieve the desired final concentration of cDNA, and
stored at 4 °C until required. All reagents were obtained from Invitrogen
(Poole, UK).
7.2.1.4 Genomic Standard Curve
Genomic DNA (Promega, Southampton, UK) was diluted in MBGW to
known concentrations and 50 µl aliquots were added to 50 µl of PCR
master mix (RT-PCR master mix, forward RAD52 primer, reverse RAD52
primer, TAMRA-labelled RAD52 probe, 18S ribosomal RNA (rRNA)
forward and reverse primer, and Victor labelled probe), in 96-well plates.
All samples were carried out in duplicate. Following mixing and brief
centrifugation, plates were run on an ABI 7900HT Sequence Detection
System (for Taqman) and data was analysed using the software
provided. The cycle threshold was set at 0.3 and 0.2 for RAD52 and 18S
rRNA respectively, which represents the cycle number at which
duplicates are tightly associated during the exponential phase of
amplification. Inclusion of a standard curve on each reaction plate
allowed for the quantification of mRNA copy number.
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Primer and probe details are given below:
Gene Primer Sequence Fluorophore
RAD521 Forward AGACCTCTGACACATTAGCCTTGAA
Reverse AAGATCCAGATTTTGCTTGTGGTT
Probe CCAGAACAGGACTCCACACAGCGTTTG FAM-TAMRA
rRNA 18s2 Forward CGGCTACCACATCCAAGGAA
Reverse GCTGGAATTACCGCGGCT
Probe TGCTGGCACCAGACTTGCCCTC VIC-TAMRA
Reaction plates containing irradiated and unirradiated TK6-derived cDNA
were set up in a similar manner, to simultaneously detect RAD52 and
18S rRNA. The inclusion of a probe and primers specific to 18S rRNA, a
housekeeping gene that should not fluctuate with treatment, provided an
internal control for relative mRNA content, to which RAD52 mRNA levels
were corrected.
7.2.2 Molecular Beacon Studies
7.2.2.1 Treatment
MCL-5, TK6, A549 or SKOV3 cells (as stated in the text) were irradiated
or exposed to chemical treatment in a manner analogous to that
described in Chapters 2 & 3.
7.2.2.2 Sample Preparation
7.2.2.2.1 Live Cell Applications
Cells were transfected with FRET-MB in the manner described in Section
6.2.4, exposed to MMS at 4 h, and FRET-MB fluorescence monitored by
flow cytometry at 4 and 24 h.
7.2.2.2.2 Fixed Cell Applications
Live cells were treated chemically or irradiated as necessary, and ethanol
fixed as previously described in Chapter 3: Section 3.2.5.1. Fixed cells
1 Primers originally designed by Smith, C.C 2006: GenBank Accession; U1234.1
2 Commercially available: obtained from Applied Biosystems
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were washed in PBS and incubated with 100 – 200 nM MB (as specified
within the text), for 1 h at 37 °C followed by DAPI staining as necessary
(1 µg/ml DAPI in PBS) in 96-well plates, then briefly washed with PBS
and analysed for fluorescence. For microscopy applications, suspension
cells were cytospun onto slides following incubation with MB, and cover
slipped using VectorShield HardSet mountant. Adherent cells were
cultured on cover slips contained in 24-well plates and the MB incubation
step performed directly in wells. Cover slips were subsequently inverted
onto microscope slides prior to analysis.
7.2.2.3 Antibody Studies
Ethanol fixed cells were blocked and probed for protein expression in a
manner analogous to that described in Section 3.2.5.2. For studies
conducted here, a combination of rabbit anti-RAD52 primary (Abcam,
USA) and goat anti rabbit-Cy3-conjugated secondary antibody (Invitrogen
Molecular Probes, Poole, UK) was employed. The procedure for cell
staining with FITC conjugated anti-H2AX is described in Section 3.2.5.2.
7.2.2.4 Microscopy
Images of cells were captured using a Zeiss wide-field fluorescence
digital imaging set-up, and FAM fluorescence was detected at 485 / 520
nm (ex / em).
7.2.2.5 TK6 Cells
Images acquired of TK6 cells were analysed for RAD52-MB activation by
scoring the number of cells displaying multiple (> 3) discrete fluorescent
foci.
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7.3 Results
7.3.1 FRET-MB: Analysis of MMS Exposure in Living Cells
FRET-MB (described in Sections 6.3.3 – 6.3.9) was introduced into A549
cells by Oligofectamine transfection, and subsequently exposed to 12.5
µg/ml MMS. Fluorescence was measured by flow cytometry, which
revealed no change in FRET signal after 2 and 4 h (Figure 7.1 B). At 24 h
however, FRET-MB induction above basal levels was detected in a larger
fraction (33 %) of MMS exposed cells, relative to the vehicle control
population (Figure 7.1 B). However, the raw data from which these values
were derived (not shown here) indicated that the proportion of fluorescent
cells was several fold lower at 24 h compared with measurements taken
at 2 h (i.e. soon after transfection), an effect that was most prominent in
untreated cells. Thus, cell proliferation was speculated to dilute FRET-MB
at the population level, since it is not passed between generations. In
accordance with this notion, cell proliferation was reduced by 25 %
following MMS exposure, relative to control populations (Figure 7.1 A).
Consequently a greater proportion of treated cells were anticipated to
measure positive for background FRET-MB, thus contributing to elevated
‘noise’ at the population level, and so complicating the analysis process.
As a consequence of the high background signal of FRET-MB, possibly
due to intracellular enzymatic degradation, further studies were
conducted using a 2’-O-methylated RNA MB (FAM-MB: see Sections
6.3.10 – 6.3.12), which was predicted to display preferential stability in
cells (Tsourkas et al., 2002). Transfection of cells with FAM-MB using
previously optimised conditions (Oligofectamine) however, resulted in a
high level of cell death (Figure 7.2). Based on these observations, and
together with MB dilution as the consequence of cell proliferation (Figure
7.1), it was deemed appropriate to continue validation studies by treating
cells, followed by fixation and incubation with FAM-MB. In the event that
this proved successful, further optimisation and consideration of
alternative transfection conditions was envisaged.
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Figure 7.1 Effect of MMS Treatment on A549 Cells: FRET-MB
A549 cells were transfected with FRET-MB and exposed to MMS (12.5 µg/ml)
or vehicle control (DMS0) for up to 24 h. (A) Images of A549 cells following 24 h
exposure to MMS; left: 0 µg/ml and right: 12.5 µg/ml; the fold increase in cell
number at 24 h relative to vehicle control cells is given also. (B) The percent of
cells with elevated FRET signal following MMS exposure was noted. N = 2.
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Figure 7.2 Transfection of Live A549 Cells with FAM-MB
Cells were analysed for fluorescence at 18 h post-transfection with FAM-MB
(using Oligofectamine reagent). (A) Cells plated in 96-well plates were analysed
for background FAM fluorescence using a plate reader (485/ 520 nm; ex/em)
and corrected to mock transfected controls. Readings were also obtained after
replenishing the media, which indicated diminished fluorescence as a
consequence of cell loss. N = 6 +/- SEM. (B) Images of A549 cells at the time of
transfection (top) and at 18 h; left; mock transfected and right; FAM-MB
transfected.
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7.3.2 Intracellular FAM-MB Studies
Flow cytometric histograms revealed a shift in total population
fluorescence to the right, indicative of elevated fluorescence, following
incubation with FAM-MB, under control conditions (Figure 7.5 B). This
most likely represents hybridisation of FAM-MB with constitutively
expressed RAD52 mRNA. Consequently, it was deemed appropriate to
monitor the mean fluorescence intensity of entire populations rather than
the proportion of cells displaying FAM-MB fluorescence above a defined
threshold. Data presented in forthcoming sections was derived from the
mean fluorescence intensity of a user-defined ‘region’ on flow cytometric
plots, which is portrayed in Figure 7.3 A. Values were subsequently
normalised to the smallest denominator in negative control populations.
7.3.3 MMS Treatment
TK6 and MCL-5 cells cultured with or without MMS for 24 h were ethanol
fixed and incubated with FAM-MB for 1 h (37 °C). In TK6 cells, FAM-MB
fluorescence was induced in a concentration-dependent manner up to 25
µg/ml, at which point fluorescence was significantly elevated relative to
control samples (Figure 7.3 B). Following 50 µg/ml MMS exposure, FAM-
MB fluorescence was attenuated in TK6 cells, as indicated by diminished
fluorescence relative to 25 µg/ml exposed cells (Figure 7.3 B). Under
similar conditions, FAM-MB fluorescence was significantly greater than
basal levels, in MCL-5 cells, at 25 and 50 µg/ml MMS (Figure 7.3 B).
Collectively, this data suggested a trend for elevated FAM-MB activation
concomitant with increasing MMS concentration. Therefore a positive
correlation between FAM-MB activation and DSB generation may be
tentatively inferred. Consistent with data obtained during H2AX antibody
studies (Figures 3.3 and 3.4), the magnitude of FAM-MB activation,
following MMS exposure relative to unexposed control populations, was
greater in TK6 cells compared with MCL-5 cells and displayed a similar
pattern of induction.
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Figure 7.3 Effect of MMS on FAM-MB Activation
Cells were cultured in MMS for 24 h, ethanol fixed, incubated with FAM-MB (100
nM; for 1 h at 37 °C) and analysed for fluorescence by flow cytometry (A) Flow
cytometric plots of cells following treatment and incubation with FAM-MB: left:
control, and right: 12.5 µg/ml MMS exposed MCL-5 cells. (B) MCL-5 cells (N = 3
+/- SEM) (pale bars), and TK6 cells (N = 8 +/- SEM) (dark bars). Data was
normalised to the lowest FAM-MB fluorescent signal detected in control
populations
+ P < 0.05; * P < 0.01 as determined using ANOVA with Dunnetts post test.
+
* *
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7.3.4 PhIP Treatment: MCL-5 Metabolically Competent Cells
In Chapter 3, the application of antibody studies revealed a trend for
elevated H2AX levels, following PhIP exposure. This effect was most
pronounced in replicating S phase cells at the highest concentration
investigated (100 µM PhIP), leading to the hypothesis that PhIP adducts
may generate DSB upon collision with the advancing replication fork. It
was therefore reasonable to speculate that, in the presence of
homologous chromatids during late S phase, breaks would be primarily
directed for HR repair. If this were the case then RAD52 transcriptional
up-regulation may be anticipated, as part of the cellular response to PhIP
exposure. In the present studies a trend for elevated FAM-MB was
observed following 24 h continuous exposure of metabolically competent
MCL-5 cells to increasing concentrations of PhIP (1 – 100 µM), however
in each instance the FAM-MB signal was no greater than the no-
treatment controls (Figure 7.4 A). While this suggests that PhIP exposure
failed to induce RAD52 mRNA expression, inspection of the raw data
suggests a possible effect of PhIP on overall FAM-MB fluorescence,
which was diminished below background levels. This raises the possibility
that absorbance properties of PhIP, a common trait of aromatic chemicals
may interfere with fluorescence at wavelengths employed here for
monitoring FAM-MB activation. Thus further investigation is necessary.
7.3.5 CLP Treatment: TK6 Cells
FAM-MB underwent significant activation following exposure (24 h) of
TK6 cells to CLP at all concentrations investigated (2.5–10 µM),
corresponding to an approximate 3- and 4-fold increase in mean
fluorescence intensity at 2.5 and  5 µM, relative to unexposed control
cell populations (Figure 7.4 B). In contrast, H2AX (Figure 3.5 C) and MN
studies (Ansah, C unpublished data) have failed to indicate DSB
induction in human cells, despite reports of elevated MN incidence in
rodent cells under similar conditions (Ansah et al., 2005).
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Figure 7.4 Effect of PhIP and CLP on FAM-MB Activation
TK6 cells were cultured in the presence of PhIP (A) or CLP (B) for 24 h, ethanol
fixed, and incubated with FAM-MB (100 nM: 1 h; 37 °C). FAM-MB activation
was monitored by flow cytometry. Data was normalised to the lowest FAM-MB
fluorescent signal detected in control populations, except for PhIP (A), for which
the raw data is presented also.
N = 4 +/- SEM + P < 0.05 * P < 0.01 (ANOVA)
+ * *
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7.3.6 IR ofTK6 Cells
Gamma-irradiated TK6 cells were ethanol fixed and incubated with FAM-
MB to investigate the possibility of a RAD52 transcriptional response.
Within 1 h of IR, FAM-MB fluorescence was elevated above basal levels
following 0.1, 1 and 5 Gy IR, although not to a significant degree (Figure
7.5 A and B). Images of cells irradiated at 5 Gy in the absence of FAM-
MB confirmed the absence of signal interference by intrinsic auto-
fluorescence (Figure 7.5 C). Data obtained by flow cytometry was
confirmed by images captured using fluorescence microscopy (Figure 7.6
A), which revealed elevated FAM-MB fluorescence in irradiated, but not
unirradiated cells. Concurrent with dose, an apparent trend for increased
discrete foci was noted also (Figure 7.6 A), which was confirmed by
manual scoring (Figure 7.6 B). While apparently nuclear, the precise
nature of these foci remains uncertain
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Figure 7.5 Effect of IR on FAM-MB Activation in TK6 Cells
(A) Graphical representation of FAM-MB activation in TK6 cells following IR (N
= 3 +/- SEM). Data obtained from flow cytometric plots shown in (B), was
normalised to the lowest FAM-MB fluorescent signal detected in control cell
populations. FAM-MB activation was deemed not significant by ANOVA. (B)
Flow cytometric plots: top; cells alone (no FAM-MB), middle and bottom; cells
incubated with FAM-MB following 0 and 5 Gy IR respectively: M indicates the
marker containing cells with FAM-MB fluorescence intensity elevated above
basal levels. (C) Images were captured by microscopy at 1 h following 5 Gy IR:
left phase contrast and right; under FAM compatible fluorescence filters (485
/520 nm): white circles indicate cell positions.
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Figure 7.6 Analysis of FAM-MB Activation in TK6 Cells Following IR
TK6 cells were -irradiated, fixed and incubated with FAM-MB (1 h; 37 °C) and
images were captured by fluorescence microscopy (A) top: 0 Gy centre 0.5 Gy
and bottom 5 Gy: left 1 h and right 6 h post IR (B) Discrete nuclear foci were
noted and the frequency of cells with greater than 3 foci per cell were scored
(100 cells/ sample). Images captured under x 40 magnification.
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7.3.7 IR of Adherent A549 Cells
Microscopy studies employing FAM-MB as an indicator of RAD52 mRNA
levels were continued using A549 adherent cells for ease of sample
processing. The possibility of auto-fluorescence contributing to the signal
in the FAM channel was ruled out by inspecting images captured
following 5 Gy IR in the presence of DAPI staining alone (Figure 7.7 A).
To determine whether background FAM signal was the consequence of
FAM-MB activation upon hybridisation of constitutively expressed RAD52
mRNA, cells were treated with a combination of RNase A and RNase H,
to remove cellular RNA, and subsequently incubated with FAM-MB.
Unexpectedly, an extremely intense signal was detected in the nucleus of
cells (Figure 7.7 A), therefore suggesting that FAM-MB is susceptible to
RNase mediated hydrolysis. The application of cell fixation during these
studies renders this of minor incidence, however this would have
implications for progressing this work into living cells.
Images captured of control, unirradiated A549 cells incubated with FAM-
MB (100 nM) revealed fluorescence, which was largely restricted to the
nucleus (Figure 7.7 B), to a greater extent in comparison withTK6 cells
(Figure 7.6 A). Despite the longevity of localised fluorescence following
IR, an additional faint, pan-nuclear distribution of FAM-MB was indicated
specifically in response to IR (1 Gy), concomitant with homogeneous
staining in the peri-nuclear region of the cytoplasm (Figure 7.7 B centre).
Cytoplasmic activation of FAM-MB in close proximity of the nucleus was
possibly connected with RAD52 mRNA export from the nucleus, into the
cytoplasm for ribosomal translation. Fixed unirradiated cells incubated
sequentially with target ON and FAM-MB (1:1 ratio) displayed a similar
pattern of distribution to 1 Gy IR cells (Figure 7.7 B right).
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Figure 7.7 Analysis of FAM-MB Activation in Adherent Cells Post IR
A549 cells cultured on glass cover slips were ethanol fixed at 1 h post IR and
incubated with FAM-MB (100 nM; 1 h; 37 °C). (A) Left (white circles depict cell
outlines) and centre; IR cells (no FAM-MB) (+/- DAPI stain respectively), and
right; cells + excess RNase + FAM-MB. (B) FAM-MB was incubated with A549
cells at 1 h post IR: left; 0 Gy, centre; 1 Gy and right; 0 Gy [cells + target ON +
FAM-MB (1:1 ratio)]. (C) Unirradiated (left) and 1 Gy irradiated (right) SKOV3
(p53 mutated) cells were fixed at 1 h and incubated with FAM-MB (100 nM) and
DAPI. Images captured under x 40 magnification.
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C
100 nM FAM-MB 100nM FAM-MB
0 Gy IR 1 Gy IR 1:1 Target
No MB: 5 Gy 1 h 5 Gy 1h + DAPI 0 Gy + RNase A/H
+ FAM-MB (100 nM)
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7.3.8 IR of Adherent SKOV3 p53 Mutated Cells
SKOV3 cells displayed elevated cytoplasmic levels of FAM-MB only in a
subset of cells under control conditions, as demonstrated in pictures
captured by fluorescent imaging (Figure 7.7 C left). Similar to A549 cells,
discrete regions of FAM-MB activation were evident in the nucleus of
control cells, although in SKOV3 cells, multiple small foci were observed
as opposed to the few large foci detected in A549 cells (Figures 7.7 B &
C). In contrast to TK6 cells, there was no evidence of elevated foci
number following IR.
7.3.9 Behaviour of RAD52 Following IR
Immuno-fluorescence studies were conducted using A549 and SKOV3
cells to determine whether RAD52 abundance or cellular distribution was
affected by IR. Under control conditions RAD52 signal was observed
throughout the nucleus of A549 cells, using a RAD52 primary antibody
and a Cy3-conjugated secondary antibody combination (Figure 7.8 A &
B left). No obvious redistribution of RAD52 was detected at 1 h post IR
(Figure 7.8 B right).
SKOV3 cells exhibited both a diffuse and local pattern of RAD52
distribution throughout the cytoplasm and nucleus under control
conditions, which remained relatively constant at 1 h following 1 Gy IR
exposure (Figure 7.8 C). Sequential staining with anti-RAD52 and anti-
H2AX antibodies revealed limited co-localisation of the two proteins in
irradiated SKOV3 cells (Figure 7.8 D), which suggested the repair of only
a subset of DSB by HR.
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Figure 7.8 Analysis of RAD52 in Adherent Cells Post IR
Adherent cells were irradiated, fixed at 1 h, and probed for RAD52 protein
expression +/- anti-H2AX. (A) Unirradiated A549 cells (B) A549 cells; left; 0 Gy
and right; following 1 Gy IR (C) SKOV3 p53 mutated cells; left; 0 Gy, and right;
following 1 Gy IR. (D) A single SKVO3 cell following 1 Gy IR (RAD52: red,
DAPI: blue and H2AX: green). Image series and individual images are denoted
by bold or normal text respectively. Images captured under x 63 magnification.
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Individual A549 Cells: Anti-RAD52
0 Gy 1 Gy: 1 h
A field of multiple A549
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7.3.10 Quantifying RAD52 mRNA in TK6 Cells Following IR
Irradiated TK6 cells (1 Gy) were analysed for RAD52 mRNA expression
at 1, 2, 4 and 8 h by qRT-PCR, as described in Section 7.2.1. Inspection
of the raw data revealed that the average copy number of RAD52 mRNA
per cell was approximately 2,500, with basal levels apparently increasing
between 1 and 4 hours. This was postulated to be cell cycle related,
since the copy number diminished again after 4 h, thus raising the
possibility that a greater abundance of protein or latent mRNA transcript
may be advantageous during replication. As such, this may enable cells
to elicit a rapid response to replication fork associated stress.
Matched samples (0 Gy or 1 Gy IR) at each time point were quantified
for RAD52 mRNA by qRT-PCR, and subsequently normalised to rRNA
18S mRNA levels. Using Microsoft Excel, inhouse statistical analysis,
RAD52 mRNA was induced after irradiation at 1 – 4 h, however this was
only deemed statistically significant at 1 h (Figure 7.9) RAD52 mRNA,
was elevated 1.6-fold (Figure 7.9), in comparison with previous data
obtained using an identical probe and primer set, which revealed a 4-5
fold induction in response to MMS and etoposide treatment. This is likely
the consequence of cells engaging in alternative modes of repair, such
that IR associated DSB are primarily repaired by NHEJ (Allen et al.,
2003), while MMS and etoposide, which typically generate DSB
intermediates during replication, would engage in HR repair, which
prevails during S and G2- phase of the cell cycle (Rodrigue et al., 2006)
(Sonoda et al., 2006).
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Figure 7.9 Confirming RAD52 Transcription in TK6 Cells Post IR
RNA isolated from matched samples at the stated time was used in a reverse
transcription reaction, followed by PCR to quantify mRNA content. RAD52
mRNA levels were normalised to that of the house keeping gene rRNA 18S
transcript. N = 3 +/- SEM.
*
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7.4 Discussion
FAM-MB was selected as the most appropriate of three molecular
beacons, for detecting RAD52 mRNA in human cells, due to superior
hybridisation kinetics, and was also predicted to display optimal
intracellular stability. Herein, data was obtained under the assumption
that elevated FAM-MB fluorescence intensity at the cell population level,
was directly relevant to intracellular RAD52 mRNA content. This was
based on the previous observation of RAD52 mRNA up-regulation
following MMS treatment by approximately 5-fold in human cell lines
(Smith et al., 2006), which was repeated here in whole cells, albeit to a
lesser degree. Following MMS treatment, FAM-MB fluorescence was
elevated above basal levels, in MCL-5 and TK6 cells, in a concentration-
dependent manner, and exhibited a similar trend to that of H2AX
incidence at corresponding concentrations (see Section 3.3.4). Taken
together, FAM-MB induction was assumed to be indicative of RAD52
mRNA transcriptional up-regulation, as part of the DSB response.
Ideally an MB for detecting mRNA events should be capable of diffusing
throughout the entire cell volume, to detect not only transcriptional events
within the nucleus, but also mRNA exported into the cytoplasm for
ribosomal translation. Herein, the ability of FAM-MB to produce a signal
throughout the entire cell following exposure to DSB inducing stimulus
suggested access to all cellular compartments. However, data presented
here, was derived from studies conducted in fixed cells, and thus the
behaviour and kinetics of FAM-MB in living cells is not defined.
One concern highlighted during this investigation was the nature of
background FAM-MB signal, which was predominantly nuclear. It is
speculated that MB molecules have an affinity for nuclear compartments,
and that non-specific activation may proceed upon association with
hairpin binding proteins. An additional confounding issue was the
apparent hydrolysis and subsequent false positive ‘activation’ of FAM-MB
following RNAse treatment, which needs to be overcome for FAM-MB
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application in living cells. Further optimisation of FAM-MB design, time
and method of MB delivery into cells, and incubation conditions will be
necessary to diminish background nuclear signal and therefore achieve
optimal signal detection in living cells. These issues are considered in
more depth in Chapter 8.
Nevertheless, a trend for elevated FAM-MB signal following DSB
inducing treatment, in particular lesions expected to undergo HR repair
(i.e. MMS induced DSB) was demonstrated here, along with the
verification of MB specificity in a cell free system (as described in Chapter
6), and confirmation of RAD52 mRNA up-regulation following IR by qRT-
PCR. Collectively, these data provide a strong correlation between FAM-
MB signalling and intracellular RAD52 mRNA levels. An attenuated
transcriptional up-regulation of RAD52 following exposure of human cells
to IR versus MMS treatment (Smith et al., 2006), as confirmed using
qRT-PCR, is possibly the outcome of repair pathway bias. It is suggested
that with MMS, replication associated lesions are more likely to undergo
HR mediated repair (Lundin et al., 2005), whilst IR generated DSB are
primarily rejoined by NHEJ (Rothkamm et al., 2003).
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8 Discussion
8.1 Project Background
DSB inducing agents are among the most potent of mutagens, and so the
accurate identification of such compounds is fundamental to genetic
toxicology. Of contemporary relevance is the development of reliable in
vitro tests, to ascertain genetic toxicology potential, as part of a strategy
to refine, reduce and replace the use of animals in toxicology testing, and
has the additional benefit of reduced expenditure, relative to in vivo
assays.
8.2 Thesis Synopsis
The primary objective here was to identify DSB associated biochemical
events, with the initiative of developing a novel, fluorescent based
mutagenicity assay capable of reporting DSB, in real-time, in human
cells. Specifically, ATM mediated events, recognised as fundamental to
the mammalian DSB response were explored, along with the previously
reported up-regulation event of RAD52 mRNA in response to various
DSB inducing stimuli (Ding et al., 2005) (Smith et al., 2006). The two
main branches of work described within this thesis were investigated in
parallel, due to the high risk associated with cloning strategies, such as
those employed here, in the creation of a FRET based sensor of damage.
Additionally, for the purpose of validating a novel reporter, the impact of
DSB inducing treatment on cell cycle distribution, viability and relative
growth was evaluated for cell lines of DSB relevant phenotypes. These
studies also contribute towards the generation of hypotheses regarding
mode of action of the anti-malarial alkaloid CLP, and the dietary
heterocyclic amine PhIP.
8.3 Cytotoxicity Monitoring
A recent report highlighted discrepancies in cytotoxicty data obtained
using diverse biological parameters, including membrane integrity, mitotic
index and colony forming capacity (Fellows and O'Donovan, 2007). In
agreement, work conducted here demonstrated colony formation
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(adherent cells) and relative suspension growth (suspension cells) as
more sensitive indicators of subtle deviations in cellular function, in
comparison with trypan blue exclusion, which reportedly underestimates
population toxicity (Fellows and O'Donovan, 2007). Furthermore, with the
use of automatic cell counters, which can be set with predefined size
exclusion values, to count only healthy cells, RSG is simple to measure
and provides reliable, unbiased data.
Human TK6 lymphoblastoid cells were the primary choice for validation
purposes, due to their prevalent application in genetic toxicology and
extensive characterisation (Liber and Thilly, 1982) (Zhang et al., 1995)
(Hilliard et al., 1998) (Hastwell et al., 2006) (Bryce et al., 2007).
8.4 Irradiation Treatment of Cells
8.4.1 IR: Induction of DSB in Various Human Cell Lines
In accordance with the concept of IR as a potent cytotoxic agent of
mutagenic tendency, application of the MN assay and H2AX antibody
studies employed here, confirmed a positive correlation between IR and
DSB induction. Specifically, significant mutagenic potential was indicated
at exposure levels sufficient to impede cellular proliferation two fold.
Disappearance of discrete H2AX foci, presumably as the consequence
of DSB repair, was inversely related to clinical exposure relevant doses
( 5Gy), and as previously suggested, H2AX loss may provide a useful
tool for measuring the kinetics of repair following low levels of DSB
(Banath et al., 2004) (Bouquet et al., 2006). The persistence of DSB at 6
h was possibly due to saturation of NHEJ repair capacity; the ‘fast’ mode
of repair predominant in G1 and early S phase cells (Rothkamm et al.,
2003); and thus residual H2AX foci may represent breaks awaiting repair
by HR, which proceeds with comparatively slower kinetics (Weibezahn
and Coquerelle, 1981) (Metzger and Iliakis, 1991). Amplification of the
H2AX signal at 6 h post 10 Gy IR possibly signals irreparable lesions,
or DSB arising from clusters of unstable SSB in close proximity, however
the latter is reported to occur within the first 30 min following IR (Gulston
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et al., 2004). Alternatively, the accumulation of RPA coated ssDNA
regions (MacPhail and Olive, 2001) (Robison et al., 2004), which is
associated with the stalled replication fork during S-phase arrest, may
enhance the H2AX signal at later time-points (i.e. at 6 h).
The repair, or tolerance of amounts of DSB induced following 1 and 5 Gy
IR exposure, over the 6 h time course investigated here, was supported
by cell cycle data. Dose-related intra-S and G2/M phase cell cycle arrest
was inferred at 4 h, which appeared less pronounced at 24 h, thus
implying cell recovery and recommencement of the cell cycle. All aspects
of the cell cycle are tightly co-ordinated to ensure the quantitative and
qualitative accuracy of DNA replication, (Laskey et al., 1989) with
activation of check points functioning to prevent passage of damaged
DNA to daughter cells.
Despite the accumulation of breaks at 6 h following high IR exposure
and their apparent repair at lower doses ( 5 Gy), as suggested by
H2AX antibody studies, the MN assay indicated plateau at 5 Gy. This
was most likely due to overt cytotoxicity at 10 Gy IR, characterised by a
significant reduction in replication and mitosis, both of which are
necessary for clastogenic events to manifest as MN.
8.4.2 p53 Deficiency
SKOV3 cells (p53 mutated) exhibited sensitivity to the DSB inducing
effect of IR, such that H2AX foci incidence at 1 h was elevated to a
greater extent relative to A549 p53-proficient cells, which coincided with
increased survival at 10 days. Following 5 Gy IR however, SKOV3 cell
survival was attenuated at 10 days in the absence of correct p53 function.
These data suggest a possible growth advantage in SKOV3 cells after
low dose IR, possibly due to diminished p53-dependent apoptosis,
which is compensated for at high doses, such that cell death proceeds
via a p53-independent pathway.
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8.4.3 ATM Deficiency
The importance of ATM in mammalian cells is widely ascribed to the
participation of ATM in DSB signalling. Findings described here support
this notion, since a higher fraction of AT cells contained MN under control
conditions, representing accumulation of endogenously occurring breaks.
Furthermore, compared to TK6, AT cells were more responsive to the
clastogenic effects of bleo (a radiomimetic drug), which was
accompanied by attenuated cell cycle arrest. Thus ATM signal
transduction impacts multiple aspects of the DSB response following bleo
treatment.
8.5 MMS Studies
As described in Chapter 2, MMS is a potent alkylating agent, which
necessitates removal of the modified base by BER, during which SSB are
transiently produced, with the potential to manifest as DSB during S
phase replication (Pascucci et al., 2005). However, the capacity for MMS
to induce DSB remains a subject of debate, and herein the impact of
MMS treatment on cell lines of DSB relevant phenotypes was
investigated.
8.5.1 Suspension Cells
Studies conducted here indicated MMS associated cell cycle arrest at 24
h, in ATM proficient cell lines only, although TK6 cells displayed a more
drastic response at lower concentrations of MMS compared to MCL-5
metabolically competent cells. In accordance with this result, H2AX was
induced to a greater magnitude at corresponding concentrations of MMS
in TK6 cells, although viability was more severely compromised in MCL-5
cells. The disparity in H2AX induction between cell lines was postulated
to be partly due to the biochemical make-up of cells, including factors
such as intrinsic kinase activity, and H2AX abundance, which would be
anticipated to impact the overall magnitude of response. Thus, prior
characterisation of cell lines would be beneficial for H2AX studies.
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Furthermore, in the case of TK6 and MCL-5 cells, it would appear that a
more pronounced H2AX response (i.e. in TK6 cells) and cell cycle
arrest, is preferential for cell survival, possibly by initiating the repair of
DSB.
Investigation of cells with DSB relevant phenotypes revealed increased
sensitivity of SKOV3 p53 mutated cells to the effects of MMS treatment.
Since the first line of cellular defence towards MMS is BER, which is
controlled by p53 (Offer et al., 2001) (Seo et al., 2002), and elevated
H2AX incidence was observed in SKOV3 cells, it was speculated that
DSB manifest upon collision of methyl-modified bases with the replication
fork, rather than SSB intermediates of BER (Pascucci et al., 2005). Here,
SKOV3 cells exhibited attenuated long-term survival, compared to p53
proficient cells, despite the expectation that p53-dependent apoptosis
would be absent. Thus p53 inactivity apparently sensitised SKOV3 to the
cytotoxic and DSB potential of MMS treatment, and it was postulated that
cell death, as the result of DSB accumulation, occurs via an alternative
pathway, such as p53 independent necrosis (Vakifahmetoglu et al.,
2007). Under conditions employed here, elevated H2AX was associated
with a reduction in long-term cell survival, in line with a previous report
(Banath and Olive, 2003).
8.6 Predicted Success and Application of a Novel FRET Based
Reporter of DSB
Within this thesis is described the creation of a human expression vector,
encoding a novel protein construct, hypothesised to generate a
measurable change in FRET upon DSB activation of the ATM signal
transduction pathway. Specifically the ATM phosphorylation consensus
encoded within the C-terminus of H2AX was connected to the phospho-
peptide binding domain of NBS1 via a flexible linker, and sandwiched
between FRET capable fluorescent proteins (cfp and yfp). ATM is well
established as the predominant transducer of DSB, of which H2AX is one
of the earliest and widespread of substrates to become phosphorylated
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(Rogakou et al., 1998), and NBS1 participates in a multitude of DSB
relevant multi-protein complexes (Bekker-Jensen et al., 2006). Thus the
FRET reporter designed and developed here was postulated to provide a
specific and universal marker of DSB induction. Recently published work
describes the validation of a transiently expressing reporter HeLa cell
line, which incorporates a mammalian ATM substrate domain (CHK2)
and the FHA domain of yeast rad53 protein, sandwiched between cfp and
yfp (Johnson et al., 2007) in a manner analogous to that employed here.
Based on physical similarities, the novel reporter constructs reported
herein, are predicted to have been devised with a high chance of
success, in terms of their ability to generate a quantifiable signal, in
response to ATM kinase mediated events. Thus the only concerns
envisaged, involve the verification of specificity of recombinant protein
interacting domains, and the feasibility of expanding this into an assay
suitable for high throughput analysis.
A stably expressing TK6 CNHY cell line was successfully created, and
preliminary studies have confirmed transcription and translation of CNHY,
by several analytical platforms. Due to time constraints however, a full
characterisation of CNHY behaviour, and demonstration of FRET
following DSB induction remains to be confirmed.
8.7 FAM-MB
8.7.1 Overcoming Initial Problems
Preliminary investigations with MB’s revealed a number of issues
associated with living cell models, such as treatment (MMS) related
effects on cellular replication, which caused MB dilution at the population
level. Additionally, a high background of FRET-MB fluorescence was
observed in control cells, which compromised signal: background noise
upon treatment with DSB inducing agents. This was speculated to be the
outcome of enzymatic hydrolysis of the FRET-MB DNA backbone, which
is supported by observations made in earlier reports (Abe and Kool,
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2006), and so raised concerns of false positive signals in living cells.
Consequently further pilot studies were conducted using a 2’-
O’methylated RNA backbone (which is predicted to confer enhanced
intracellular stability), FAM-modified variation of FRET-MB (designated
FAM-MB). As the consequence of cytotoxicity following transfection of
FAM-MB into living cells however, studies were performed in fixed cells.
Ideally, introduction of MB into living cells prior to treatment would enable
tracking of MB activation and intracellular movement in real time, using
live cell imaging or flow cytometry, although additional controls such as
cells containing scrambled, non-hybridising, MB would be necessary to
account for the interference of foreign oligonucleotide presence during
treatment. Presently an array of techniques proffer to introduce MB into
living cells, such as microinjection (Sokol et al., 1998) (Drake et al., 2005)
(Perlette and Tan, 2001), transient pore formation in biological
membranes by Streptolysin O peptide (Abe and Kool, 2006),
electroporation, and lipid-based transfection. Each method however,
exhibits limitations, for example electroporated cells require 24 - 48 h for
full cell recovery, and lipid-based transfection entails up to 24 h
incubation for optimal results, thus there is time for cell replication,
thereby diluting MB. Furthermore, external means of facilitating the
introduction of foreign material into cells, may potentiate the effects of
chemical exposure, by encouraging compound uptake for example.
Consequently, microinjection appears most suitable for MB studies,
however the procedures and the necessary equipment are not routine in
standard laboratories.
8.7.2 Validating FAM-MB Activity
During these investigations, FAM-MB fluorescence was consistently
elevated, in a dose-dependent manner, following MMS exposure,
regardless of cell type. Since MMS induced DSB are predicted to be
substrates for HR repair, the biochemical pathway to which RAD52
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contributes, and a connection between RAD52 mRNA levels and MMS
exposure was previously made (Smith et al., 2006), it was assumed that
FAM-MB activation equates to a RAD52 mRNA transcriptional up-
regulation event.
8.7.3 RAD52 Transcriptional Regulation: IR
Herein, the ability of A549 lung adenocarcinoma cells to respond
appropriately to DSB inducing stimulus was confirmed by IR treatment,
although a slightly attenuated response was noted relative to TK6 cells.
Similar to TK6 cells, the A549 cell line has found widespread application
in toxicology studies (Vock et al., 1998) (Zhu et al., 2005) (Zhu and
Gooderham, 2006), and reports of differentially expressed DNA repair
genes in response to DSB inducing agents in both cell lines rendered
them suitable models for investigating RAD52 mRNA up-regulation
events (Akerman et al., 2005) (Boesewetter et al., 2006)
Following IR treatment, FAM-MB produced a diffuse fluorescent signal
throughout the nucleus and cytoplasm of cells, indicative of elevated
RAD52 mRNA, at all doses between 0.1 and 5 Gy, as reported by flow
cytometric analysis, and confirmed by fluorescent microscopy. However,
discrete regions of fluorescence were noted in the nucleus of all human
cell lines investigated here, under control conditions, the frequency of
which increased in TK6 cells only, following IR. Significantly, various
distinct nuclear bodies have been described in association with
transcriptional events such as Caja bodies and ‘Speckle’ splicing factor
compartments (SFC) (Spector, 1993) and the average mammalian cell is
predicted to have at least 2000 transcription factories, which co-ordinate
transcription of nascent RNA and splicing of pre-mRNA (Beyer and
Osheim, 1988) (Wang et al., 1991) (Wei et al., 1999). It was hypothesised
here that foci of activated FAM-MB observed in unirradiated cells possibly
corresponds to regions of constitutively transcribed RAD52 mRNA,
awaiting export into the cytoplasm for translation. As such, the diffuse
fluorescence detected following IR is postulated to represent FAM-MB
activation upon hybridising RAD52 mRNA contained within SFC, which
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are characterised by their speckled nature throughout the nucleus
(Spector, 1993). Hence this would account for the homogeneous nature
of nuclear FAM-MB activation observed following DSB inducing
treatment. Furthermore, the cytoplasmic activation of FAM-MB reported
herein, particularly in close proximity of the nuclear perimeter is
consistent with the export of fully processed mRNA from the nucleus and
thus microscopy data apparently reaffirmed the assumption of FAM-MB
as a reporter of RAD52 mRNA, and more specifically, transcriptional
events may be inferred.
In accordance with data presented here, alterations in global gene
expression have been previously reported to a comparable magnitude
following IR of human lymphoblastoid cells, which includes a subset of
DNA repair associated genes (Akerman et al., 2005) (Ding et al., 2005)
(Lin et al., 2007) (Long et al., 2007). Strikingly however, investigations
performed by Zschenker, et al suggests that RAD51C, which aids RAD51
accumulation at repair centres, is the only DNA repair gene to undergo a
transcriptional up-regulation following IR (data obtained at 3 h following a
2 Gy exposure) (Zschenker et al., 2006). The contribution of RAD51C to
HR repair appears to exhibit a degree of functional redundancy with
RAD52 as described in Chapter 1, and so it is perhaps not surprising that
both genes would be transcriptionally regulated in response to DSB
inducing stimulus. It is conceivable that up-regulation of the RAD51C and
RAD52 genes would afford a high level of co-ordination of the HR
response, by tightly controlling the loading of RAD51 onto chromatin at
sites of DSB. FAM-MB data was supported here by qRT-PCR, which
revealed a small, yet significant induction of RAD52 mRNA (by 1.6-fold)
at 1 h post IR only. Possibly IR induced damage is repaired by
alternative pathways including BER and NHEJ, depending on the precise
nature of damage and cell cycle phase, thus accounting for the minor
induction of RAD52 mRNA. Indeed, recent work contributing to radiation
biology indicates that IR evokes a complex response in mammalian
cells, which fails to adhere to a linear dose or time response, possibly
due to the variety of DNA damage ensued (Lin et al., 2007) (Long et al.,
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2007) (Jin et al., 2008). Consequently a multitude of biochemical
pathways are apparently activated to provide a distinct response to IR
damage, depending on the dose received and time of analysis.
A similar trend for FAM-MB induction following IR was observed in
SKOV3 p53 mutated cells, compared with p53 proficient TK6 and A549
cells, implying that RAD52 mRNA abundance is elevated after IR, thus
suggesting that RAD52 does not depend on p53 for transcriptional
activation. The recently described role of tumour suppressor PTEN in the
regulation of RAD51 mRNA (Shen et al., 2007) raises the possibility that
RAD52 may also be regulated in a similar manner.
8.7.4 Relating mRNA Levels to Protein Abundance
Whilst the accumulation of RAD52 into RPA and RAD51 containing HR
related foci is well described (Park et al., 1996) (Rapp and Greulich,
2004) (Liu and Maizels, 2000) (Navadgi et al., 2006) this study failed to
indicate IR specific focus formation of RAD52, possibly the outcome of
dynamic, transient interactions of RAD52 with sites of damaged
chromatin (Essers et al., 2002) (Lisby et al., 2003). This was despite
previous reports of RAD52 accumulation into discrete foci at between 0.5
and 8 h after IR (Liu and Maizels, 2000) (Kitao and Yuan, 2002) (van
Veelen et al., 2005). One explanation for this apparent discrepancy may
be differences in the cell cycle distribution of populations employed in
each study, since HR is of greater significance during replication and
mitotically active stages than in resting cells (Rothkamm et al., 2003).
Alternatively, the application of different cell types, or differences in
specific experimental conditions (i.e. antibody used, and dilution) may
account for the absence of RAD52 accumulation into discrete foci
following IR.
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8.8 New Insights into Old Chemicals
8.8.1 Cryptolepine: An Overview
CLP exhibits a tendency for nuclear localisation, where it intercalates with
DNA, and stabilises DNA bound Topoisomerase II (Bonjean et al., 1998).
Thus it is reasonable to anticipate the generation of strand breaks, and
indeed clastogenicity has been previously demonstrated in rodent cells
(Ansah et al., 2005). Here, CLP treatment led to a significant dose-related
induction of FAM-MB, which appeared marginally attenuated at 10 µM
CLP, although in contrast the percent of H2AX positive cells was
diminished relative to control samples at doses up to 5 µM, and
significantly increased only after 10 µM exposure. It was speculated that
H2AX observed at high doses may be apoptosis related, a notion
supported by the cytotoxicity profile in TK6 cells, and that CLP, which
intercalates DNA, possibly masks the H2AX epitope, thus accounting for
a greater intensity of antibody staining in control populations. Immuno-
blotting, which entails protein disruption using a detergent, may help to
clarify this phenomenon. Additionally, microscopy analysis of fluorescent-
antibody stained H2AX would indicate whether fluorescence detected by
flow cytometry does indeed represent discrete DSB related foci, or rather
apoptotic associated genome fragmentation.
8.8.2 PhIP: DSB Formation: A Replication Related Phenomenon?
PhIP mediated genotoxicity presents primarily as DNA adducts, although
a low incidence of strand breaks was previously reported using the
COMET assay (Wolz et al., 2002). This is supported by investigations
conducted here, in which a trend for elevated DSB, confined to S phase
populations, was implied by anti-H2AX studies. Only a fraction of the
adducts produced during PhIP exposure (estimated to be approximately
0.5 adducts / 107 bp) (Yamashita et al., 1988), were speculated to
manifest as DSB upon collision with the replication fork, hence
accounting for the connection of DSB and replicating S phase cells and
the small magnitude of H2AX induction, relative to IR and MMS
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treatment. In this hypothesis, it is anticipated that the majority of adducts
would be successfully eliminated by mechanisms distinct from those
involved in HR, so providing an explanation for the lack of FAM-MB
activation. It is reasonable to postulate that transcriptional events would
be induced only above a certain damage threshold, to prevent
unnecessary consumption of cellular energy and resources, thus
providing one possible explanation for the discrepancy between H2AX
and RAD52 mRNA data. A further possibility to be explored is that of
intrinsic absorbance properties of the PhIP aromatic nucleus interfering
with FAM-MB signal, thus accounting for diminished fluorescence
following exposure, relative to control untreated samples. While the
parent compound, PhIP exhibits optimal absorbance at 315 nm, outside
the range of FAM fluorescence (Marsch et al., 1994), the active
metabolite may display different absorbance properties.
8.8.3 CLP and PhIP Summary
CLP and PhIP have both been previously shown to induce a
transcriptional response of cell cycle genes in human cells (Zhu et al.,
2005), and based upon observations made during H2AX and FAM-MB
studies we tentatively extend this observation to RAD52 in the case of
CLP although data surrounding PhIP remains inconclusive, for reasons
given above. Further investigation is envisaged to clarify the cellular
response to these compounds, confirm the induction of DSB in TK6 cells
(i.e. by MN analysis) and to elucidate the relationship, if any, between
H2AX formation and RAD52 mRNA regulation, possibly with additional
time points, for a more comprehensive overview. Despite the inconclusive
nature of data surrounding PhIP and CLP, work presented here highlights
some interesting points to pursue regarding the mode of toxicity.
8.9 Final Overview
To draw comparisons between diverse biological parameters, such as
transcriptional events, and MN and H2AX incidence, is a challenging
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task, not least due to fundamental disparities between analytical method
employed and the nature of the endpoint measured. As exemplified in
Chapters 2 and 3, a massive difference in the magnitude of H2AX
induction relative to control cells was observed between data obtained
using flow cytometric and fluorescence microscopy imaging platforms,
the consequence of differences in platform sensitivity. Here, the analysis
of MN incidence as a direct measure of clastogencity proved the most
sensitive approach for detecting DSB in TK6 cells following exposure to
irradiation, although H2AX studies proffer a method for rapidly detecting
DSB related events and facilitates the monitoring of DSB repair kinetics.
While seemingly preferential to the MN assay, which necessitates a full
round of DNA replication for the formation of micronuclei, high throughput
analysis of H2AX using flow cytometry is not without problems, such as
the necessity to distinguish between DSB per se and apoptotic events.
While this may be overcome by dual staining with propidium iodide or
fluorescent microscopy, this increases the complexity of analysis,
concurrently threatening the high throughput nature of analysis.
A further concern is the prevalence of in vitro mutagenicity assays
performed using fixed as opposed to living cells, and so the development
of a novel, constitutively expressed FRET capable reporter of damage
(CNHY) described here, aspires to abolish the requirement for cell
fixation. Although in the early stages of development, and necessitating
full characterisation to validate specificity and sensitivity of FRET,
creation of a CNHY stably expressing human cell line, takes steps
towards making DSB detection in real time, an attainable goal.
Finally, preliminary work employing a RAD52 mRNA specific molecular
beacon, of 2’-O-methylated RNA backbone, as a hypothetical marker of
DSB substrates of HR was described herein. While FAM-MB induction
appeared to provide a consistent marker of damage, in a dose-dependent
manner, further investigation is envisaged to determine with certainty the
nature of FAM-MB activation in relation to RAD52 mRNA content, such
216
as the use of inhibitors of transcription. Alternative applications for FAM-
MB would include the quantification of RAD52 mRNA in tumour samples,
with potential relevance to the clinical setting, since diminished amounts
of RAD52 transcript have been documented in relation with various
neoplastic states (Galamb et al., 2006) (Nowacka-Zawisza et al., 2006).
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Reagent Recipe
Weise buffer pH 6.4 1 tablet /L dH20
Phosphate buffered saline 1 tablet /200ml dH20
BSA (1 %) 1% BSA /ml PBS
Ethidium Bromide stock 10 mg EtBr powder /ml dH20
TBE (5 x) 54g Tris-base + 27.5g boric acid + 20ml EDTA
(0.5M pH8)/L in dH20
Agarose gel (1 %) 1g agarose + 5µl stock EtBr /100 ml TBE
EDTA (0.5 M pH 8) 18.6 g EDTA + 10 g NaOH /100 ml dH20
Methyl methane sulphonate 5 mg /ml 2 %DMSO
Acridine orange 100 mg acridine orange /L Weise buffer
4 % Paraformaldehyde 4 g PFA powder /100 ml PBS + NaOH
Stacking gel Tris 30 g, SDS 2 g, to 500 ml dH20 pH 6.8
Resolving gel Tris 91 g, SDS 2 g, to 500 ml dH20 p H8.8
SDS running buffer Tris 3.03 g, glycine 15 g, SDS 5 g to 1 L dH20
Transfer buffer (TB) 10 x Tris 30 g, glycine 140 g, to 1 L dH20
Transfer buffer 1 x 10 x TB100 ml, methanol 200 ml to 1 L dH20
Wash buffer Tween 500 µl/ L 1 x PBS
Blocking solution 5 g powdered milk/100ml wash buffer
APS 10 % ammonium persulphate
Sample cocktail buffer (SCB) 0.5 M Tris pH 6.8 1.8 ml, 10 % SDS 6 ml,
glycerol 3 ml, dH20 2.12 ml
Loading buffer DTT 1.39 g, 1 % bromophenol blue
Final loading solution SCB 325 µl, loading buffer 50 µl
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A Molecular Beacon Approach for Detecting DNA Double Strand Breaks
Lucy C Riches1, Anthony M Lynch2 and Nigel J Gooderham1
Biological Chemistry, Imperial College London, SW7 2AZ, UK1 and GlaxoSmithKline, Ware, Herts,
SG12 0DP, UK2 lucy.riches@imperial.ac.uk
The induction of DNA double strand breaks can result in chromosomal aberrations or gene mutations,
if incorrectly repaired. Identification of an early biomarker of DNA double strand breaks would be
very useful for mechanistic genotoxicity studies. Our previous work established a significant increase
in RAD52 mRNA following treatment of human cells with genotoxic agents (Smith et al., 2005).
Here we describe a dual labelled molecular beacon for the detection of double strand breaks in living
cells, based on RAD52 mRNA expression. Fluorescence resonance energy transfer (FRET) has been
exploited to achieve optimal separation of excitation/emission wavelengths employed for fluorescence
based studies.
A molecular beacon was designed by modifying a probe complimentary to RAD52 mRNA, with an
extension to promote self-hybridisation and stem formation. The probe region is flanked by two
adjacent fluorophores (FITC and TAMRA) separated by four thymidine bases, and a quencher
(dabcyl). Probe hybridisation with RAD52 mRNA is predicted to force the molecular beacon into the
linear conformation, and consequently relieve dabcyl imposed
quenching of FITC. Subsequent excitation of FITC results in
fluorescence emission by TAMRA. Using both cell-free and
cell-based systems, we have optimised the molecular beacon-
target interaction and established a positive fluorescent
response using microscopy, flow cytometry and fluorimetric
plate reader platforms. Following incubation with equimolar
quantities of synthetic RAD52 oligonucleotide in a cell free
assay, FRET is observed within 30min (Figure 1) and appears
to be maximal within 60 min. The limit of detection achieved
with 200nM molecular beacon lies between 10 and 20nM
complementary oligonucleotide (figure 1). In the presence of
target (ratio 1:1) and excess non-hybridising DNA (equivalent
to that of 10,000 cells), FRET is induced by up to 12-fold.
Figure 1: molecular beacon-FRET induction following incubation with complementary oligonucleotide
(n=3 ± SEM)
The molecular beacon approach has been used to detect RAD52 mRNA in living cells. We have
optimised molecular beacon transfection in human cells, confirmed stability and demonstrated a
response to double strand break inducing agents. These preliminary studies suggest that the RAD52
molecular beacon may be useful in understanding the dynamics of double strand breaks and provide
the opportunity to follow DNA damage in real-time.
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A Molecular Beacon to Detect Transcription of RAD52 in Response to DNA Double Strand
Breaks
Lucy C Riches1, Anthony M Lynch2 and Nigel J Gooderham1
Department of Biomolecular Medicine, Faculty of Medicine, Imperial College London SW7 2AZ1
Genetic Toxicology, GlaxoSmith Kline, Ware, Hertfordshire SG12 0DP
Lucy.riches@imperial.ac.uk
The induction of DNA double strand breaks (DSB) may result in chromosomal aberrations or gene
mutations, if incorrectly repaired. Identification of a marker, either of DSB formation, or subsequent
repair processes would contribute considerably to our understanding of the spatio-temporal kinetics
governing the cellular response to genotoxic insult.
RAD52 reportedly contributes to the repair of DSB in mammalian cells, through its role in
homologous recombination. Although the precise role and importance of RAD52 remains elusive,
transcriptional up-regulation has been demonstrated by micro-array analysis and qRT-PCR also1. We
previously presented a molecular beacon, which demonstrates specific and sensitive binding of human
RAD52 mRNA, in a cell free system, resulting in a significant increase in fluorescence2. We have
extended these observations to whole cells, and here we present data to support the role of RAD52 in
the cellular response to double strand breaks.
Our recent work has indicated a dose-dependant increase in molecular beacon fluorescence, following
exposure of human TK6 lymphoblastoid cells to gamma irradiation. Irradiated cells were fixed at 1 or
6h, and samples analysed either for H2AX phosphorylation status, or molecular beacon activation.
H2AX phosphorylation is commonly used as a marker of DSB, however the specificity has recently
been questioned, since phosphorylation demonstrates a degree of cell cycle dependance.
Microscopic analysis has revealed a significant increase in molecular beacon activation, detected as
discrete fluorescent foci, at 1h, which appears diminished by 6h at low dose (0.5 or 5Gy), yet
continues to increase at high dose (10Gy) (figure 1). This result indicates transcriptional activation of
RAD52 and engagement of the cell in homologous recombination repair.
We observed a delay in RAD52 mRNA transcription in cells exposed to high dose irradiation (10Gy),
however in contrast with cells receiving a lower dose, this response continued throughout the time
course of our experiment, suggestive of an inability of these cells to carry out DSB repair. Supporting
data confirmed the presence of DSB by staining for phosphorylated H2AX, and so we propose our
RAD52 mRNA specific molecular beacon as an appropriate method for detecting DSB in whole cells.
Figure 1) Analysis of Molecular Beacon
Activation in Response to DSB Formation
Irradiated TK6 cells were fixed and
incubated with molecular beacon for 1h.
Fluorescence was analysed by microscopy
and the number of discrete foci scored per
cell. The frequency of fluorescent foci is
presented here (200 cells per sample)
A substantial increase in fluorescence at 1h,
relative to unirradiated samples, is indicative
of increased levels of RAD52 mRNA.
N=3 +/-SEM; * P<0.01 **P<0.001
1Smith CC, Aylott MC, Fisher KJ, Lynch AM, Gooderham NJ. 2005 J Gene Med.
2Riches LC, Lynch AM, Gooderham NJ. 2006 Toxicology. 226, 59
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